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Abstract 
Mycobacterium tuberculosis is the leading cause of death from an infectious disease worldwide. 
An understanding of tuberculosis transmission dynamics in outbreak settings is vital for its 
control. The advent of affordable whole genome sequencing (WGS) has provided scope for 
superior resolution of tuberculosis outbreaks, compared to previous methods. However, the 
challenge lies in standardising the vast quantities of resulting data in a structured manner which 
lends itself to easy comparison of isolates. Gene-by-gene Multi-Locus Sequence Typing (MLST) 
methods of analysing WGS data, as opposed to Single Nucleotide Polymorphism (SNP) mapping, 
have shown promise in providing a uniform platform for outbreak resolution. 
WGS was performed on clinical isolates from three M. tuberculosis outbreaks in South West 
Wales. Molecular typing by MIRU-VNTR and epidemiological investigation had resulted in 
conflicting conclusions. Outbreak analysis and phylogenetic typing of all isolates was carried out 
using the WGS gene-by-gene MLST analysis method of core genome MLST (cgMLST) and 
traditional WGS SNP mapping. Where DNA quality was unsatisfactory, an ancient DNA library 
preparation was used successfully. Provean and BEAST software analysis provided physiological 
information and ancestral dating respectively on outbreak isolates. WGS successfully resolved 
all three outbreaks, with cgMLST providing clear conclusions across each outbreak. Traditional 
SNP mapping provided greater resolution than cgMLST in one outbreak. Ancestral dating also 
proved useful in understanding the outbreaks.  
Phylogenetically, the dataset was dominated by Euro-American lineage strains, providing the 
first snapshot of tuberculosis diversity within Wales. Provean analysis identified physiological 
features in isolates worthy of future research. 
In summary, WGS was successfully used to resolve three M. tuberculosis outbreaks across South 
West Wales and correlated better with the epidemiological data than molecular typing by MIRU-
VNTR had done. The study highlighted the dominance of the Euro-American lineage within the 
outbreaks and included the first use of ancient DNA library preparation in a clinical outbreak. 
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1.1: Mycobacteria 
Mycobacteria are a genus within the family Mycobacteriaceae and the order Actinomycetales 
(King et al., 2017, Ryan and Ray., 2004). They are aerobic, non-motile, non-spore forming and 
are rod shaped. Their size varies from 0.1 to 0.6 µm in width and 1.0 to 10 µm in length (Ryan 
and Ray., 2004). They grow at temperatures that range between 30 and 45oC, and the speed at 
which they grow also varies. Some take over 7 days to form visible colonies (slow growers),  while 
others do so more rapidly (rapid growers) when sub-cultured on Lowenstein-Jensen media (Ryan 
and Ray., 2004). 
Mycobacteria can be further divided into one of three major groups: Mycobacterium 
tuberculosis complex species (MTBC), non-tuberculosis mycobacterial (NTM) species and 
Mycobacterium leprae (Health, 2010, Ryan and Ray., 2004, Parish and Brown, 2009), the 
causative agent of leprosy (Young et al., 1985, Ryan and Ray, 2004). Human tuberculosis is a 
predominantly (though not exclusively) pulmonary disease caused by members of the MTBC 
(Ryan and Ray., 2004, Frothingham and Meeker-O'Connell., 1998, Van Soolingen et al., 1997), 
which contains eight established members capable of causing tuberculosis in humans or 
animals. The complex contains three human-specific members, M. tuberculosis, M. canetti and 
M. africanum as shown in Table 1.1 (Van Soolingen et al., 1997, Sharma et al., 2016, Niemann 
et al., 2004, Ryan and Ray., 2004). The rest infect animal hosts primarily but share the potential 
to infect humans (Ryan and Ray., 2004). The most prominent of these is M. bovis, which is the 
causative agent of bovine tuberculosis, a disease which is currently responsible for a large 
economic burden within the UK livestock industry, amounting £500 million in the last decade 
with the most recent report showing the annual cost rising to £34.1 million in 2013, as opposed 
to £28.6 million in 2008, paid in compensation across England alone (Grange., 2001, DEFRA., 
2013). M. bovis can infect humans, causing zoonotic tuberculosis (De la Rua-Domenech R., 
2006). Prior to the advent of milk pasteurisation and strict cattle culling programmes between 
1935 and 1950, M. bovis was endemic across the UK with reports showing around 2,500 
individuals were dying from the pathogen annually (De la Rua-Domenech R., 2006). 
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Table 1.1: The primary host of currently defined MTBC members and three further ill-defined 
ones of the complex which appear at the bottom of the table. The latter three have limited 
evidence of zoonotic transfer to humans (Van Ingen et al., 2012, World Organisation of Animal 
Health, 2016) 
 
Member Primary Host 
Mycobacterium tuberculosis Human 
Mycobacterium africanum Human 
Mycobacterium bovis Cattle 
Mycobacterium canetti Human 
Mycobacterium caprae Deer 
Mycobacterium mungi Mongoose 
Mycobacterium pinnipedi Pinnipeds (seals and sea lions) 
Mycobacterium microti Voles 
Mycobacterium suricattae Meerkats 
Dassie bacillus Rock hyrax 
Oryx bacillus Bovidae including Oryx, Gazelles and Deer 
 
Non-Tuberculosis Mycobacterium (NTMs) account for over 150 mycobacterial species and are 
ubiquitous in the natural environment, being present in soil, ground water, drinking water and 
even pasteurised milk and cheese, although the latter are rare events (Greenwood., 2012, Spahr 
and Schafroth., 2001). They are generally less pathogenic in humans. However, certain species 
including M. abcessus and M. kansassi can be pathogenic (Nguyen.,1997, Greenwood., 2012), 
especially in individuals who are immuno-compromised or those with concurrent pulmonary 
disease such as cystic fibrosis (Jeong et al., 2004, Nguyen., 1997, Greenwood., 2012). Clinical 
manifestations of disease caused by an NTM may be pulmonary but species do also cause skin, 
lymphatic, soft tissue and disseminated infections (Uslan et al., 2006, Greenwood., 2012). 
Although causing less of a disease burden than the MTBC species, numbers of NTM infections in 
immuno-compromised individuals, such as those suffering from AIDS and cystic fibrosis, is 
substantial (Greenwood., 2012). 
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Mycobacteria are characterised by having a cell wall that is thick, hydrophobic, waxy and 
contains long chain fatty acids, called mycolic acids (Barry et al., 1998). Each mycolic acid 
molecule contains between 60-90 carbon atoms but the exact number varies between 
mycobacterial species (Barry et al., 1998). The presence of mycolic acids contributes to the 
robustness of the mycobacteria, conferring increased resistance to chemical damage, 
dehydration, hydrophilic antibiotics and various biocides (Greenwood, 2012, Ryan and Ray, 
2004a).  
1.2.1: Mycobacterium tuberculosis  
Despite all members of MTBC having the ability to cause disease, M. tuberculosis is the one that 
represents the primary causative agent of tuberculosis in humans, especially in more developed 
countries such as the UK whereby M. tuberculosis accounts for over 98% of all tuberculosis cases 
(Brosch et al., 2002, Huard, R. C et al., 2003, Public Health England., 2017).  
M. bovis and M. africannum represent the two other MTBC agents that commonly cause 
tuberculosis, although their impact is largely restricted to areas of Africa and in reality are a 
significantly lesser burden in relation to the global epidemic of tuberculosis (WHO., 2016, WHO., 
2017, Public Health England., 2014, Public Health England., 2017). The number of human cases 
caused by M. bovis  varies by geographic region, with 10,000 of the 13,400 worldwide deaths 
from M. bovis in 2015 occurring on the African continent (World Organisation of Animal Health., 
2016). In more developed countries, M. bovis is not a prominent human pathogen, causing only 
0.9% of human tuberculosis cases in the UK in 2016 (Public Health England., 2016, World 
Organisation of Animal Health., 2016, WHO., 2016). The majority of M. africanum cases  are 
restricted to West African individuals and are thus not as prominent globally, causing around 
1.6% of all tuberculosis cases in 2015 (WHO., 2016) and only 1.4% of culture-confirmed ones in 
the UK as of 2014 (Public Health England., 2014). 
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1.2.2: M. tuberculosis lineages and strains 
M. tuberculosis strains can be categorised into 1 of 7 phylogenetic major lineages, based 
originally on large sequence polymorphism classification (Gagneux et al., 2006, Gagneux and 
Small., 2007) and subsequent WGS single nucleotide polymorphism (SNP) mapping (Comas et 
al., 2013, Reiling et al., 2013, Firdessa et al., 2013, Yimer et al., 2015).  
The 7 phylogenetic major lineages are split into phylogeographically related groups: Lineage 1 -
Indo-Oceanic, Lineage 2 -East-Asian, Lineage 3 -East African-Indian, Lineage 4 -Euro-American, 
Lineage 5-West Africa 1, Lineage 6-West Africa 2 and Lineage 7 -Horn of Africa (Gagneux and 
Small., 2007). Previous studies have shown that the different lineages (and sub-lineages within 
them) of M. tuberculosis have different clinical phenotypes with regards to transmissibility, drug 
resistance, host interaction, latency and vaccine efficacy (Reed et al., 2009, Reiling et al., 2013, 
Firdessa et al., 2013). Identifying which lineages are present within an area is important with 
regards to understanding the epidemiological background of tuberculosis in that area, especially 
with global human migration blurring the phylogeographic restrictions of the lineages. Lineages 
can be grouped into those that are evolutionarily modern and those that are ancient (Gagneux 
and Small., 2007). Lineages 1, 5 and 6 are thought to represent more ancient lineages that 
coexisted with humans prior to Neolithic expansion of anatomically modern Homo sapiens 
(Comas et al., 2013). Strains from these ancient lineages have been shown to initiate a greater 
immune response and are more likely to become latent than their modern relatives (Portevin et 
al., 2011). In contrast, the modern strains of Lineages 2, 3 and 4 appear to possess more virulent 
phenotypes with higher transmissibility, more readily causing active disease and propensity for 
drug resistance, and are more geographically dispersed (Sarkar et al., 2012, Gagneux., 2012). In 
particular, Lineage 2 (East Asian) and Lineage 4 (Euro-American) contain strains, such as the 
Beijing and Haarlem genotypes respectively, which are notorious for their association with 
tuberculosis outbreaks and are over-represented amongst drug resistant cases (Bifani et al., 
1996, Mardassi et al., 2005, Marais et al., 2006,).  
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The W/Beijing genotype is a strain found within Lineage 2, which has been regularly associated 
with large M. tuberculosis outbreaks (Thwaites et al., 2008, Bifani et al., 1996). In particular, the 
W/Beijing strains are known to have a higher propensity for acquisition of drug resistance genes, 
causing the development of multi-drug and extensively-drug resistant strains (Bifani et al., 1996, 
Thwaites et al., 2008). They have been shown to disseminate rapidly and cause more severe 
disease phenotypes. This was particularly evident in a large outbreak caused by the strain in 
New York in the 1990s (Bifani et al., 1996, Thwaites et al., 2008). The W/Beijing genotype has 
the ability to produce a unique phenolic glycolipid that attenuates the host’s immune response 
(Nicol et al., 2005). Meningeal tuberculosis caused by W/Beijing strains also has a more rapid 
progression, with shorter symptom duration when compared with meningeal infection caused 
by other lineage strains (Nicol et al., 2005). W/Beijing strain infections are associated with low 
levels of cerebro spinal fluid (CSF) leukocytes, which is an independent risk factor for death or 
severe disability from meningeal tuberculosis (Thwaites et al., 2008). 
The Haarlem genotype is found within Lineage 4 and has also been associated with large 
outbreaks of M. tuberculosis. This genotype accounts for 25% of tuberculosis cases in Europe, 
as well as central America and the Caribbean, where research suggests its presence may be 
correlated with post-Columbus European colonisation (Cubillos-Ruiz et al., 2010). Its significance 
is based on its global dissemination and its predominance in multi-drug resistant outbreaks 
(Mardassi et al., 2005, Marais et al., 2006, Khanipour et al., 2016). A  study in Tunisia showed 
Haarlem strains cause 22-fold more multi-drug resistant cases than non-Haarlem Euro-American 
strains (Mardassi et al., 2005). Haarlem genotype strains have been found to have an increased 
clonal expansion rate compared to non-Haarlem strains which, it has been postulated, allows 
them to spread quickly whilst also being multi-drug resistant (Mardassi et al., 2005, Tessema et 
al., 2013). 
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1.3: Tuberculosis in history 
Tuberculosis represents a disease that has plagued human kind throughout its recorded history 
for millennia. The earliest records of a tuberculosis-like disease were written in 2000-3000 BC in 
the Chinese Huang Ti Nei-Ching and the legal texts of Babylonian King Hammurabi (Herzog., 
1998, Bynum., 2012). A consumptive disease, characteristic of tuberculosis has also been 
described in other famous historical documents and figures such as the Ebers Paparus of ancient 
Egypt (circa 1500 BC) (Cave and Demonstrator., 1939), Homer’s Iliad (circa 800 BC), the 
documents of Hippocrates during Greek antiquity (410-400 BC) and reports by Aristotle (384-
322 BC) and Galen (174 AD) (Herzog., 1998, Frith., 2014). Anatomical evidence for tuberculosis 
cooperative history with hominids dates back as far as Homo erectus in the middle Pleistocene 
(circa 490,000 years BC) (Hershkovitz et al., 2008), with molecular diagnosis of tuberculosis being 
reported in skeletons of an early eastern Mediterranean settlement (9000 years BC) 
(Hershkovitz et al., 2008). However, it was not until 1679 that we see the appearance of the 
term ‘tubercles in phthisis’ when Sylvius de la Boë described phthisis of the lung as tubercular 
granulosa disease (Frith., 2014). The term consumption then became synonymous with the 
disease, being used as a lay term for phthisis between the 17th and 19th centuries, until 
tuberculosis was used by Johann Lukas Schönlein in 1839 (Frith., 2014). Tuberculosis became a 
major pandemic across Europe during the 18th and 19th centuries (Dormandy., 1999), killing a 
quarter of the total adult population, having a mortality rate of 1000 per 100,000 per year during 
those centuries (Daniel., 2006). The disease severely affected the European continent, causing 
1 in 6 deaths in France by 1918, and killing over 4 million people in England and Wales from 
1851-1910 (Segen., 1992 Daniel., 2006). During this era, the disease was commonly known as 
“the robber of youth” due to one third of those between 15-34 years old being killed by 
tuberculosis (Bynum., 2012). In 1882, Robert Koch provided the first major breakthrough in 
tuberculosis research. His work identified the tubercle bacilli as responsible for the disease 
(Frith., 2014). The confirmation of the causative agent then led to further key developments in 
28 
 
the diagnosis and treatment of tuberculosis, such as the Pirquet and Mantoux tuberculin skin 
tests in 1907; the Bacillus Calmette-Guérin vaccine in 1921; and eventually to Selman 
Waksman’s Streptomycin discovery in 1943, which represented the first successful antibiotic 
used to treat Tuberculosis (Frith., 2014). 
1.4: Current status of tuberculosis disease worldwide 
In 2016, tuberculosis killed more people globally than any other infectious agent and is currently 
the ninth leading cause of death worldwide (WHO., 2017). In 2016, tuberculosis disease caused 
the deaths of 1.3 million people worldwide and contributed to a further 400,000 deaths in co-
infected HIV patients (WHO., 2017). Around 10.4 million new cases were reported in 2016, with 
5.9 million men suffering from tuberculosis, followed by 3.5 million women and 1.4 million 
children (WHO., 2017). The current tuberculosis burden is larger than earlier thought, with 
around 4.9 million previously ‘missing’ cases being documented in 2015, the majority in the 
South East Asia region (World Health Organisation: Jim Yong Kim., 2017). Poor surveillance is to 
blame for these ‘missing cases’, with India reporting a 34% increase in disease notification after 
the private health sector was included in the national tuberculosis programme there in 2015 
(World Health Organisation: Jim Yong Kim., 2017). Countries such as Bangladesh, Myanmar and 
Indonesia also heavily under-report cases (World Health Organisation: Jim Yong Kim., 2017). Six 
countries account for around 60% of all new cases, namely India, China, Indonesia, Nigeria, 
South Africa and Pakistan (WHO., 2016).  Tuberculosis is still largely a disease of poverty, with 
Africa harbouring the most severe burden relative to its population, with 281 cases per 100,000 
people - double  the global average of 133 (WHO., 2015). Global progress is largely dependent 
on the prevention of tuberculosis within these countries (WHO., 2016).  
Europe represents the region with the lowest incidence of tuberculosis disease and much of this 
burden is borne by eastern European countries (European Centre for Disease Prevention and 
Control/WHO Regional Office for Europe., 2017). However, it is calculated that tuberculosis kills 
around 7 people every hour across the European Union with around  
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32,000 deaths and 323,000 cases per year (European Centre for Disease Prevention and 
Control/WHO Regional Office for Europe., 2017), equating to a rate of between 35.5 per 100,000 
individuals (European Centre for Disease Prevention and Control/WHO Regional Office for 
Europe., 2017). The UK reported an incidence of 9.4 cases per 100 000 population in its most 
recent national report (Public Health England., 2017). In addition, the rate of multi-drug 
resistance(MDR) is higher in European cases than elsewhere in the world (European Centre for 
Disease Prevention and Control/WHO Regional Office for Europe., 2017). The most recent 
reports have suggested that there is also an increase in the number of extensively drug resistant 
(XDR) cases across eastern European countries, potentially making up 1 in every 4 MDR cases 
there (WHO., 2017¸ European Centre for Disease Prevention and Control/WHO Regional Office 
for Europe., 2017). The financial burden tuberculosis imposes across the European Union now 
stands at an estimated €5.9 billion per annum (European Centre for Disease Prevention and 
Control/WHO Regional Office for Europe., 2017) and treatment of multi-drug resistant strains 
contributes heavily to this.  
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1.5: Tuberculosis in Wales 
During the industrial revolution, the onset of the major coal mining and steel industries, and into 
the early 20th century, tuberculosis was a major health issue in Wales. Statistics from the start 
of the 20th century show England and Wales to have an incidence of over 1000 in every 100,000 
individuals (Frith., 2014, Jackson et al., 2016), far greater than the rate in countries considered 
high-incidence today, such as South Africa (Frith, 2014, Jackson et al., 2016). However, M. 
tuberculosis infection was exacerbated by the living conditions during the industrialisation of 
the UK in the late 19th and early 20th centuries, which was a major contribution to the 
tuberculosis disease burden. M. bovis infections were also a major contributor to the 
tuberculosis burden in that time, with unpasteurised cow’s milk being a major source of the 
disease, causing 65,000 deaths between 1912 and 1937 (Wilson., 1943). In 1913, of all the 
counties in the UK, the five with the highest incidence of tuberculosis were in Wales (Michael., 
2008). Tuberculosis was so common in Wales that it was considered part of someone’s genetic 
profile and thought to be an inherited disorder (Michael., 2008). Today tuberculosis incidence 
in Wales is low, with around 116 to 200 cases per year over the past decade (Public Health 
England., 2014, Public Health Wales., 2014, Public Health Wales., 2016).  This correlates to an 
incidence of between 3.7-4.5 cases per 100,000 population (Public Health Wales., 2014, Public 
Health Wales., 2016), compared to 9.4 per 100 000 for the UK as a whole in the most recent UK-
wide report (Public Health England., 2017). Although the overall incidence of tuberculosis in 
Wales is lower than that seen in England and the UK as a whole, the overall UK rate masks major 
differences between regions as London has about 40% of all UK cases (Public Health England., 
2016).  In addition, in terms of deaths, the 2014 UK-wide report noted that Wales was the region 
with the highest proportion of deaths in drug-sensitive cases, at 11.7% (16 out of 137 cases in 
2012) (Public Health England., 2016). The incidence of tuberculosis in an area is often heavily 
affected by immigration from high TB-burden countries (Public Health England., 2016). In areas 
of high immigrant populations, the level of incidence of tuberculosis is higher than in areas with 
lower immigrant populations (Public Health England., 2016). The Public Health England 2016 
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tuberculosis report stated, that in England the rate of tuberculosis was 15 times higher in non-
UK born individuals, and in 2015 made up 73% of all cases in England (Public Health England., 
2016).  
In Wales, the structure of the NHS Trust responsible for health protection, Public Health Wales, 
links microbiology, public health and epidemiology into one organizational team, with an active 
tuberculosis programme group which meets regularly. Wales is uniquely placed to provide a 
model for other such programmes, with an ideal setting for studying the disease. The relatively 
stable population enables detailed analysis of links between cases, which is not possible with 
more transient populations and fractured services. Thus, it is possible to obtain very detailed 
epidemiological information about each case of tuberculosis. Despite the stable population and 
low incidence of tuberculosis, outbreaks still occur in Wales and since 2005; the number has 
risen in the South West region of Wales.  
1.5.1: Tuberculosis in Wales – Overview of demography.  
The incidence of tuberculosis is heavily affected by international immigration from countries 
with a high tuberculosis-burden (Public Health England., 2016). Wales has a relatively stable 
population, with international migration fluctuating between small net influxes and effluxes 
since the early 1990`s (Statistics Bulletin., 2013). In 2016, 50% of all tuberculosis cases in Wales 
occurred in people born outside the United Kingdom (UK), with UK born individuals accounting 
for 44% of reported cases and 6% of cases being of unknown birth place (Public Health Wales., 
2017). Thus, a substantially lower proportion of cases are born outside the UK than in England 
where the figure is 74% (Tuberculosis in England.,2017, Public Health England report., 2018).  
Most cases known to be born outside the UK originated from South Asia and Sub-Saharan Africa 
(Public Health Wales., 2017). A total of 80 cases were culture-confirmed in 2016, and of these 
78 were due to infection by M.tuberculosis, one was caused by M. bovis and one by M. 
africanum. Two cases (2.5%) of MDR-TB were reported among culture-confirmed cases in 2016, 
higher than the English proportion of 1.5% phenotypically tested and confirmed MDR-TB in the 
same year, although the Welsh numbers are small, meaning proportions should be interpreted 
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with caution (Public Health Wales., 2017).  The rate of any resistance to one or more first line 
drug was 5% - again absolute numbers are small. No extensively drug resistant cases were 
reported in Wales in 2016 (Public Health Wales., 2017).   
Within Wales, the highest rates of tuberculosis are found in the South-east, in Cardiff and 
Newport, which have incidence rates of tuberculosis of 15.4 per 100,000 population and 6.6 per 
100,000 population respectively (Public Health Wales., 2017), see Figure 1.1. Tuberculosis 
incidence within Wales also correlates with poverty, as would be expected. The rate of 
tuberculosis in those living in the most deprived fifth Wales was 7.0 per 100,000 population, 
whilst in the wealthiest fifth of the country there was a rate of only 1.1 per 100,000 population 
(Public Health Wales., 2017). Like the rest of the United Kingdom, tuberculosis in Wales is 
associated with social risk factors such as drug abuse, alcohol abuse, homelessness or 
imprisonment with these risk factors having more of an impact on the tuberculosis demographic 
in Wales than is seen in England. Around 14% of all cases in 2016 reported at least one risk 
factor, higher than the figure for England (11.1% of cases) (Public Health Wales., 2017, Public 
Health England., 2017). Seven percent of all cases reported a history of or current drug abuse, 
4% reported a history of or current abuse of alcohol, 7% were reported in the homeless 
population and 9% had a history of or were currently in prison (Public Health Wales., 2017). The 
Welsh cohort had increased proportion of cases with the social risk factors of drug abuse, 
homelessness and imprisonment in comparison with England, where these social risk factors 
accounted for 4.2%, 4.5% and 4% respectively.  
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Figure 1.1: A Geographical map extracted from the Public Health Wales Annual tuberculosis 
report for 2016 (Public Health Wales., 2017). The map is split up into the different counties of 
Wales and the key depicts the colours relevant to the rate of tuberculosis per 100,000 
individuals.   
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1.6: Pathogenesis of tuberculosis 
M. tuberculosis is transmitted to individuals through inhalation of droplet nuclei. Following 
inhalation these lodge within the terminal air spaces of the lung (Glickman and Jacobs., 2001), 
allowing them to be ingested by alveolar macrophages (Glickman and Jacobs., 2001). Following 
ingestion into macrophages, the tubercle bacilli may either be destroyed by the host’s immune 
system or survive and replicate within the alveolar macrophages. This will lead to an active 
infection or a latent state as a consequence of the activity of the host’s immune system 
(Glickman and Jacobs. 2001). Only around 5-10% of individuals progress to active disease state 
following initial infection. The remaining 90-95% harbour the infection in a latent state (Asante-
Poku et al., 2015). Only around 10% of individuals carrying the latent form of tuberculosis 
infection will go on to develop active disease (Flynn and Chan., 2001). However, in immuno-
compromised individuals, such as those co-infected with HIV, the likelihood of progression to 
active disease is greater (Flynn and Chan, 2001). It is thought that a third of the world’s 
population carry the latent form of the disease, which acts as a major reservoir supporting the 
disease`s continuous presence, making eradication difficult (Flynn and Chan, 2001). 
1.7: Treatment of tuberculosis  
The first treatments for tuberculosis were based on surgical methods such as artificial 
pneumothorax and plombage, both of which involved the physical collapse of the infected area 
of the lung (Kendall., 1915). The discovery of streptomycin in 1943 caused surgical procedures 
to become less used and was the dawn of the anti-tuberculosis drug era (Thomas E Herchline., 
2017). Currently, the empiric treatment for tuberculosis recommended by the World Health 
Organisation involves the prescription of 4 first-line drugs: isoniazid, rifampicin, pyrazinamide 
and either streptomycin or ethambutol (Thomas E Herchline, 2017., WHO 2010., WHO 2017., 
Milburn et al., 2010). The recommended treatment period for drug susceptible tuberculosis is 6 
months. For the last four months,  rifampicin and isoniazid can be used alone if the strain is 
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completely susceptible (Thomas E Herchline., 2017., WHO 2017). Treatment of drug-resistant 
strains is much more complex, toxic and expensive and is outside the scope of this thesis.  
1.7.1: Tuberculosis Vaccination 
A vaccine for M. tuberculosis, named the Bacillus Calmette–Guérin (BCG) vaccine, has existed in 
medical practice since 1921, has been rolled out as part of the WHO’s Expanded Programme on 
Immunization (EPI) since 1974 and is the sole vaccine available to prevent tuberculosis. The 
vaccine is a live-attenuated M. bovis strain which has lost its ability to confer disease in humans 
but still confers immunity to M. tuberculosis albeit with varying efficacy across different 
populations. The BCG vaccine has proven successful in preventing TB meningitis in children, 
having an efficacy of 70-80% of preventing the disease (Colditz et al., 1994, Rodrigues et al., 20                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
11). However, the efficacy of the vaccine for preventing adult pulmonary tuberculosis ranges 
between 0-80% (Colditz et al., 1994, Rodrigues et al., 20                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
11). Within the UK its efficacy is estimated to be between 60-80% in protecting against 
pulmonary tuberculosis disease (Colditz et al., 1994). In countries closer to the equator the 
efficacy of the BCG vaccine has been reported as 0% (Rodrigues et al., 2011). Due to its variable 
effect in preventing adult pulmonary disease, efforts have been made to develop novel vaccines. 
However, as of 2018 no such breakthroughs have been made. The need to develop new 
tuberculosis vaccines has been reported by the WHO as an essential part of the end TB strategy 
(WHO, 2017).  
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1.8: Control measures and strain typing 
The spread of multi-drug resistant and extensively drug resistant strains, along with the lack of 
novel vaccines and anti-tuberculosis drugs means prevention through the application of 
successful control programmes is critical to public health globally. Early diagnosis and 
epidemiological investigation through systematic screening of contact and high-risk groups has 
become one of the key pillars of the end-tuberculosis strategy developed by the World Health 
Organisation, which aims to end the global tuberculosis epidemic by 2050 (WHO., 2015).  
1.8.1: Tuberculosis control  
The strategy for tuberculosis control in the community is based primarily on passive and active 
case-finding, contact tracing and molecular strain typing techniques. The contribution of both 
traditional contact tracing and molecular strain typing allows epidemiological investigations to 
identify the most appropriate control programmes. Passive case-finding relies on infected 
individuals noticing symptoms of disease and report themselves to local practitioners, meaning 
they will not be documented until they are already symptomatically ill (Zachariah, R et al ., 2003, 
Den Boon, S et al ., 2008). In contrast, active case-finding involves healthcare workers actively 
searching for cases to get patients treated as quickly as possible. However, active case-finding is 
more expensive and requires skilled healthcare workers and infrastructure, features that are 
barriers in developing countries (Zachariah, R et al ., 2003, Den Boon, S et al ., 2008). In the UK, 
both passive and active case-finding are practiced. The use of mobile radiography units 
successfully led to a decrease in the incidence of tuberculosis in the UK between 1940-1960 
(Levitt., 2003, Watson et al., 2007) and the units are still useful to target hard-to-reach 
populations such as the homeless (Story et al., 2012, Watson et al., 2007). Pre-entry screening 
of migrants from  countries with a  high incidence of tuberculosis (> 40 cases per 100,000 
population) was credited for a decrease in active pulmonary tuberculosis among non-UK born 
individuals (Public Health England, 2014), and is a recently used form of active case-finding.  
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1.8.2: Strain typing 
For effective control measures, not only within an outbreak, accurate strain typing is vital (Small 
et al., 1993), and is important both in mycobacterial research and clinical practice (van Embden 
et al., 1993). In research, strain typing provides information which elucidates the evolution, 
diversity and phylogenetic features of different M. tuberculosis strains (van Embden et al., 1993). 
In clinical practice it is important in epidemiological investigations as it provides accurate 
information on the extent and nature of the outbreak,  and for applying the most suitable control 
measures (Crampin et al., 2010, Witney et al., 2016). Clinically it is also important for detecting 
laboratory cross-contamination events, which occur occasionally in laboratories handling 
isolates of M. tuberculosis, and for distinguishing re-infection from a relapse of a previous TB 
infection (Crampin et al., 2010, Small et al., 1993). 
Strain typing can be achieved through several different techniques. Early approaches used 
phenotypic typing such as phage typing and drug susceptibility profiling (Schürch and van 
Soolingen, 2012, Schuitemaker, 1968). These methods were low in discriminatory power 
although useful in the days before molecular methods were available (Schuitemaker, 1968). 
Phage typing is still reported to be useful in detecting laboratory cross-contamination (Schürch 
and van Soolingen, 2012). The advent of molecular strain typing techniques such as spacer 
oligonucleotide typing (spoligotyping), IS6110 Restriction fragment length polymorphism typing 
(IS6110 RFLP) and Mycobacterial Interspersed Repetitive Unit Variable Number Tandem Repeat 
typing (MIRU-VNTR) greatly increased the discrimination of strain typing and substantially 
increased the success of control programmes due to increased accuracy of outbreak 
investigations (Table 1.2); (Schürch and van Soolingen., 2012, Small et al., 1993). 
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Table 1.2: List of the established M. tuberculosis typing methods, with corresponding 
comments relating to the features, advantages and disadvantages of each method.  
Typing method Comments 
Spoligotyping Older method which has been modernised. Still useful as a 
secondary discrimination method to be used with other 
methods such as MIRU-VNTR for strain confirmation.  
Reproducible, rapid and allows significant phylogenetic and 
evolutionary data to be gleaned digitally which MIRU-VNTR 
and RFLP do not.  
IS6110 RFLP A Very high discrimination level, has long been described as 
the gold standard for tuberculosis strain typing. Slow, 
laborious, difficult to modernise and share results between 
independent labs accurately. Could be becoming redundant. 
MIRU-VNTR Far more rapid than IS6110 as it is PCR-based and can be 
done directly on the sample. More effective in rapidly acting 
on outbreaks. Using 16-24 loci MIRU-VNTR discrimination 
equals RFLP. Better discrimination than RFLP in strains with 
low IS6110 copy numbers. 
WGS Provides the highest possible level of resolution. Provides 
evolutionary information and data which cannot be achieved 
by other methods. More phylogenetic power and more 
discriminatory than all other methods. Currently difficult to 
standardize. 
 
1.8.3: Spoligotyping 
Established in the 1990s, spoligotyping is a PCR-based reverse-hybridisation blotting method, 
for genotyping strains of M. tuberculosis (Kamerbeek et al., 1997, March et al., 1996). It allows 
rapid amplification and analysis of strain-dependant polymorphisms found in the spacer regions 
of a direct repeat locus (DR-locus) contained in the MTBC genome. Spoligotyping has been used 
to assay the genetic diversity of this locus for use in the clinical laboratory, evolutionary and 
population genetics (Brudey et al., 2006).  Because it is PCR-based and requires few copy 
numbers, spoligotyping allows for simultaneous detection and strain typing of M. tuberculosis 
from a clinical sample containing the bacterium within one day (Augustynowicz-Kopec et al., 
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2007). The main advantages over the other methods listed in Table 1.2, are its speed and its 
easily presented results in a digital format that can then be used to create a database (Brudey 
et al., 2006), thus making communication between independent laboratories practical. In 
addition, spoligotyping is well-established in assigning individual M. tuberculosis strains to 
phylogeographic clades that are submitted to globally accessible databases such as SpolDB4 
(Brudey et al., 2006). The DR locus is phylogenetically informative and spoligotyping can 
distinguish between lineages and sub-lineages within the M. tuberculosis genome (Abadia et al., 
2011, Filliol et al., 2006). However, in comparison to other molecular typing procedures, 
spoligotyping has a lower resolution and underestimates the clonal diversity of M. tuberculosis 
when used alone (Augustynowicz-Kopec et al., 2007).  
Despite being deemed unreliable when used as a single molecular typing tool, studies have 
highlighted that traditional spoligotyping can be used to support the primary typing methods 
such as IS6110 RFLP and MIRU-VNTR. Most recently, spoligotyping has been incorporated into 
the use of data gleaned from WGS of M. tuberculosis strains. Spoligotype patterns can now be 
identified in silico, meaning spoligotype data can be obtained from sequence data following 
WGS, thus done at no extra cost allowing them to be grouped rapidly into phylogenetically 
informative spoligotype clades without the need to carry out a separate procedure (Xia et al., 
2016). 
1.8.4: IS6110 RFLP 
IS6110 restriction fragment length polymorphism (RFLP) is a genotyping technique, which has 
long been regarded as the gold standard for M. tuberculosis complex genotyping, because it has 
been the method with the highest discriminatory power (Christianson et al., 2010). IS6110 is an 
insertion sequence in the M. tuberculosis chromosome belonging to the IS3 insertion sequence 
family of Enterobacter and is present in all MTBC species but not in the more distantly related 
mycobacteria (Thierry, D et al, 1990). This insertion element can range in copy number between 
strains from zero up to 25 copies. They vary in their sites of insertion, and this feature is essential 
in the ability of the method to discriminate between strains of  
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M. tuberculosis. RFLP involves digesting these insertion elements using restriction enzymes and 
visualising the resulting fragments by probe hybridisation. The pattern of fragments defines the 
different strains (Park et al., 2000). IS6110 RFLP is highly discriminatory and, as stated, is the 
gold standard in differentiating strains, such as in outbreak investigations. However, the use of 
IS6110 in phylogenetic and evolutionary studies is somewhat limited, because the insertion 
elements are restricted to two thirds of the genome around the DR locus. Also, within the 
genome there are IS6110 hotspots in the DR and the ipl loci. These factors have led some authors 
to question the method`s utility as a reliable marker for population genetics and phylogenetics 
studies of M. tuberculosis (Fang et al., 1998). 
IS6110 RFLP has other important limitations.  It is labour intensive, time consuming and more 
expensive than a PCR based method such as spoligotyping (Christianson et al., 2010). It is also a 
gel-based method and, as such, is susceptible to interpretive errors (Christianson et al., 2010). 
There is no PCR amplification step and thus it requires prior culture to provide sufficient biomass 
to get enough DNA for testing (Christianson et al., 2010). This makes it a slow process and a 
more rapid PCR-based method has often been used initially, using IS6110 RFLP as a confirmatory 
test (Ruddy et al., 2004). There is also the problem of comparing IS6110 patterns between 
independent labs or even ones that are separated in time due to differing experimental 
conditions, operator interpretation of the result, and also changes in the software used to 
analyse the patterns (Das et al., 2005). Therefore, despite its discriminatory ability, the results 
are not as easy to use, as the digitalised ones obtained from spoligotyping and MIRU-VNTR, 
which allow for continuously updated data to be distributed as standards. Thus as discriminatory 
as it is, this method is not the answer to rapid response to control outbreaks; rather its power is 
in providing confirmation of strain types (Das et al., 2005). 
1.8.5: VNTR and MIRU-VNTR 
Variable Number of Tandem Repeat (VNTR) typing is a PCR-based technique (Supply et al., 2006, 
Supply et al., 1997) which was originally devised as an epidemiological typing method by 
Frothingham and Meeker-O`Connell in 1998, and involved exact tandem repeat sequences 
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(ETRs) (Supply et al., 2006) located at five different chromosomal loci: ETR-A, ETR-B, ETR-C, ETR-
D, ETR-E and ETR-F (Frothingham and Meeker-O'Connell, 1998, Supply et al., 2006). These loci 
show substantial length polymorphism ranging from 53-79 base pairs and differ in the regions 
of DNA they reside in (Supply et al., 2006). The genotype of an isolate is represented by a five-
digit allele profile specifying the number of repeat elements at each of these loci. The allele 
profile is determined by the size of the amplified products. The variations within these 
sequences can affect expression of certain genes within strains providing further features 
unique to that strain (Frothingham and Meeker-O'Connell, 1998b). Loci used in VNTR strain 
typing may also be Major Polymorphic Tandem Repeat (MPTR) ones, which are different from 
ETRs as they are found in multiple genomic clusters and are imperfectly repeated units. ETRs are 
found at a unique locus and have a unique spacer sequence (Hermans et al., 1992), whilst the 
MPTR loci consist of 15 base-pair repeats with a single consensus sequence. However, there is 
significant sequence variability between the adjacent repeats making them useful as markers to 
determine both species and strains within the M. tuberculosis complex.  
1.8.6: MIRU-VNTR  
Since the release of the whole genome sequence of the H37Rv strain of M. tuberculosis, 41 
MIRU-VNTR loci have been identified, consisting of both ETRs and MPTRs.  These together are 
referred to as Mycobacterial Interspersed Repetitive Units (MIRUs), now known as MIRU-VNTR 
(Supply et al., 2006). The MIRU sequences contain between 40 - 100 base-pairs and are scattered 
randomly throughout the chromosome of the M. tuberculosis genome (Supply et al., 2006). 
MIRU-VNTR is a PCR based method which amplifies the repeated sequences of the MIRU-VNTR 
defined loci. The size of the PCR product correlates with the number of repeats present,  and 
the pattern of these results allows a numerical genotype to be assigned for each isolate (Van 
Soolingen et al., 2001). An original set of 12 MIRU-VNTR loci, representing 12 mini-satellite-like 
regions of the M. tuberculosis chromosome, was described in a 2001 study by Mazars et al and 
provided a level of resolution similar to that of the established IS6110 RFLP typing (Mazars et 
al., 2001). The original 12 loci proposed were then expanded to 15 and have now been further 
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supplemented to a 24-locus test, with a discriminatory power comparable to that of IS6110 
(Supply et al., 2006, Christianson et al., 2010). Due to it being PCR-based, the MIRU-VNTR 
method is rapid and although not quite as discriminatory, the application of 15 and 24 loci MIRU-
VNTR typing in conjunction with supporting spoligotyping data has shown discrimination close 
to that of IS6110 RFLP (Christianson et al., 2010, Jonsson et al., 2014). In fact, MIRU-VNTR may 
have higher discrimination when the IS6110 copies within a given isolate are below 6 (Jonsson 
et al., 2014). The MIRU-VNTR method allows easy construction of a digital global database 
allowing for efficient epidemiological studies of tuberculosis worldwide, with the MIRU-VNTR 
plus online database being a widely-used platform (Weniger et al., 2010). MIRU-VNTR digitalised 
platforms have been adopted in combination with digitalised spoligotyping data, providing an 
international basis for large-scale genotyping at a high-throughput and globally accessible level 
(Weniger et al., 2010). For these reasons MIRU-VNTR replaced IS6110 in the first decade of this 
century as the international standard for M. tuberculosis molecular typing, with IS6110 reserved 
as a confirmatory procedure. Thus, MIRU-VNTR allows large scale global surveillance and large-
population based analysis due to its speed, simplicity and ease of comparison between 
laboratories worldwide. 
1.8.7: Limitations of MIRU-VNTR typing 
Various studies have highlighted the shortcomings of MIRU-VNTR typing in resolving outbreaks 
and sometimes contradicted contact tracing data (Gardy et al., 2011, Walker et al., 2013a, 
Walker et al., 2013b,  Kohl et al., 2014, Walker et al., 2015, Takiff and Feo., 2015, Witney et al., 
2016). MIRU-VNTR typing does not account for the heterogeneity of isolates included within the 
same outbreak that is caused by microevolution (Walker et al., 2013). A previous study 
highlighted that M. tuberculosis can harbour a level of within-host heterogeneity that rivals the 
variation seen between patients within a given outbreak (Pérez-Lago et al., 2013). This 
heterogeneity is caused by the microevolution of the mycobacteria within the host over time 
(Pérez-Lago et al., 2011, Pérez-Lago et al., 2013). MIRU-VNTR, along with IS6110 and 
spoligotyping, is unable to account for this microevolution and thus provides inaccuracies when 
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used to trace the route of transmission within an outbreak, or determining whether isolates are 
part of an outbreak, when they may harbour minor differences (Takiff and Feo, 2015). In 
addition, MIRU-VNTR does not have the ability to identify super-spreaders within an outbreak. 
Super-spreaders are cases within an outbreak that can disproportionally infect secondary cases. 
The presence of super-spreaders presents public health challenges and may dramatically affect 
control programmes related to the outbreak (Stein, 2011). The identification of super-spreaders 
in other diseases has shown to be beneficial in reducing the number of future cases through 
halting transmission from the super-spreader (Stein, 2011). The use of MIRU-VNTR typing also 
provides no information for the identification of the source case of outbreaks. Key information 
such as potential super-spreaders and source cases are dependent on contact tracing 
investigation with no molecular typing support. 
1.9: Whole Genome Sequencing  
The advent of high-throughput and affordable WGS, whereby the complete DNA of an organism 
is sequenced and analysed, presents an opportunity to provide the ultimate level of molecular 
resolution to infectious disease outbreaks (Le and Diep, 2013). Through WGS it is possible to 
identify genetic markers, referred to as single nucleotide polymorphisms (SNPs), that can be 
used to distinguish two separate isolates from each other, with the number of polymorphisms 
indicating how distantly related to each other given isolates are. Certain SNPs are as associated 
with, drug resistance, increased transmissibility and immune evasion, thus have the potential to 
be used as markers to aid treatment optimisation and the understanding of an outbreak’s 
physiology (Takiff and Feo., 2015, Walker et al 2015). Through analysis of drug resistance-
associated SNPs within certain pathogens it has been possible to develop assays to aid treatment 
programmes. An example is the GeneXpert© diagnostic assay for identifying rifampicin 
resistance in M. tuberculosis (Rie et al., 2010). The test allows identification of M. tuberculosis 
and the presence of rifampicin resistance within 90 minutes  (Rie et al., 2010).  
Through sequencing the genome of organisms within an outbreak, it is possible to understand 
the relationship between the isolates using these SNPs as genetic markers (Takiff and Feo, 2015). 
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Previous studies have highlighted that, when used in conjunction with traditional 
epidemiological investigation, WGS allows elucidation of transmission dynamics, identification 
of super-spreaders and source cases in outbreaks with various pathogens. Examples include 
outbreaks of Escherichia coli and Vibrio cholerae (Rohde et al., 2011, Chin et al., 2011). WGS also 
provided the first conclusive evidence for person-to-person transmission of M. abscessus, as the 
study showed that two separate outbreaks were caused by the same resistant clone transmitted 
between cystic fibrosis sufferers (Le and Diep, 2013).  
1.9.1: Whole Genome Sequencing of M. tuberculosis 
The commonly used laboratory strain H37Rv was the first MTBC genome to be sequenced 
completely and published in 1998 (Cole et al., 1998). This was a milestone in tuberculosis 
research that provided unprecedented information on the biology, metabolism and evolution of 
the pathogen. The sequencing of this first strain paved the way for the extensive search for SNPs 
within the genomes of all MTBC strains. 
1.9.2: Genome plasticity 
Sequencing revealed that the M. tuberculosis genome was 4.6 million base pairs in size, has 
around 4000 genes and has a high G+C content which is consistent across the genome (Cole et 
al., 1998). The genome encompasses a circular chromosome, whereby >90% of the genomes 
coding capacity is used (Cole et al., 1998). M. tuberculosis is rich in repetitive DNA especially 
insertion sequences, duplicated housekeeping genes and polymorphic multi-gene families (Cole 
et al., 1998). Initial comparative sequencing studies demonstrated that the sequence diversity 
of M. tuberculosis is much lower than that seen for many other bacteria such as the 
Streptococcus pneumoniae PMEN1 or E. coli O157:H7 strains (Musser et al., 2000, Mellman, et 
al., 2011, Koser et al., 2011). Population genetic studies have shown that M. tuberculosis has a 
highly clonal population structure (Hirsh et al., 2004, Supply et al., 2003, Feil and Spratt, 2001). 
WGS of other MTBC members revealed that MTBC is highly conserved with only 2,437 SNPs 
separating M. tuberculosis strain H37Rv from the M. bovis strain AF2122/97. Horizontal gene 
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transfer has not been documented in M. tuberculosis, which again contributes to its low genomic 
diversity as a species (Gagneux and Small, 2007). Genome plasticity is also relevant to acquisition 
of drug resistance within M. tuberculosis strains as unlike some other pathogenic bacteria; M. 
tuberculosis does not contain plasmids, which often confer resistance in Gram negative 
organisms (Trauner et al., 2014). Rather, the evolution of resistant strains is driven by sequential 
acquisition and accumulation of random point mutations on the chromosome directly (Trauner 
et al., 2014) which are subject to selection pressure in the presence of anti-tuberculous 
chemotherapy.  
 The monomorphic nature of M. tuberculosis populations means standard multi-locus 
sequencing of housekeeping genes has no value in providing useful discrimination of strains 
within an outbreak (Jolley and Maiden, 2010). Thus, IS6110 RFLP, spoligotyping and MIRU-VNTR 
which exploit polymorphic regions within the genome, have been preferred to assess strain 
diversity. However, further analysis has shown that sequence diversity does exist within M. 
tuberculosis and has highlighted the utility of large sequence polymorphisms (LSP) as well as 
SNPs for stable genetic markers in strain typing (Gagneux and Small., 2007).  
1.9.3: WGS for M. tuberculosis outbreak resolution 
Multiple studies have shown that WGS provides a level of outbreak resolution above and beyond 
that provided by other molecular typing methods, such as MIRU-VNTR (Comas et al., 2009, 
Gardy et al., 2011, Kohl et al., 2014, Walker et al., 2013a, Walker et al., 2013b, Witney et al., 
2016). Studies have confirmed, through novel WGS (Walker et al., 2013b, Pérez-Lago et al., 
2013), that intra-patient micro-evolution can affect the validity of both IS6110 and MIRU-VNTR 
(Al-Hajoj et al., 2010), and impact on the detection of transmission events within an outbreak 
(Pérez-Lago et al., 2011, Walker et al., 2013b). The use of WGS for outbreak resolution accounts 
for micro-evolution and allows the tracing of SNPs within an outbreak (Witney et al., 2016). 
When used with epidemiological data, WGS allows for the identification and confirmation of 
previously suspected super-spreaders. As M. tuberculosis reproduces by binary fission, if a 
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super-spreader is present then WGS data produces a star-like phylogenetic topology (Walker et 
al., 2013b).  
1.9.4: Limitations of traditional WGS methods 
Parallel WGS of multiple bacterial genomes now provides the ability to produce 
epidemiologically useful data at a relatively low cost (Jolley and Maiden, 2010).  Many previous 
studies are based on WGS SNP mapping of multiple isolates, using often in-house un-
standardised pipelines (Walker et al., 2013b, Gardy et al., 2011). The portability and 
standardisation of WGS SNP mapping analysis is one of the main barriers to its widespread use. 
However, within tuberculosis research, the results of these SNP mapping based studies have 
allowed for the estimation of a stable mutation rate for M. tuberculosis, and led to the 
development of a 12 SNP threshold for isolate separation (Walker et al., 2013b). In other words, 
it is considered that differences exceeding 12 SNPs between isolates, indicates that they are not 
directly related. SNP mapping parameters have led to the development of online databases, 
such as the Centre for Genomic Epidemiology (Kaas et al., 2014) which provides an openly 
accessible and standardised pipeline for SNP mapping of selected isolates (Kaas et al., 2014). 
However, SNP mapping is still hampered by the need for a high-quality reference sequence and 
complete sequence data. It cannot be used with partial sequence data, which is often outputted 
using current sequencing platforms (Sheppard et al., 2012, Maiden et al., 2013).  
1.9.5: Application of gene-by-gene WGS multi-locus sequence types (MLST) 
WGS provides vast quantities of data which are difficult to standardise (Maiden et al., 2013, 
Sheppard et al., 2012, Jolley and Maiden, 2010). Gene-by-gene WGS MLST methods have 
attempted recently to provide a standardised, globally relevant and accessible databases for the 
application of WGS data to outbreak resolution and tuberculosis phylogeny (Jolley and Maiden, 
2010, Junemann et al., 2013). The use of a gene-by-gene MLST method allows the comparison 
of assembled genomes from multiple isolates without the need for a high-quality reference 
genome. Gene-by-gene MLST uses alleles at selected genes as the unit of comparison rather 
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than the whole genome nucleotide sequence used by traditional SNP mapping analysis (Maiden 
et al., 2013). 
Gene-by-gene MLST methods also allow for the development of pre-defined MLST schemes. 
These allow selective comparison across certain sets of genes, providing information of interest 
such as MLST specific to core genomes, accessory genomes or ribosomes (Jünemann et al., 2013, 
Jolley et al., 2012). This has been shown to be useful in  the resolution of a tuberculosis outbreak, 
where only the core genes were selected for analysis (Kohl et al., 2014). This allowed the 
exclusion of ppe/pe genes known to be highly polymorphic and have the ability to skew the true 
picture of isolate relationships within an outbreak (Jünemann et al., 2013, Kohl et al., 2014). 
Comparison of coding regions also allows for the exclusion of large indels which occur frequently 
in non-coding regions (Coll et al., 2014). The occurrence of small insertions and large deletions 
have been reported as being 5 and 17 times higher respectively in non-coding regions than in 
coding regions (Coll et al., 2014). Therefore, the inclusion of only coding regions provides 
resolution that is based on more stable genomic regions in comparison to WGS SNP mapping 
which is based on WGS analysis. WGS gene-by-gene MLST typing has been used successfully in 
previous investigations into Campylobacter, Staphylococci, and Salmonella outbreaks (Maiden 
et al., 2013, Sheppard et al., 2012). A previous study highlighted how the WGS gene-by-gene 
based method successfully resolved an outbreak of meningococcal disease at a UK university 
(Jolley et al., 2012). The approach produced three different MLST schemes (conventional, 
extended and ribosomal MLST). The outbreak was resolved completely. The investigation 
demonstrated that multiple closely-related but distinct strains  were present in asymptomatic 
and disease states, with two strains causing disease and one responsible for the outbreak itself 
(Jolley et al., 2012). Both WGS gene-by-gene MLST and WGS SNP analysis gave comparable 
results in terms of phylogenetic information.  
With the introduction of WGS gene-by-gene MLST-based software such as the Bacterial Isolate 
Genome Sequence Database (BigsDB) (Jolley and Maiden., 2010) and Ridom SeqSphere 
(Jünemann et al., 2013), the resolution of an outbreak is possible in a standardised manner, 
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without the need for a high quality reference genome and the results can be rapidly submitted 
to a global database. The Ridome SeqSphere software has developed and published a core 
genome MLST, based on 2891 core genes found across the MTBC genome (Jünemann et al., 
2013, Kohl et al., 2014). Application of this cgMLST scheme allows for the multiple alignments, 
across the 2891 core genes, of M. tuberculosis isolates of interest and outputs the number of 
allelic differences between the given isolates. Such data can then be used to clarify genomic 
relationships between isolates, such as whether two isolates are directly related or not. This 
cgMLST scheme has resolved an outbreak of M. tuberculosis to an adequate level for 
epidemiological conclusion although it provided less resolution than a WGS SNP mapping 
method used in the same study (Kohl et al., 2014).  
1.10: Aims of the study 
This thesis describes the analysis of WGS data from a collection of clinical isolates of M. 
tuberculosis from South West Wales, collected between 2004 and 2011. The collection includes 
isolates from three separate M. tuberculosis outbreaks, which occurred in the region during this 
time-period. Of interest is the fact that in some cases epidemiological conclusions were at odds 
with the molecular MIRU-VNTR results.  Thus, the aim of this thesis was to use WGS-based 
methods on the isolates to aid outbreak resolution and provide a level of this that would either 
support or refute the MIRU-VNTR typing conclusions. Finally, the study also aimed to provide 
further information on the presence of potential super-spreaders and outbreak source cases 
which could not be achieved through use of MIRU-VNTR. The study also aims to reveal how 
further applications, based on WGS data, could glean additional phylogenetic and physiological 
information on outbreak isolates. 
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Chapter 2 
Materials and Methods 
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2.1: Sample collection and epidemiological information 
DNA from 80 Mycobacterium tuberculosis isolates collected between 2004 and 2011 was 
obtained from the Wales Centre for Mycobacteriology (WCM), Public Health Wales, Llandough 
Hospital, Cardiff. Forty of the isolates were directly associated with outbreaks from the 
Gorseinon, Townhill, Neath Port Talbot and Llwynhendy regions of South West Wales, according 
to both MIRU-VNTR typing and epidemiological investigations. The MIRU-VNTR typing had been 
carried out by the Public Health Wales Molecular Unit, Cardiff and based on 15 loci: ETRA, ETRB, 
ETRC, ETRD, ETRE, MIRU2, MIRU10, MIRU16, MIRU20, MIRU23, MIRU24, MIRU26, MIRU27, 
MIRU39 and MIRU40. A further 40 isolates from the same areas of South West Wales, apparently 
not belonging to any outbreak, were selected at random from the WCM’s collection. 
Epidemiological information for each isolate had been obtained through face-to-face interviews 
with a senior public health nurse from Public Health Wales, as part of the routine management 
of these cases.  
2.2: Sequencing and assembly 
The 80 isolates were cultured using a BACTEC™ MGIT™ 960 System (Becton Dickinson Diagnostic 
Systems, Sparks, MD, USA), and the resulting bacterial suspension boiled at 110oC for 35 minutes 
and centrifuged. The boilates then underwent genomic DNA sequencing using a MiSeq benchtop 
sequencer (Illumina, San Diego, CA, USA). Sequencing libraries were prepared using Nextera XT 
library preparation kits (Version 3, Illumina) and paired-end 500 bp reads generated with the 
MiSeq run kit (Version 3, Illumina). The resulting paired-end reads were quality filtered with the 
Trimmomatic tool software (version 0.32; Anthony et al 2014) using a sliding 
window approach of 5 bases and a quality score of Q20. The contigs/genomes were assembled 
using SPAdes genome assembler (version 3.9.0; Bankevich et al., 2012).  The SRA sequences for 
the 179 lineage-defined isolates were also assembled using the SPAdes genomic assembler. 
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2.3: Core genome MLST analysis 
To investigate the genetic relationship between the sequenced isolates, all assembled genomes 
were uploaded onto the Ridom SeqSphere software version 4.1.9 (Ridom; Münster, Germany) 
and core genome MLST (cgMLST) analysis carried out for each outbreak.  
2.3.1: Analysis using the established Ridom SeqSphere cgMLST scheme 
Each isolate sequence was aligned to the Ridom SeqSphere M. tuberculosis cgMLST scheme of 
2891 core genes, which is based on the H37Rv reference genome (GenBank accession 
number NC_000962.3; Cole et al., 1998), and is previously defined for alignment and subsequent 
genomic analysis (Kohl et al., 2014). Successful alignments to the cgMLST were defined as “good 
targets” by the Ridom SeqSphere software, and full cgMLST analysis was carried out on isolate 
sequences that conferred >90% “good targets”. Inclusion as outbreak associated isolates was 
based on a threshold of 12 allelic differences defined by Kohl et al. (2014). 
2.3.2: Analysis using an in-house cgMLST scheme 
An in-house cgMLST scheme was developed using the “cgMLST target definer” application 
within Ridom SeqSphere (Ridom; Münster, Germany). Firstly, the genome sequences of the 
relevant isolates were aligned to the H37Rv reference genome and only genes present across all 
isolates were included in the in-house cgMLST analysis. 
2.3.3 Extended 3646 gene-by-gene MLST  
Ridom SeqSphere software also has an accessory genome MLST scheme consisting of 755 M. 
tuberculosis genes of an accessory nature (Kohl et al., 2014, Jünemann et al., 2013). For the 
extended gene-by-gene MLST analysis, a 3646 gene scheme was developed, that consisted of 
the 2891 core genes (section 2.4.1) and an additional 755 accessory genes. 
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2.4: Ancestral dating 
Single nucleotide polymorphisms across selected isolates were extracted using the “extract 
SNVs (Single nucleotide variants) from target groups” application within the Ridom SeqSphere 
software. Single nucleotide variant (SNV) is a synonym for Single nucleotide polymorphism 
(SNP). The default setting for SNP extraction was applied with indels and SNPs within 10 bps of 
each other being removed from the analysis. Extracted SNPs were then concatenated using 
ClustalX (version 2; Larkin et al, 2007). To obtain ancestral dating results, concatenated 
sequences were then submitted to the BEAST ancestral dating software (version 1.8.2) under 
default parameters (Drummond et al., 2012, Ansari and Didelot, 2016), and a strict molecular 
clock of 0.5 mutations per genome per year was used as this is the mutation rate previously 
described for M. tuberculosis (Walker et al , 2013).  
2.5: Whole Genome Sequence Single Nucleotide Polymorphism Mapping   
For single nucleotide polymorphism (SNP) mapping, the whole genome sequences (WGS) of 
isolates relevant to each analysis were uploaded to the conserved signature indels (CSI) 
phylogeny web-server (version 1.3; https://cge.cbs.dtu.dk/services/CSIPhylogeny/). The SNP 
mapping parameters were set to the default  setting of: minimum depth at SNP positions: 10x, 
minimum relative depth at SNP positions: 10%, minimum distance between SNPs: 10 bp, 
minimum SNP quality: 30, minimum read: 25, mapping quality minimum Z-score: 1.96 (Kaas et 
al., 2014). The threshold for direct transmission in WGS SNP mapping was defined as 12 SNPs 
(Walker et al, 2013). 
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2.5.1: SNP bar-coding 
Firstly, isolates were aligned to the H37Rv reference genome using Burrows-Wheeler Alignment 
(BWA, version 0.7.17;Li and Durbin, 2009). SAMtools version 1.3.1 (Li et al., 2009) was then used 
to call SNPs from each of the 60 designated loci previously described by Coll et al (2014), with 
the omission of the two M. bovis loci at H37Rv reference genome positions 1882180 and 
2831482. Isolates were then classified based on the pattern of SNPs (SNP barcode) at the 
designated loci using the previously defined phylogenetic classifications listed in table 2.1 below 
(Coll et al., 2014). SNP bar-coding classification provided major lineage, sub-lineage and 
spoligotyping family phylogenetic assignments. 
Table 2.1: A table extracted from the Coll et al (2014) publication which highlights the 
correlating phylogenetic lineage and sub lineage to specific SNP`s at designated loci (Coll 
et al., 2014).  
Reference allele/Polymorphism Genome position* Phylogenetic assignment 
G/A 615938 Indo-Oceanic 
G/A 4404247 Indo-Oceanic 
G/A 3021283 Indo-Oceanic 
G/A 3216553 Indo-Oceanic 
G/A 2622402 Indo-Oceanic 
G/A 1491275 Indo-Oceanic 
C/A 3479545 Indo-Oceanic 
C/T 3470377 Indo-Oceanic 
G/A 497491 East-Asian 
C/T 1881090 East-Asian (non-Beijing) 
G/A 2505085 East-Asian (Beijing) 
C/T 797736 East-Asian 
C/T 4248115 East-Asian 
G/A 3836274 East-Asian 
G/T 346693 East-Asian 
C/A 3273107 East-African-Indian 
G/A 1084911 East-African-Indian 
G/C 3722702 East-African-Indian 
C/G 1237818 East-African-Indian 
G/A 2874344 East-African-Indian 
T/C** 931123 Euro-American  
G/A 62657 Euro-American (X-type/Haarlem) 
C/T 514245 Euro-American (X-type) 
C/T 1850119 Euro-American (X-type) 
T/G 541048 Euro-American (X-type) 
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C/T 4229087 Euro-American (X-type) 
A/G 891756 Euro-American (Haarlem) 
C/T 107794 Euro-American (Haarlem) 
G/C 2411730 Euro-American 
A/C 783601 Euro-American (Ural) 
C/A 1487796 Euro-American 
T/C 1455780 Euro-American (TUR) 
C/G 764995 Euro-American (LAM) 
C/A 615614 Euro-American (LAM) 
G/A 4316114 Euro-American (LAM) 
C/G 3388166 Euro-American (LAM) 
G/A 403364 Euro-American (LAM) 
G/A 3977226 Euro-American (LAM) 
G/A 4398141 Euro-American (LAM) 
C/T 1132368 Euro-American (LAM) 
C/A 1502120 Euro-American (LAM) 
G/A 4307886 Euro-American 
G/A 4151558 Euro-American 
G/A 355181 Euro-American (S-type) 
G/C 2694560 Euro-American 
G/A 4246508 Euro-American 
G/T 1719757 Euro-American 
G/A 3466426 Euro-American 
G/C 4260268 Euro-American (Uganda) 
G/A 874787 Euro-American 
G/C 1501468 Euro-American 
G/C 4125058 Euro-American 
C/G 3570528 Euro-American 
C/T 2875883 Euro-American (Cameroon) 
C/G 4249732 Euro-American (mainly T) 
G/A 3836739 Euro-American (mainly T) 
G/T** 1759252 Euro-American (H37Rv-like) 
C/A 1799921 West-Africa 1 
C/G 1816587 West-Africa 2 
G/A 1137518 Lineage 7 
** In these two cases the reference allele is the one specific to the lineage 
* based on reference NC_000962.3 
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2.5.2: Extraction of individual SNPs 
Individual SNPs within the 2891 core genes from the isolate cases in question were extracted 
using the “extract single nucleotide variants (SNVs) from target groups” application in Ridom 
SeqSphere (Junemann et al., 2013). The coding regions corresponding to the location of each 
SNP were extracted using the Ridom SeqSphere software, and BioEdit version 7.0.5 (Hall, 1999) 
was used to manually identify whether the identified polymorphisms harboured an amino acid 
change, thus being non-synonymous, or not (synonymous). 
2.5.3: Functional analysis of non-synonymous SNPs 
Non-synonymous SNPs were extracted using the method described in section 2.5.2, with indels 
included in the extraction and synonymous SNPs ignored. The amino acid sequences for each 
gene with details on each polymorphism (codon position and amino acid alteration), were 
submitted to the Provean protein functional prediction online tool (version 1.1, 
http://provean.jcvi.org/seq_submit.php), with deleterious predictions defined as values of -2.5 
or less (Choi and Chan, 2015), thus identifying if any changes in functionality had occurred due 
to the non-synonymous SNP. 
2.6: In silico spoligotyping 
Each isolate sequence was submitted to the Python based SpolTyping (version 2.0) in silico 
software for prediction of spoligotype pattern (Xia et al., 2016). Resulting octal and binary 
patterns were then submitted to the SitVit database (http://www.pasteur-
guadeloupe.fr:8081/SITVITDemo/trouverSouchesParSpoligo.jsp) for determination of 
international typing assignment and assignment to globally recognised spoligtoype clades 
(Demay, C et al., 2012, Yeboah-manu et al., 2011, Yeboah-manu et al., 2016). This allows for 
correlation of in-house spoligotyping results with strains of M. tuberculosis strains worldwide in 
a standardized manner (Demay, C et al, 2012). 
Additionally, spoligotype patterns were submitted to the TB-lineage online tool  online 
(http://tbinsight.cs.rpi.edu/run_tb_lineage.html) which assigns isolates to recognized 
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international phylogenetic lineages based on their spoligotype octal or binary sequences 
obtained from the SpolTyping software mentioned above (Shabbeer et al., 2012). The TB-lineage 
online tool employed the Conformal Bayesian Network (CBN) parameters which employ a 
hierarchical Bayesian network based on PCR-based spoligotype biomarkers, to assign isolates 
into phylogenetic lineages (Aminian, M et al., 2014). 
2.7: Principal Genetic Grouping (PGG) 
Gene sequences for gyrA and katG were extracted from the WGS of each isolate using Ridom 
SeqSphere and analysed manually using BioEdit V7.0.5 (Hall, 1999) to identify the presence of 
PGG-defining amino acids at codons 95 and 463, PGG informative sites within genes gyrA and 
katG as previously documented by Streevatsan et al (1997). Based on the composition of amino 
acids at these loci, each isolate was then assigned a PGG as defined in Table 2.2 (Grimes et al., 
2009). 
Table 2.2: The combinations of amino acids seen at the loci gyrA and katG and the 
possible PGGs (Sreevatsan et al., 1997).   
Loci Principal Genetic Group 
gyrA95 katG463 
Threonine Leucine 1 
Threonine Arginine 2 
Serine Arginine 3 
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2.8: SNP Cluster Grouping (SCG) 
Each isolate was assigned a SNP cluster group based on the nucleotides present at nine specific 
loci  shown in Table 2.3 (Alland et al., 2007). Firstly the isolates were aligned to the H37Rv 
reference genome using Burrows-Wheeler Alignment (BWA, version 0.7.17;Li and Durbin, 2009). 
SAMtools version 1.3.1 (Li et al., 2009) was then used to call SNPs from the 9 specific loci defined 
in table 2.3. Phylogenetic analysis was carried out on only those isolates with each of the nine 
loci present.  
 Table 2.3: List of the nine loci derived from Alland et al. (2007) used for assigning 
isolates into one of six SNP cluster groups.  
 
2.9: Construction of cgMLST phylogenies for phylogenetic assignment 
A set of 179 isolates assigned a lineage in the Comas et al. (2014) study were downloaded from 
NCBI (Coordinators, N.R., 2016), and assembled using SPAdes (section 2.2). The resulting 179 
genomes were then analysed alongside the sequenced Welsh isolates, making a total of 236 
isolates. All the isolates were then submitted to the cgMLST scheme described in section 2.3.1. 
The resulting phylogeny comparison was determined using Unweighted Pair Group Method 
with Arithmetic Mean (UPGMA) trees produced by the Ridom seqSphere software (Ridom; 
Münster, Germany), and further annotated and modified using iTol version 4 (Letunic and Bork, 
2006). 
SCG 
Base at SNP position in H37Rv: 
1977 54394 74092 105139 144390 232574 311613 913274 2154724 
1 G G C C G G T G A 
2 G G C A G G T C A 
3a G G C C G G T C A 
3b G G C C G G T C C 
3c G G C C G T T C C 
4 G G C C A T T C C 
5 G A C C G G T C C 
6a A A C C G G T C C 
6b A A C C G G G C C 
58 
 
2.10:  Sub-lineage genotyping 
Sub-lineage genotyping was carried out by analysis of SNPs that are specific to different 
phylogenetic groups, which are described in more detail below (Rad et al., 2003, Mestre et al., 
2011, Comas et al., 2009, Cubillos-Ruiz et al., 2010, Alix et al., 2006). SNPs were initially identified 
through extraction of gene sequences relevant to certain genotypes (defined in sections 2.10.1, 
2.10.2, 2.10.3, 2.10.4 and 2.10.5 below) from each isolate using the sequence extraction 
application within Ridom SeqSphere and detected manually using BioEdit Version 7.0.5. 
2.10.1: Beijing genotyping 
Isolates LL9, BK21 and BK25 were assigned to the Beijing sub lineage by the SNP barcode method 
(described in section 2.5.2 and shown in figure 3.4). Each isolate assigned to the Beijing sub-
lineage, in chapter 3 figure 3.4, was extracted from the dataset and analysed for SNPs associated 
with the Beijing sub-lineage which are  described in a previous study (Rad et al., 2003) Genes 
mutT2, mutT4 and ogt were analysed for polymorphisms as follows: the mutT2 mutation is due 
to an amino acid change at codon position 58, whilst the mutT4 and ogt mutations are due to 
nucleotide polymorphisms at positions 142 and 36, respectively (Rad et al., 2003). Further 
Beijing genotyping was carried out through analysis of a selected barcode of 48 SNPs across 22 
genes listed in table 2.4 below and defined in a previous study (Mestre et al., 2011). The 48 SNPs 
were extracted as described in section 2.10 and the resulting SNPs were concatenated using 
ClustalX version 2 (Larkin et al., 2007), and then used to produce a phylogenetic tree UPGMA 
using the iTol software (Letunic and Bork, 2006). A distance matrix based on the 48 SNPs was 
constructed using MEGA7 (version 7.0) (Kumar et al 2016). 
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Table 2.4: A table showing the 48 loci across 22 genes analysed for Beijing genotyping. The 
nucleotide positions defined below are relevant to the within gene position.  
Gene Nucleotide position 
ligD 
485 
1030 
1038 
1738 
radA 
456 
557 
827 
recF 
734 
807 
recX 
23 
175 
458 
dnaQ 
227 
263 
483 
631 
recR 
130 
267 
recG 853 
uvrC 
496 
865 
1164 
1301 
ruvB 843 
ligB 
230 
271 
recD 
360 
416 
831 
tagA 
537 
385 
uvrD1 1384 
dnaZX 
274 
291 
nei 229 
nth 
5 
101 
365 
alkA 
31 
34 
ligC 
630 
938 
mutT2 172 
ogt 
36 
110 
mutT4 
142 
297 
rv2979 41 
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2.10.2: Latin American Mediterranean (LAM) genotyping  
The Rv0129c gene sequence was extracted for each LAM sub-lineage isolate (Comas et al., 
2009), and the presence of a polymorphism at nucleotide position 309 detected manually as 
described in section 2.10. The nucleotide at position 309 can be one of either a G or an A with 
the latter defining isolates as LAM isolates. 
2.10.3: Haarlem genotyping 
The mtgC, ogt and ung genes were extracted for each Haarlem sub-lineage assigned isolate (Alix 
et al., 2006, Cubillos-Ruiz et al., 2010, Dou et al., 2008) and the relevant polymorphisms 
described below were detected manually as described in section 2.10. The mtgC marker is based 
on an amino acid change at codon position 182, whilst the ogt and ung mutations are at 
nucleotide positions 44 and 501, respectively. 
2.10.4: X family genotyping 
 The Rv3221c and Rv2330 gene sequences were extracted for each X family sub-lineage assigned 
isolate (Comas et al., 2009), and the relevant polymorphisms described below were manually 
detected as described in section 2.10. X family related polymorphism are found at position 30 
within gene Rv3221c, and at nucleotide position 426 in gene Rv2330.  
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2.10.5: Lineage 1 genotyping of BK22 
Lineage 1 genotyping of BK22 was based on polymorphisms at the well-characterised loci  
Rv0005, Rv0006, Rv0410c, Rv0934, Rv1996, Rv2462c, Rv3132c, Rv3221c, Rv0006, Rv0164, 
Rv0288, Rv0410c, Rv1009, Rv1996, Rv2030c, Rv2031c and Rv3261, and detected manually  as 
described in section 2.10. Lineage 1 isolates can be sub-divided into either Manila or non-Manila 
strains. The Manila strains are identified due to the presence of polymorphisms at loci Rv0006, 
Rv0164, Rv0288, Rv0410c, Rv1009, Rv1996, Rv2030c, Rv2031c and Rv3261 (Comas et al., 2009).  
2.11: Statistical analysis for lineage association 
The probability of correct lineage assignment was determined for each isolate included in the 
cgMLST phylogeny analysis using Microsoft Excel (MS Excel, 2013). Prior to inclusion of Welsh 
isolates, the within lineage genomic distances of the lineage defined isolates were analysed. The 
mean and standard deviation of the internal genomic distances between isolates of each lineage 
were calculated through analysing the number of allelic differences between each isolate within 
each lineage. The distance distribution for each isolate (within a given lineage) from the lineage 
mean was then calculated through analysis of the normal distribution of allelic differences seen 
across all isolates within each lineage. By using the distributions calculated from each lineage 
we can calculate the probability that each given Welsh isolate falls into each of the lineages 
included in this study. By comparing this value, for each Welsh isolate across each lineage, we 
can measure which lineage is more credible as the group the Welsh isolate belongs to. Confident 
assignments were designated as those whereby the value for probability was 100%. Microsoft 
Excel (MS Excel, 2013) was used to carry out these calculations and to produce the 
corresponding graphs. 
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2.12: Gel electrophoresis  
Gel electrophoresis was used to determine if DNA was present in the boilate samples. 1 % (w/v) 
agarose gels in TAE (40mM Tris acetate, 1mM EDTA) were made with SYBR™ Safe DNA Gel Stain 
(Invitrogen, Paisley, UK) and submerged in 1 x TAE electrophoresis buffer. DNA samples were 
mixed with one fifth their volume of 6 × DNA loading buffer (Promega, Southampton, UK) and 
loaded into slots in the gel formed by insertion of the appropriate comb prior to gel solidification. 
The gel was electrophoresed using a Bio-Rad horizontal gel electrophoresis tank at 75 volts for 
40 minutes and visualised using a UV transilluminator. The size and concentration of DNA 
fragments were estimated by co-electrophoresing 10 μl GeneRulerTM 1kb DNA ladder as size 
standards (Promega, Southampton, UK). 
 
  
63 
 
2.13 Ancient DNA extraction and library preparation protocol 
2.13.1: Ancient DNA extraction protocol 
DNA was extracted using an adapted Tris-phenol chloroform extraction protocol (Sambrook and 
Russell, 2006). The  M. tuberculosis boilates were transferred into Fastprep lysing matrix E tubes 
(MP-Biomedicals, Santa Ana, California, United States). 500µl of breaking buffer (2% Triton-
X100, 1% SDS, 100mM NaCl, 10mM Tris-HCl pH8, 100mM EDTA pH8) and 500 µl Phenol: 
Chloroform: Isoamyl alcohol (Sigma-Aldrich, St. Louis, MO, United States) were added to each 
tube. The tubes were then homogenized in a Thermo Savant FastPrep 120 Cell Disrupter 
Fastprep machine (GMI, Ramsey, MN, USA) at speed setting 6, for 5 x 20 second bursts with 
cooling on ice between cycles. Each tube was then centrifuged for 10 minutes at 16,000 X g in 
an Eppendorf 5415R centrifuge (Eppendorf Ltd, Stevenage, UK). The aqueous upper phase of 
the suspension was then transferred into a clean microcentrifuge tube. Two volumes of 700 µl 
ice cold absolute ethanol (Thermo Scientific, Waltham, MA, USA) was added to each tube and 
mixed, then centrifuged for 10 min at 16,000 X g. The supernatant was removed and 700 µl of 
70% ethanol added to the tubes, avoiding disruption of the pellet. Ethanol was then decanted 
and the remaining pellet was then dried through incubation at 70 OC for 10 minutes on a Techne® 
digital Dri-Block® heater (Sigma-Aldrich, St. Louis, MO, United States). The pellet was then re-
suspended in 50ul de-ionised water containing 10ug/ml RNase A (Sigma-Aldrich, St. Louis, MO, 
United States). The amount of DNA present in the samples was then quantified using an Agilent 
Bioanalyser 2100 instrument (Thermo Scientific, Waltham, MA, USA). Following extraction, the 
samples were fragmented for 20 cycles of 30 seconds within a Diagenode bioruptor 300.  
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2.13.2: Ancient DNA library preparation and sequencing of DNA  
The DNA extracted in Section 2.13.1 was then subjected to the novel BEST aDNA library building 
protocol (Carøe C et al, 2017). The samples were pooled in equimolar concentrations and then 
sequenced on an Illumina HiSeq platform (Illumina, San Diego, CA, USA) in 80 bp single-end read 
mode at The Danish National High-Throughput DNA Sequencing Centre, University of 
Copenhagen, Denmark. The resulting single-end reads were quality filtered with the 
Trimmomatic tool and contigs assembled as described in section 2.2.  
2.14: Production of Geographical map 
The geographical map(s) were constructed using the online National Geographic MapMaker 
programme (https://mapmaker.nationalgeographic.org/#/). 
2.15: Statistical analysis of in-house and established cgMLST variation. 
The number of allelic differences between each isolate and the remaining isolates within the 
dataset was taken from both the established and in house core genome MLST results. The 
average number of differences each isolate had across the whole dataset (variation) was 
calculated using MS Excel (2013). These values were then used to determine the average 
amount of variations seen across the dataset for both cgMLST schemes. An unpaired T-test was 
performed using GraphPad Prism (version 7.00), to calculate the P Value for whether the amount 
of variation seen in the results of the in house cgMLST scheme and Established cgMLST scheme 
is different.   
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Chapter 3 
Phylogenetic analyses of M. tuberculosis isolates 
from across South West Wales. 
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3.1: Introduction 
3.1.1:  M. tuberculosis strains and lineages 
Evidence for different M. tuberculosis strains conferring different disease phenotypes and levels 
of virulence has been documented since the early part of the twentieth century (Gagneux and 
Small, 2007). A study in 1948, using a guinea pig model, showed that a M. tuberculosis strain 
from India was less virulent than one from a British case. This result has since been supported 
by various other studies (Mitchison et al., 1960, Mitchison et al., 1961 Singh, 1964, Collins and 
Smith, 1969). Further research also showed, based on aerosol infection of guinea pigs, that the 
less virulent Indian strains were also less infectious than the British ones (Balasubramanian et 
al., 1992, Williams et al., 2005). Evidence for strain variation effects on outbreak phenotypes 
was put forward in the 1990s when an outbreak in Kentucky, USA was caused by the CDC1551 
strain (North et al., 1999, Williams et al., 2005,). Initially suspected of increased virulence (North 
et al., 1999, Williams et al., 2005),  analysis showed that while it was more transmissible than 
the reference strain, its pathogenicity was not increased(Bishai et al., 1999, Manca et al., 1999). 
More recently, the HN878 strain, found in outbreaks in Los Angeles, USA has shown a 
consistently hyper-virulent phenotype across various experimental models (Gagneux and Small, 
2007). Despite the well-recognised differences in disease characteristics between strains, the 
monomorphic genomic nature of M. tuberculosis is recognised in comparison with other 
pathogenic bacteria.  However,  large sequence polymorphisms (LSP) and single nucleotide 
polymorphisms (SNP) for the analysis of sequencing data, has revealed how different MTBC 
members, different M. tuberculosis lineages and sub-lineages can have significantly different 
pathobiology, virulence, functional genomic variation and physiological features (Gagneux and 
Small., 2007, Homolka et al., 2012) Thus,  the genomic diversity of tuberculosis has been 
historically underestimated prior to the use of LSP and SNP based genomic analysis (Gagneux 
and Small., 2007).  
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3.1.2: M. tuberculosis major lineages 
Within M. tuberculosis seven major lineages have been recognised globally (Gagneux et al., 
2006, Hershberg et al., 2008, Homolka et al., 2012, Comas et al., 2013, Yimer et al., 2015). Each 
lineage has a different characteristic with regards to its evolutionary status, transmissibility, drug 
resistance, host interaction, latency and vaccine efficacy (Thwaites et al., 2008). Lineages can be 
grouped into those that are evolutionarily modern and ones that are ancient (Gagneux and 
Small., 2007). M. tuberculosis lineages 2, 3 and 4 are considered modern and 1, 5 and 6 are 
considered ancient, with lineage 7 thought to be intermediate (Comas et al., 2013, Firdessa et 
al., 2013). The more ancient lineages 1, 5 and 6 coexisted with humans prior to Neolithic 
expansion of anatomically modern Homo sapiens populations (Comas et al., 2013). Ancient 
lineages have been shown to exist in pre-Neolithic human populations which rarely exceeded 
20 individuals (Blaser and Kirschner., 2007, Comas et al., 2013). It is thought that ancient strains 
were adapted to this low population density demographic, to sustain a continuous infectious 
reservoir within smaller populations, a feature consistently seen across bacterial species that 
infect populations of low density (Blaser and Kirschner, 2007). During the post-Neolithic era, 
with its higher-density human populations, the more modern lineages (2, 3 and 4) have 
dominated, evolving to become more representative of a crowd disease than the more ancestral 
and readily latent ancient lineages 1, 5 and 6 (Comas et al., 2013). 
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The ancient lineages cause a more marked immune response (Reiling et al., 2013) and are also 
more likely to become latent than their modern relatives, progressing more slowly to active 
disease (Portevin et al., 2011, Comas et al., 2013). This observation is supported by the fact that 
infection rates with ancient strains are in decline, in contrast to the increased dissemination of 
the modern lineages such as lineage 2 Beijing strains and lineage 4 Euro-American strains (Comas 
et al., 2013). Despite the ancient lineage 1 being found in predominantly South East Asia, the 
current hypotheses is that the lineage arose in Africa around 68,000 years ago and followed 
human migration out of the continent (Wirth et al., 2008, Reed et al., 2009, Comas et al., 2013). 
Modern lineages appear more virulent and readily able to cause active disease, elicit a less 
marked immune response, have higher rates of transmission and increased replication rates and 
are more geographically dispersed (Gagneux et al., 2006, Hershberg et al., 2008, Homolka et al., 
2012, Comas et al., 2013, Yimer et al., 2015). Lineage 4 isolates have been shown to be less 
capable of extra-pulmonary TB disease, including meningeal disease, than other lineages 
(Portevin et al., 2011) and are less likely to be associated with HIV co-infection (Caws et al., 2006, 
Middelkoop et al., 2009). Lineage 3 has been shown to be phylogenetically close to lineage 2 
(Portevin et al., 2011, Comas et al., 2013), and is predominantly restricted to India. However, its 
presence is significant amongst the Indian population within the UK and has caused outbreaks 
(Sarkar et al., 2012). In comparison with the other modern lineages, lineage 3 has shown 
significant association with extra-pulmonary tuberculosis (Rindi et al., 2012). However, it also 
appears that it may be less virulent than the other modern lineages in terms of rate of 
replication, having the lowest rate of intracellular growth within human macrophages of the 
modern lineages (Sarkar et al., 2012).  
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3.1.3: M. tuberculosis sub-lineages 
Each M. tuberculosis lineage can be divided into sub-lineages, which can then be further divided 
into specific strains and genotypes. Sub-lineages also have phenotypic variations, including 
differences in their virulence and ability to cause disease (Anderson et al., 2013).  In particular, 
lineages 2 (East Asian) and 4 (Euro-American) contain strains, such as Beijing (also known as 
W/Beijing) and Haarlem genotypes respectively, which are notorious for their association with 
tuberculosis outbreaks and over-representation amongst drug resistant cases (Bifani et al., 
1996, , Mardassi et al., 2005, Marais et al., 2006, De Jong et al., 2008). Lineage 2 can be divided 
into non-Beijing strains and Beijing strains, with Beijing strains also being split into modern and 
ancient sub-lineages (Thwaites et al., 2008). The modern Beijing sub-lineages appear more 
virulent (Mestre et al., 2011). The lineage 2 Beijing strains have a higher propensity to acquire 
drug resistance than lineage 4 Euro-American strains (Thwaites et al., 2008, Ford et al., 2013). 
The Lineage 2 Beijing strains are considered the most successful ones over recent years, as they 
have disseminated globally (Wirth et al., 2008) and have been associated regularly with large M. 
tuberculosis outbreaks (Bifani et al., 1996, Thwaites et al., 2008). The Beijing strains are known 
to have a higher propensity for acquisition of drug resistance, causing the development of multi-
drug and extensively-drug resistant strains within the lineage (Bifani et al., 1996, Thwaites et al., 
2008). They have been shown to disseminate rapidly and cause more severe disease. This was 
particularly evident in a large outbreak of the strain in New York in the 1990s (Bifani et al., 1996, 
Thwaites et al., 2008). The Beijing genotype has the ability to produce a unique phenolic 
glycolipid that attenuates the host’s immune response (Nicol et al., 2005). Meningeal 
tuberculosis caused by Beijing strains has a more rapid progression, with shorter symptom 
duration when compared with meningeal infection with other lineage strains (Nicol et al., 2005). 
Beijing strain infection is associated with low levels of CSF leukocytes, which is an independent 
risk factor for death or severe disability from meningeal tuberculosis (Thwaites et al., 2008). 
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Lineage 4 represents the most diverse and geographically widespread lineage of M. tuberculosis, 
with each sub-lineage having different phenotypic characteristics (Rasigade et al., 2017, Comas 
et al., 2014, Stucki et al., 2016). Major sub-lineages within lineage 4 include X, T, Latin American 
Mediterranean (LAM) and Haarlem (Fitzgibbon et al., 2013). Of the lineage 4 sub-lineages, the 
presence of Haarlem strains is of particular interest as they are thought have a higher propensity 
to cause outbreaks of increased severity and drug resistance in comparison with other lineage 4 
sub-lineages (Mardassi et al., 2005). LAM sub-lineage strains have also been associated with 
widespread epidemics and drug resistance (David et al., 2012). The Haarlem genotype accounts 
for 25% of tuberculosis cases in Europe, as well as central America and the Caribbean, where 
research suggests its presence may be correlated with post-Columbus European colonisation 
(Cubillos-Ruiz et al., 2010). Its significance is based on its global dissemination and its 
predominance in multi-drug resistant outbreaks (Marais et al., 2006, Khanipour et al., 2016, 
Mardassi et al., 2005). A   study in Tunisia showed Haarlem strains caused 22-fold more multi-
drug resistant cases than non-Haarlem Euro-American strains (Mardassi et al., 2005). Haarlem 
genotype strains have been found to have an increased clonal expansion rate compared to other 
ones that has been postulated to allow them to spread quickly whilst also being multi-drug 
resistant (Tessema et al., 2013, Mardassi et al., 2005). Identifying the presence of such sub-
lineages within a Welsh dataset would be of interest to public health and outbreak control. 
Identification of strains known to harbour drug resistant qualities is also in line with the recent 
public health England movement to genomics for tuberculosis control (Votintseva et al., 2017). 
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3.1.4: Robust genetic markers for phylogenetic classification M. tuberculosis 
Previous typing methods, based on MIRU-VNTR profiling and spoligotyping, have allowed the 
classification of isolates into phylogeographically related clades and families and have led to the 
development of readily available databases such as SpolDB4 ( Brudey et al., 2006, Gagneux and 
Small., 2007) and MIRU-VNTR plus (Weniger et al., 2010). These databases provide a large 
amount of information on strains from across the globe; however, the methods are based on 
sequence information extracted from polymorphic repetitive regions. Due to the nature of these 
regions, convergent evolution occurs whereby strains show the same profile but are actually 
unrelated (Gagneux and Small., 2007, Müller et al., 2014). The advent of WGS comparative 
analysis has showed that on the whole genome level, M. tuberculosis displays a substantial 
genetic divergence (Gagneux and Small., 2007). This has been exploited for the identification of 
robust genetic markers for phylogenetic strain assignment. Such markers are found as either 
Large Sequence Polymorphisms (LSPs), used for the original lineage classification of isolates by 
Gagneux in 2006, or SNPs (Gagneux et al., 2006, Gagneux and Small., 2007). SNPs are reliable, 
phylogenetically informative markers as the low sequence variation and lack of horizontal gene 
transfer makes independent recurrent mutations unlikely and one does not encounter the 
convergent evolution problem of the previously mentioned methods (Warren et al., 2002, 
Gutacker et al., 2002, Gutacker et al., 2006, Gagneux and Small., 2007). Lack of horizontal gene 
transfer also prevents the re-acquisition of large sequence regions within strains that have 
previously lost them, thus increasing the robustness of LSP (Gagneux and Small., 2007). LSP 
analysis requires the use of micro-arrays while SNP markers can be found and analysed in silico 
from WGS (Gutacker et al., 2006). The use of both methods has shown more potential in 
providing genetic markers for production of deep phylogenies in comparison with spoligotyping 
and MIRU-VNTR profiling (Warren et al., 2002, Gutacker et al., 2006, Gagneux and Small., 2007). 
The in silico application of WGS data means multiple sequences from various strains can be 
analysed and compared within the same study (Gagneux and Small., 2007). It is worth noting 
that despite the benefits of using robust genetic markers such as SNPs and LSP, the SpolDB4 
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database has proven useful, showing clear correlations between spoligotype-defined clades 
within lineages and sub-lineages defined by LSP and SNP genetic groupings (Baker et al., 2004, 
Brudey et al., 2006). 
3.1.4.1: Principal Genetic Grouping 
Principal genetic groups (PGGs) classify isolates into one of the three PGGs based on non-
synonymous variants at the katG and gyrA genes at codons 463 and 95 respectively as 
summarised in Table 2.1, section 2.9 (Sreevatsan et al., 1997b). The current consensus is that 
PGG1 consists of isolates that are ancestral to all the others represented in PGG2 and PGG3 
(Sreevatsan et al., 1997), a notion supported by spoligotype analysis, which further indicates 
that PGG3 isolates are descended from isolates of PGG2 (Soini et al., 2000). Studies have shown 
that PGG2 and PGG3 isolates comprise modern lineages but more specifically modern Euro-
American lineages (Grimes et al., 2009).  PGGs correlate with  patterns of drug resistance, and 
PGG2 and PGG3 contain more susceptible strains compared to PGG1 (Arjomandzadegan et al.,  
2012). 
3.1.4.2: SNP cluster grouping 
SNP cluster grouping (SCG) is a method used to classify isolates into phylogenetically relevant 
groups (Filliol et al., 2006, Alland et al., 2007).  The original method was based on a 212 SNP 
analysis, resulting in the division of M. tuberculosis isolates into six phylogenetically distinct 
groups: SCG-1-6 with a seventh group containing all M. bovis isolates (Filliol et al., 2006). Alland 
et al. (2007) adapted this method to comprise 9 loci from M. tuberculosis, (M. bovis was 
excluded, Table 2.2) allowing further discrimination of SCGs 3 and 6 into five subgroups: SCG-
3a, 3b, 3c, 6a and 6b. Each of the SCGs are geographically distinct and have correlating 
spoligotype families as shown in Table 3.1. 
  
73 
 
Table 3.1: A matrix showing the correlation between the SCG and spoligotype families, 
adapted from Filliol et al. (2006) and Alland et al. (2007).  
SCG Group 
SC
G
-1
 
SC
G
-2
 
SC
G
-3
a 
SC
G
-3
b
 
SC
G
-3
c 
SC
G
-4
 
SC
G
-5
 
SC
G
-6
a 
SC
G
-6
b
 
Spoligotype  EAI Beijing CAS H, T, 
LAM 
X X H T, S, 
LAM, 
H, X 
T, S, 
LAM, 
X, H 
EAI=East African Indian, CAS=Central Asian, LAM=Latin American Mediterranean, H=Haarlem, 
T= T family, S=S family, X= X family. 
Each SCG has been also been shown to correlate with a specific PGG. Therefore by using both 
methods discrepancies in the PGG or SCG assignments can be identified and isolates can be 
ascribed evolutionary timescales (Filliol et al., 2006). Filliol et al (2006) elucidated that SCG1, 
SCG-3a and SCG-2 all fall into PGG1, each representing isolates which were the earliest to 
diverge from the most recent common ancestor with M. bovis; PGG2 isolates include SCG-3b, 
SCG-3c, SCG-4 and SCG-5; and isolates from PGG3 comprise SCG-6a and SCG-6b, the most 
recently diverged groups. Over time SCGs and PGGs have also been correlated with the LSP and 
SNP analysis defined lineages and sub-lineages already described (Gagneux and Small., 2007).  
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3.1.4.3: Robust SNP barcode method 
Although SNPs represent phylogenetically informative markers for the assignment of isolates 
into phylogenetic lineages and sub-lineages, extraction of SNPs from the whole genomes of 
multiple isolates produces a large amount of data lacking in the level of standardisation offered 
by methods such as MIRU-VNTR and spoligotyping. Both these methods have well-established, 
standardised and accessible online databases (Weniger et al., 2010, Brudey et al., 2006b) 
allowing for the phylogenetic analysis of M. tuberculosis and comparison with strains from 
across the globe. Coll et al. (2014) developed a robust SNP barcode method analysing 60 loci, 
capable of assigning M. tuberculosis isolates into major lineages and sub-lineages.  The method 
increases the level of resolution in comparison to the more primitive PGG and SCG SNP sets. In 
addition, this robust SNP barcode provides correlation with well-known spoligotype families and 
results can be compared with a globally established database. A key feature of the SNP barcode 
method is that it provides results based on a standardised set of genetic markers that are often 
difficult to attain from standard WGS analysis due to the comparatively low sequence variability 
in M. tuberculosis isolates and impracticality of comparing large amounts of WGS data in a 
reproducible manner (Hamolka et al., 2012). 
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3.1.5: Novel use of a core genome MLST method for phylogenetic purposes 
Currently, the lack of WGS data standardisation is one of the barriers to its widespread usage 
(Kohl et al., 2014, Walker et al., 2013b). In addition, the output of partial sequence data from 
current sequencing platforms and the need for robust high-quality reference sequences has 
often meant that SNP mapping analysis, such as that done in previous studies (Walker et al., 
2013a, Walker et al., 2013b),  is less ableto analyze sequence data that is incomplete, which is 
often outputted by sequencing platforms (Maiden et al., 2013, Sheppard et al., 2012). However, 
recently the development of WGS gene-by-gene MLST methods and software such as the 
Bacterial Isolate Genome Sequence database (BIGSdb) (Jolley and Maiden, 2010) and Ridom 
SeqSphere (Junemann et al., 2013) have resulted in a more standardised and automated 
approach than traditional WGS SNP mapping (Maiden et al.,  2013, Sheppard et al., 2012). For 
example, Ridom SeqSphere allows isolate sequences to be aligned and compared in a 
standardised manner using a globally defined core genome MLST (cgMLST) scheme (Junemann 
et al., 2013, Kohl et al., 2014). To date, this method has only been used for providing clinical 
resolution of tuberculosis outbreaks (Kohl et al., 2014), and has not been used to analyse the 
phylogenetic composition of a M. tuberculosis  isolate dataset.  
3.1.6: Aims and objectives 
The objective of the work in this chapter was to analyse phylogenetically 80 Welsh M. 
tuberculosis isolates by PGG, SCG, SNP bar-coding and gene-by-gene based cgMLST. Each 
method will allow the isolates to be assigned to relevant phylogenetic groups, lineages and sub-
lineages in comparison to global M. tuberculosis isolates. The first aim was to provide a snapshot 
of their diversity in the context of global M. tuberculosis phylogenetics, something which has 
not been done previously. Secondly, an aim was to provide the first assessment of the use of 
cgMLST gene-by-gene analysis for the phylogenetic classification of M. tuberculosis isolates and 
to whether the phylogenetic structures match that seen by more conventional but less 
standardized SNP mapping methods. Lastly, the aim was to assess any correlation between 
phylogenetic classifications, according to each method and outbreak status. 
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3.2: Methods 
3.2.1: Principal genetic grouping (PGG) 
Isolates were assigned into one of three principal genetic groups (PGGs) based on the amino 
acid combination present at loci gyrB and katG codons, codons 95 and 493 respectively. The 
Principal Genetic Group phylogeny was produced using Ridom SeqSphere software, and for 
further details on this method see section 2.7 and Table 2.2.  
3.2.2: SNP cluster grouping (SCG) 
Each Welsh isolate was assigned a SNP Cluster Group (SCG) based on the composition of 
nucleotides present at 9 specific loci defined previously (section 2.8, Table 2.3).  Isolates could 
be assigned to one of 6 major SCGs (SCG1-6). Isolates assigned to SCG3 or SCG could also be 
further resolved into sub-groups (SCG3a, 3, 3b, 3c, 6a and 6b) as described in Table 2.3. The SNP 
cluster group phylogeny was produced using Ridom SeqSphere software. 
3.2.3: Major lineage and sub-lineage assignment 
Using the pipeline described in section 2.5.1, the 60 SNP loci were extracted from the genomes 
of the Welsh isolates, whereby sequence data was of sufficient quality to analyze. The isolates 
were then assigned into major lineages, sub-lineages and correlating spoligotype families based 
on the 60 SNP barcode as described in section 2.5.1 and table 2.1.  
3.2.4: Construction of cgMLST phylogenies 
A cgMLST phylogeny was produced using the Ridom SeqSphere software, based on a total of 
236 isolates as described in section 2.9. Of the 236 isolates, the lineage of 179 has been defined 
previously (Comas et al., 2013), with the remainder of the isolates being Welsh.   
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3.2.5: Statistical analysis for lineage association 
For all isolates successfully included in the cgMLST phylogeny analysis, the statistical probability 
that the lineage associations made were reliable was calculated (section 2.11). Confident 
associations were deemed as those with 100% probability that the association between each 
Welsh isolate and the phylogenetic lineage was true.  
3.2.6: Sub-lineage Genotyping 
Sub lineage genotyping was carried out by analysis of SNPs at positions that are specific to 
different phylogenetic groups, as described in section 2.10. To support lineage and sub lineage 
assignments made by both SNP-bar-coding and cgMLST, nucleotide data were extracted on 
genetic markers that represent different sub-lineage groups. Clade-specific SNPs relevant to the 
lineage 1, Beijing, Haarlem, LAM and X clades specifically were extracted from the relevant gene 
sequence and examined manually as described in section 2.10. As the T family sub-lineage is a 
large family generically that is less defined, no polymorphisms were used to define these 
isolates. 
3.2.6.1: Beijing genotyping 
Each isolate assigned as a Beijing sub-lineage by SNP bar-coding was analysed for Beijing sub-
lineage relevant SNPs. As described in section 2.10.1, genes mutT2, mutT4 and ogt were 
analysed for polymorphisms at given codon and nucleotide positions.    
3.2.6.1.1: Advanced Beijing Genotyping 
For advanced Beijing genotyping, phylogenetic analysis of each isolate was subjected to analysis 
of 48 SNPs across 22 genes as outlined in section 2.10.1.   The 48 SNPs were extracted from the 
three Beijing-related isolates identified.  
3.2.6.2: Latin American Mediterranean (LAM) genotyping 
Gene locus Rv0129c was extracted and the nucleotide at position 309 examined for the presence 
of an A instead of G at this position (section 2.10.2). Isolates with this mutation were defined as 
harbouring the LAM genotype.  
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 3.2.6.3: Haarlem genotyping 
Isolates deemed as having the Haarlem sub lineage according to a robust SNP barcode were 
examined for specific polymorphisms at loci mtgC, ogt and ung (section 2.10.3).  
3.2.6.4: X family Genotyping 
X family related polymorphisms were examined at nucleotide positions 30 within gene Rv3221c, 
and 426 in gene Rv2330, as described in section 2.10.4. 
3.2.6.5: Lineage 1 genotyping for BK22. 
Seventeen well characterised loci, defined in section 2.10.5, were examined for lineage 1 specific 
polymorphisms, and a subset of these was examined for polymorphisms associated with the 
Manila genotype found within lineage 1 isolates.  The 17 gene sequences, in which the 
polymorphisms lie, were extracted from BK22 and the 17 relevant polymorphisms were 
detected manually as described in section 2.10. 
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3.3: Results 
Of the 80 Welsh isolates analysed (section 2.2), only 66 were successfully sequenced. Therefore 
the DNA sequence data from these isolates were analysed, as well as the reference strain H37Rv 
sequence. 
3.3.1: PGG analysis 
Fifty-seven Welsh isolates could be assigned to a PGG based on the sequence data (see section 
3.2.1). The analysis identified 31 isolates as PGG2, and 23 as PGG3, including the H37Rv genome 
(Figure 3.1). Only four isolates clustered within PGG1. Isolates BK24, BK26, GO9, BK27, LL2, LL7, 
NPTB7, BK28, and BK29 could not be assigned to a PGG due to lack of sequence data at codons 
95 and 493 in genes gyrB and katG.   
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Figure 3.1: Phylogeny highlighting the PGG assignment of 57 Welsh isolates  and H37Rv. 
Red: PGG1, green: PGG2, blue: PGG3. Letters refer to the amino acids present at each 
locus:  T = Threonine, R = Arginine, L = Leucine, S = Serine. The scale bar highlights the 
genetic divergence relevant to branch length measured in units of amino acid differences 
per site across the gyrA and katG loci.
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3.3.2: SNP cluster group (SCG) analysis 
Division of isolates into SCGs based on SNPs at 9 loci allowed further resolution of the 
information obtained from the PGG clustering analysis (see section 3.2.2). Only isolates with 
sequence data present for the whole set of 9 loci were analysed.  The two predominant SCGs 
were 6a and 3b with 16 and 15 isolates clustering to these sub-groups respectively (Figure 3.2). 
Sub-groups SCG-3c and SCG-6b contained clusters of 7 and 4 isolates respectively, whilst 8 
isolates clustered as SCG4. SCG-5, SCG-2 and SCG-1 contained 3, 2 and 1 isolates respectively. 
Sub-group SCG-3a was the only SCG not found in the dataset. Isolates BK29, BK17, NPTB7, LL10, 
BK28, BK21, GO9, BK19 and BK26 did not yield sequence data for all nine loci and were not 
analysed but further details on them can be found in the Appendix table PH1. 
 
Figure 3.2: The number of isolates in each SCG, for the 57 isolates where nucleotide 
information at the 9 defined loci was obtained.   
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More diversity was seen in the clustering of isolates by SCG than with PGG. The SCG phylogeny 
split into two clear clades; clade 1 contained SCG-6a and SCG-6b and clade 2 contained SCG-1, 
SCG-2, SCG-3b, SCG-3c, SCG-4 and SCG-5 (Figure 3.3). Clade 2 was also more diverse than clade 
1 as SCG-1 and SCG-2 branched off before further divergence was seen with SCG-3b, SCG-3c, 
SCG-4 and SCG-5. When PGG results were compared with SCG results, it was found that clade 1 
contained all the PGG3 isolates and Clade 2 all PGG1 and PGG2 isolates (Figure 3.3). The 
phylogeny also revealed that the PGG2 isolates divided into four different SCG groups (SCG-3b, 
SCG-3c, SCG-4 and SCG-5), highlighting that there is further phylogenetic diversity within this 
dataset than seen with PGG alone (Figure 3.1). The results also indicated that within clade 2, 
SCG-3c and SCG-4 share a closer relationship with each other than they do with isolates of SCG-
3b and SCG-5, and vice versa.  
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Figure 3.3: A neighbour joining phylogeny showing the SCG profile for 57 M. tuberculosis 
isolates (including the H37Rv reference genome). The phylogeny harbours two clades, 
labelled Clade 1 and Clade 2.  The PGG assigned to each isolate is shown in the furthermost 
right column. X in the PGG column denotes isolates that could not be assigned a PGG 
group. The scale bar highlights the genetic divergence relevant to branch length measured 
in units of nucleotide differences per site across 60 loci  defined in section 3.2.2. 
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3.3.3: Robust SNP bar-coding  
SNP bar coding was carried out on 59 M. tuberculosis isolates that had over 90% sequence data 
needed for the 60 loci SNP barcode analysis (see section 3.2.2). The results in Figure 3.4 show 
the lineage, sub-lineage and correlating spoligotype family data for the 59 analysed isolates. In 
terms of major lineages, lineage 4 (Euro-American) dominated the dataset, accounting for 55 of 
the 59 isolates. The remaining 4 isolates were of lineage 2 (n = 3) and lineage 1 (n = 1). 
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Figure 3.4: A phylogenetic tree of the 59 Welsh M. tuberculosis isolates based on SNPs at 
60 loci adapted to assign isolates to lineages and sub lineages.  Isolates are coloured 
according to their sub lineage assignment, see key in figure 3.4 above for details.  The scale 
bar indicates the genetic divergence relevant to branch length measured in units of 
nucleotide differences per site across 60 loci. The corresponding spoligotype families are 
also depicted in the further most right column. 
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The major lineages could then be divided into 7 sub-lineages and the proportion of each is 
presented in Figure 3.5.  These included the Lineage 4 Euro American sub lineages; Haarlem, T 
family, X family, H37Rv-like and Latin American Mediterranean (LAM) sub lineages, in addition 
to the Beijing and Indo-oceanic sub lineages of lineages 2 and 1 respectively. 
 Of these, the T, X family Euro-American and Haarlem sub-lineages dominated the dataset with 
18 (30%), 16 (27%) and 14 (24%) isolates in each respectively.  
 
Figure 3.5: Number of isolates representing each sub-lineage present within this 
collection of 59 Welsh M. tuberculosis isolates. 
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Of the T family isolates, 13 of the 18 showed a completely clonal pattern across the 60 SNPs 
(NPTA1, NPTA2, NPTA4, NPTA5, NPTA6, NPTA8, NPTB2, NPTB3, NPTB4, NPTB5, BK1, BK2 and 
BK3), correlating to the T1 and T5 spoligotypes. The remaining five (BK24, BK19, NPTA3, NPTB1 
and NPTA7) all contained T family-specific polymorphisms but did not cluster clonally as the 
other did. Of these five non-clustering isolates, only NPTA3 had sequence data for the complete 
set of 60 loci analysed (Table 3.2). Compared to the clonal isolates, NPTA3 differed at only one 
locus, specifically genomic position 3836739, and is the reason it could not be resolved into a 
specific T family spoligotype. Isolates NPTA7, BK24, BK19 and NPTB1 did not have sequence data 
for the complete set of 60 loci (Table 3.2). It is possible that the lack of sequence data at certain 
loci is responsible for the divergence seen for these isolates from the clonally-related T family 
isolates within the phylogeny (Figure 3.4). 
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Table 3.2: Percentage presence of the 60 loci analysed in the 59 isolates. Isolates with 
less than 90% of sequence data correlating to the 60 SNP barcode were omitted from 
this analysis. 
Isolate 
Loci 
present 
(%) 
Sub 
lineage 
Isolate 
Loci 
present 
(%) 
Sub 
lineage 
BK1 100 T family GO6 100 Haarlem 
BK2 100 T family GO7 100 Haarlem 
BK3 100 T family GO8 100 X family 
BK4 100 
H37Rv-
like 
GO9 98 X family 
BK5 100 
H37Rv-
like 
LL1 100 X family 
BK6 98 
H37Rv-
like 
LL2 100 X family 
BK7 97 
H37Rv-
like 
LL3 100 X family 
BK8 98 LAM LL4 100 X family 
BK9 100 LAM LL5 100 Haarlem 
BK10 100 Haarlem LL8 100 Haarlem 
BK11 100 Haarlem LL9 100 Beijing 
BK12 100 X family LL10 90 X family 
BK13 98 X family LL11 100 X family 
BK14 100 X family NPTA1 100 T family 
BK15 100 X family NPTA2 100 T family 
BK16 100 X family NPTA3 100 T family 
BK17 100 X family NPTA4 100 T family 
BK18 97 X family NPTA5 100 T family 
BK19 97 T family NPTA6 100 T family 
BK20 100 LAM NPTA7 98 T family 
BK21 98 Beijing NPTA8 100 T family 
BK22 98 
Indo-
Oceanic 
NPTB1 98 T family 
BK23 97 Haarlem NPTB2 100 T family 
BK24 93 T family NPTB3 100 T family 
BK25 90 Beijing NPTB4 100 T family 
GO1 100 Haarlem NPTB5 100 T family 
GO2 100 Haarlem NPTB6 100 X family 
GO3 100 Haarlem TH1 100 Haarlem 
GO4 100 Haarlem TH2 100 Haarlem 
GO5 100 Haarlem    
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Twelve of the 16 X family isolates had 100% sequence data and could be split into three clonally 
related clusters correlating to spoligotypes: X1 (LL11, BK14, BK15), X2 (GO8, BK12) and X3 
(NPTB6, LL1, LL2, LL3, LL4, BK16 and BK17). These clusters differ at locus positions 1850119, 
541048 and 4229087 respectively. Despite lacking a full complement of sequence data for the 
60 loci, the other four X family isolates, GO9, BK13, BK18 and LL10 all contained polymorphisms 
for the X family. GO9 and BK13 were assigned to the spoligotypes X1 and X2 groups respectively, 
whilst BK18 and LL10 diverged from the rest of the X1/X3 isolates as seen in Figure 3.4. Fourteen 
(24%) isolates clustered as Euro-American Haarlem sub-lineage. Each Haarlem-assigned isolate 
could be split into those harbouring the polymorphism at loci 62657 and 891756 (LL5), those 
harbouring polymorphisms at genome positions 891756 and 107794 (TH1, TH2, GO1, GO2, GO3, 
GO4, GO5, GO6 and GO7) and those harbouring polymorphisms at all three loci: 62657, 891756 
and 107794 (LL8, BK10, BK11 and BK23). A further four isolates (BK4, BK5, BK6 and BK7) had a 
SNP barcode identical to that of H37Rv and were thus classed as H37Rv-like strains, correlating 
to spoligotype T1. Three of the remaining isolates (LL9, BK21 and BK25) were classified into 
lineage 2 Beijing isolates and the final isolate (BK22) to lineage 1 Indo-Oceanic. 
3.3.4: cgMLST association in the Welsh isolates 
Fifty seven of the 66 Welsh isolates originally sequenced had the necessary sequence quality 
required for cgMLST analysis by the Ridom SeqSphere software and were incorporated into a 
phylogeny that included 179 isolates previously characterised into lineages by Comas et al 
(2013), see section 3.2.4. Figure 3.6 highlights the association of 57 Welsh isolates with 
previously lineage-defined ones from the Comas et al (2013) study. The figure shows only a 
subset of the isolates included in the original analysis, with the original cgMLST including all 236 
isolates being too large to present, with clear labelling, within this study. The original cgMLST, 
see Appendix figure PH1, showed Welsh isolates only clustered with isolates of lineages 1, 2 and 
4 and thus only those isolates were included in the subset phylogeny shown in figure 3.6.
90 
 
Lineage 4 associations dominate the dataset, with a total of 53 Welsh isolates clustering with 
the previously defined lineage 4 isolates. All but one outbreak-associated isolate (with prefixes 
LL, NPTA, NPTB or GO) clustered with the lineage 4 isolates with only LL9 showing a separate 
association with lineage 2 isolates. The dataset also included a minority representing lineages 2 
(3 isolates) and 1 (1 isolate). The results showed a direct correlation to the SNP bar-coding 
results, which also highlighted a dominance of lineage 4 strains with a minority of lineages 2 and 
1 within the dataset (Figure 3.4). The 3 isolates (LL9, BK21, and BK25) that clustered with lineage 
2 ones also typed as lineage 2 by SNP bar-coding (Figure 3.4); the same was true for the lineage 
1 isolate. To conclude, cgMLST analysis showed an association of 57 Welsh M. tuberculosis 
isolates with ones that had been previously lineage defined in the previous publication by 
Gagneux et al (2013). 
The full phylogeny, including lineages 3, 5, 6 and 7, was also constructed and is shown in 
Appendix Figure PH1. The phylogeny results show that lineage 5 and 6 isolates were the most 
ancestral, clustering most closely with the M. canetti isolates used to root the phylogeny. 
Following lineages 5 and 6, lineage 1 isolates harboured the most ancestral position within the 
phylogeny, branching off before the rest of the M. tuberculosis lineages (lineages 2, 3, 4 and 7). 
Lineage 7 harboured an intermediate position between lineage 1 and lineages 2, 3 and 4 in the 
phylogeny.  Lineage 4 branches off from lineage 2 and 3, suggesting that it was ancestral to 
lineages 2 and 3. Lineage 2 and 3 then go on to branch off from each other.   
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Figure 3.6: A subset of the phylogeny based on the cgMLST 
association of 57 isolates between 66 Welsh isolates and 179 
isolates that were assigned a lineage in a previous study (see 
Appendix figure PH2 for the full phylogeny). Due to the large 
size of the original full phylogeny this figure only contains 
isolates from lineages whereby the Welsh isolates associated 
to and thus is a subset to allow clearer visualisation of each 
isolate. The scale bar indicates the genetic divergence 
relevant to branch length measured in units of allelic 
differences per gene across 2891 genes defined in the 
cgMLST scheme; see sections 2.3.1 and 3.2.4 for more 
details. 
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3.3.5: Statistical analysis of lineage association 
For each of the 57 Welsh isolates, the probability that a given one was related to one of the four 
major tuberculosis lineages (1, 2, 3 and 4) was calculated (see section 2.11 and 3.2.5 for details). 
Statistically there was 100% confidence in the lineage assignment of 50 isolates by cgMLST 
association with 179 lineage-defined isolates. Seven isolates could not be assigned a lineage with 
100% confidence (see section 2.11 and 3.2.5 for details). These included: isolates BK25, BK21, 
BK19, BK6, NPTA6, GO9 and LL10. Further details on the confidence statistics for each isolate 
can be found in appendix table PH4. 
To conclude, cgMLST analysis ascribed 50 out of 57 Welsh isolates to certain lineages with 100% 
confidence. The cgMLST analysis was not able to ascribe isolates BK25, BK21, BK19, BK6, NPTA6, 
GO9 and LL10 to a given lineage with 100% confidence.  
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3.3.6: Supporting genotype information 
3.3.6.1: Beijing Genotyping 
According to SNP bar-coding, three Beijing lineage isolates were found within the collection, LL9, 
BK21 and BK25 (Figure 3.4). PGG, cgMLST association and SNP bar-coding identified isolate LL9 
as PGG1 (Figure 3.1), lineage 2 (Figure 3.6), and Beijing sub-lineage (Figure 3.4). PGG and SNP 
bar-coding assigned isolates BK21 and BK25 as PGG1 and Beijing sub-lineage.  However, despite 
clustering amongst lineage 2 isolates in the original phylogeny by cgMLST (Figure 3.6), neither 
could be assigned with statistical confidence to lineage 2 (Appendix table PH4). LL9 and BK25 
were also classified as SCG2 isolates (Figure 3.3). Due to the lack of a full SCG SNP profile, BK21 
either belongs to SCG2 or SCG3a, see Appendix table PH1 for more details. To further elucidate 
their lineage 2 and Beijing sub lineage status, the Beijing genotype genetic markers, mut2, mut4 
and ogt genes, were investigated (see sections 3.2.6.1). Both LL9 and BK25 harboured all the 
relevant SNPs associated with the Beijing genotype (Table 3.3). BK21 did not harbour the mutT2 
arginine (R) at codon position 58, or the A nucleotide at position 36 within the ogt gene, both of 
which are associated with Beijing isolates, but did harbour the mutT4 gene polymorphism for 
Beijing genotype assignment (Table 3.3). Analysis of established Beijing genetic markers in Table 
3.3 supports the original assumption by SNP bar-coding (Figure 3.4) that isolates BK21 and BK25 
are Beijing genotype isolates and supports their cgMLST association with lineage 2 as postulated 
by their clustering positions in figure 3.6. 
94 
 
Table 3.3: A SNP analysis of the 3 well-characterised Beijing genotype markers in the 3 
Welsh isolates assigned by SNP bar-coding as Beijing isolates. 
Beijing genotype Single nucleotide polymorphisms 
Isolates mutT2 mutT4 ogt SCG 
LL9 R G A SCG2 
BK21 G G G 
SCG 
2/3a 
BK25 R G A SCG2 
Polymorphism: 
Ref>Beijing 
G > R at codon 
position 58 
C > G at nucleotide 
position 142 
G > A at nucleotide 
position 36 
 
 
To further investigate the lineage 2 Beijing status of isolates LL9, BK21 and BK25, further 
assessment, using 48 well characterised Beijing strain-specific SNPs, was carried out (section 
3.2.6.1.1). All 3 isolates contained numerous lineage 2 Beijing specific polymorphisms, which are 
shown fully in Appendix table PH2. The analysis provided further evidence confirming isolates 
LL9, BK21 and BK25 as being lineage 2 Beijing ones. In addition, the analysis across 48 loci 
provided further resolution into which Beijing strains showed the closest genomic relationship 
with isolates LL9, BK21 and BK25. Within the phylogeny analysis, both LL9 and BK25 showed a 
clonal relationship across the 48 SNPs, branching off together and sharing a recent branching 
event with BmyC20 and BmyC21 Beijing strains (Figure 3.7). Further analysis also showed the 
Beijing strain BmyC10 was the closest relative across the 48 defined SNPs to LL9 and BK25 (only 
2 SNP differences in both cases; Appendix table PH3a and PH3b). However, BK21 differed in its 
phylogenetic position from LL9 and BK25. BK21 was descended from a more ancestral branching 
event within the phylogeny, sharing a recent branching point and clustering with BmyC7 and 
Bmyc25 (Figure 3.7). Further analysis identified BmyC25 as BK21s closest relative amongst the 
known Beijing strains analysed (sharing only 2 SNP differences, see Appendix Table PH3a and 
PH3b).  
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Figure 3.7: Neighbour joining phylogeny tree based on 48 SNPs containing Welsh isolates 
LL9, BK25 and BK21 and 26 well characterised Beijing isolates from the Mestre et al. (2011) 
study. The scale bar represents the genetic distance between isolates which is measured 
in units of nucleotide differences across 48 SNP positions. Three isolates known to not be 
Beijing strains were included as controls, a known Haarlem strain (H), a non-Beijing Welsh 
isolate (BK4) and H37Rv, the reference strain. 
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3.3.6.2: Latin American Mediterranean (LAM) genotyping 
Three isolates within the dataset, BK8, BK20 and BK9, were assigned LAM sub-lineage status by 
SNP bar-coding (Figure 3.4). These harboured the LAM-specific polymorphism (G>A) at 
nucleotide position 309 within Rv0129c (Table 3.4) and had been assigned previously to the 
SCG5 cluster group (Figure 3.3). See section 3.2.6.2 for more details. 
Table 3.4: Table showing the presence or absence of a SNP at position 309 of gene Rv0129, 
for the isolates designated as a LAM sub-lineage isolates. The correlating SCG is shown in 
the right column.  
Supporting Genotype information for LAM isolates 
Isolate Rv0129c: Nucleotide at position 309 
(G/A) 
LAM isolate SCG 
BK8 A Yes 5 
BK20 A Yes 5 
BK9 A Yes 5 
3.3.6.3: Haarlem genotyping 
Fourteen isolates were assigned Haarlem sub-lineage status by SNP bar-coding (Figure 
3.4). The Haarlem polymorphisms within genes mtgC, ogt and ung were examined across 
the 14 isolates, see section 3.2.6.3. All but one harboured each of the three Haarlem-
specific polymorphisms (Table 3.5). LL5 showed no Haarlem-specific polymorphism and 
thus its assignment as a Haarlem strain was not supported by genotyping. 
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Table 3.5: Table showing the Haarlem polymorphisms within genes mtgC, ogt and ung in 
14 Welsh isolates.  
Supporting Genotype information for Haarlem family isolates 
Isolate mtgC ogt ung SCG 
LL5 Arg C G SCG 3b 
LL8 His G A SCG 3b 
BK23 His G A SCG 3b 
BK10 His G A SCG 3b 
BK11 His G A SCG 3b 
TH1 His G A SCG 3b 
TH2 His G A SCG 3b 
GO1 His G A SCG 3b 
GO2 His G A SCG 3b 
GO3 His G A SCG 3b 
GO4 His G A SCG 3b 
GO5 His G A SCG 3b 
GO6 His G A SCG 3b 
GO7 His G A SCG 3b 
Reference > 
Haarlem mutation 
Arg (CGC) > His 
(CAC) at codon 
position 182 
C > G at nucleotide 
position 44 
G > A at 
nucleotide 
position 501 
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3.3.6.4: X family genotyping 
Sixteen X family sub-lineage isolates were identified within the Welsh isolates by SNP bar-coding. 
SNP cluster grouping was not uniform across the X family-assigned isolates, with six being of the 
SCG-3c group and 10 being of the SCG-4.  The results in Table 3.6 show SCG-3c and SCG-4 isolates 
do not differ in terms of their X family polymorphisms despite being from different SNP cluster 
groups. See section 3.2.6.4 for more details.   
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Table 3.6: Presence of X family specific SNPs at loci Rv3221c and Rv2330 in the 16 Welsh 
isolates assigned as X family genotypes by SNP bar-coding. 
X clade supporting information 
Isolate Rv3221c ( n = 30) Rv2330 (n = 426) SCG 
GO8 A T SCG 3c 
GO9 A T SCG 3c 
NPTB6 A T SCG 4 
LL1 A T SCG 4 
LL2 A T SCG 4 
LL3 A T SCG 4 
LL4 A T SCG 4 
BK14 A T SCG 3c 
BK18 A T SCG 4 
BK15 A T SCG 3c 
BK12 A T SCG 3c 
BK13 A T SCG 3c 
BK16 A T SCG 4 
BK17 A T SCG 4 
LL10 A T SCG 4 
LL11 A T SCG 4 
X family mutation 
(Reference> X 
family) 
G > A C > T 
 
100 
 
3.3.6.5: Lineage 1 Genotyping 
Only one isolate, BK22, was assigned to lineage 1. Further genotyping confirmed BK22 as a 
lineage 1 non-Manila strain (Table 3.7), as it harboured six out of eight lineages 1 non-Manila 
related polymorphisms and no lineage 1 Manila-related polymorphisms. See section 3.2.6.5 for 
more details. 
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Table 3.7: Analysis of 17 SNPs specific to lineage  1 genotypes. The analysis was split into 
two sections, one showing the polymorphisms relevant to lineage 1 non-Manila strains 
and second showing polymorphisms correlating to lineage 1 Manila strains. 
Polymorphisms are highlighted in red. 
Single nucleotide polymorphisms for lineage 1 genotyping 
Non-Manila Gene Nucleotide 
position 
Mutation BK22 
Rv0005 990 G > C G 
Rv0006 1151 C > T T 
Rv0410c 1842 G > A A 
Rv0934 1022 C > T T 
Rv1996 52 C > T T 
Rv2462c 1086 T > C C 
Rv3132c 1680 G > C C 
Rv3221c 85 G > A G 
Manila Gene Nucleotide 
position 
Mutation BK22 
Rv0006 1959 G > C G 
Rv0164 415 C > A C 
Rv0288 28 G > A G 
Rv0410c 2117 T > C T 
Rv1009 724 G > A G 
Rv1996 157 G > C G 
Rv2030c 1137 G > A G 
Rv2031c 426 C > T C 
asRv3261 15 T > C T 
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3.3.7: Phylogenetic composition of outbreak isolates 
The phylogenetic composition of outbreak isolates was analysed. PGG`s 2 and 3 accounted for 
58 and 42% of the outbreak isolates respectively, whilst 3 SCG`s were present amongst the 
outbreak related isolates (Table 3.8). SCG-6 and SCG-3 dominated the dataset with 43 and 40% 
of the outbreak isolates respectively, with SCG-4 making up 17% of the dataset. The T family 
sub-lineage dominated the outbreak isolates with 39%, followed by the Haarlem sub-lineage 
which accounted for 33% and the X family which accounted for 27% of the isolates. 
Table 3.8: Composition of the outbreak-related isolates with regards to their PGG, SCG 
and sub-lineage assignments.  
 
Composition of outbreak isolates (%) 
PGG SCG Sub-Lineage 
PGG1 PGG2 PGG3 SCG6 SCG3 SCG4 Haarlem T family X family 
0 18(58) 13(42) 15(43) 14(40) 6(17) 11(33) 12(39) 9(27) 
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3.4: Discussion 
This chapter has provided the first insight into the phylogenetic diversity within a collection of 
M. tuberculosis isolates from South West Wales. Major lineage assignment was carried out 
successfully on 59 of the 66 isolates by the use of an established and robust SNP barcode method 
(Coll et al., 2014). The Welsh dataset was dominated by the Euro-American lineage (lineage 4), 
which accounted for 55 of the 59 isolates, and included a variety of different Euro-American sub-
lineages, including the Haarlem genotype. PGG, SCG and strain-specific genotyping supported 
the lineage and sub-lineage assignments within this study, providing the first correlations of 
these methods with the established SNP barcode method. This study found that a gene-by-gene 
cgMLST method has the potential to provide reliable phylogenetic assignment of isolates and 
could provide an alternative method to traditional SNP mapping. However, the cgMLST results 
need to be supported by others to obtain reliable phylogenetic assignments.  The predominance 
of the Euro-American lineage observed was not unexpected as this lineage is known to 
predominate across Europe (Gagneux et al., 2006, Ojo et al., 2010 Fenner et al., 2012, Fitzgibbon 
et al., 2013) and the proportion of Euro-American lineage strains here is similar to Public Health 
England data for TB cases in indigenous people (those born in each respective country) across 
the whole of the UK and Ireland (Ojo et al., 2010, , Fenner et al., 2012, Fitzgibbon et al., 2013, 
Public Health England., 2014). This study also identified 2% of the isolates as lineage 1 and 5% 
as lineage 2, again correlating with data for the indigenous population of the UK  (Public Health 
England., 2014) and Ireland (Fitzgibbon et al., 2013, Ojo et al., 2010). A low prevalence of lineage 
2 Beijing strains has also been found in Swiss and Swedish studies (Ojo et al., 2010, 
Ghebremichael et al., 2010, Fenner et al., 2012, Fitzgibbon et al., 2013).  
Based on a previously published method (Coll et al.,2014), the SNP bar-coding results provided 
major and sub-lineage assignments and showed that the sub-lineage composition of the Welsh 
dataset was diverse, which correlated well with other studies (Ojo et al., 2010, Fenner et al., 
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2012, Fitzgibbon et al., 2013). T, X and Haarlem sub-lineages accounted for 30%, 27% and 24% 
of the isolates respectively, whilst the Latin American Mediterranean, Beijing, H37Rv-like and 
Indo-Oceanic strains accounted for 5, 5, 7 and 2% respectively. A similar South West Ireland 
study also highlighted a high proportion of X family strains (26%) and low levels of LAM (4.1%) 
and Beijing (5.9%) strains (Ojo et al., 2010). However, the Welsh data described in this chapter 
showed a much higher proportion of the T and Haarlem sub-lineages than reported in the South 
West Ireland study (Ojo et al, 2010). Also, in contrast to these results, another more recent Irish 
study found that LAM isolates predominated, including amongst outbreak ones (Fitzgibbon et 
al., 2013). LAM isolates are most commonly found in the populations of Brazil, Africa and certain 
regions of the Mediterranean (David et al., 2012, Luiz Claudio Oliveira Lazzarini., 2012). Thus, it 
would be interesting to further investigate the presence of the LAM genotype in Wales and to 
assess whether the genotype is related to a certain target group, which could aid future control 
programmes.  
The outbreak cases within this dataset were dominated by T, Haarlem and X Sub-lineages.  
Previous studies have highlighted that the Euro-American lineage correlates with PGG2 and 
PGG3 (Gagneux et al., 2007, Reed et al., 2009, Zeinab et al., 2009, Rindi et al., 2014), and lineages 
1, 2 and 3 have been shown to be associated with PGG1 (Gagneux et al., 2007, Reed., 2009, 
Ramazanzadeh et al., 2009, Rindi et al., 2014). The results here are consistent with these 
previous studies, as each Euro-American lineage isolate was categorised as either PGG2 or PGG3, 
with Lineage 1 and 2 isolates classified as PGG1. The T Family and H37Rv-like isolates correlated 
only with PGG3, whilst the Haarlem, X family and LAM sub-lineage isolates grouped with PGG2. 
Analysis of the PGG data provided the first insight into the evolutionary makeup of the dataset. 
The evolution from PGG1 to PGG3 is sequential (Gutierrez et al., 2006), meaning PGG1 isolates 
represent ancient isolates, PGG2 isolates an intermediate group and PGG3 the most modern 
group (Sreevatsan et al., 1997., Millán-Lou et al., 2013). In this study, isolates of the Haarlem, X 
and LAM sub-lineages were assigned to PGG2. The ill-defined T family (PGG3) represents the 
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more modern strains, at least within the dataset used in this study, thus providing data that are 
an extension to results presented in previous studies (Sreevatsan et al., 1997, Millán-Lou et al., 
2013) as they did not describe an association between certain sub-lineages and PGGs. Isolates 
of PGG3 within this study clustered clonally and made up 42% of the outbreak isolates. Thus, 
these observations agree with the Millán-Lou et al. (2013) study, but contrast with the earlier 
work of Sreevatsan et al (1997) that PGG3 isolates are capable of being associated with clustered 
cases of M. tuberculosis and do not represent purely sporadic ones. SCG and sub-lineage-specific 
genotyping were also applied to this study. SCGs have been shown previously to correlate with 
spoligotype families, which in turn correlated with the sub-lineage assigned by the robust SNP 
barcode used here (Filliol et al., 2006, Gagneux et al., 2007). The results revealed a 
predominance of SCG-3 and SCG-6 isolates, with SCG-3b and SCG-6a being the most common. 
Unlike for PGG, the SCG analysis highlighted a large degree of divergence within the Euro-
American lineage, consistent with the diversity seen in the SNP barcode result. The SCG analysis 
highlighted a predominance of SCG-3b (15 isolates) and SCG-6a (16 isolates) in particular. 
Interestingly, all SCG-3b isolates were identified as Haarlem lineage strains by SNP bar-coding, 
thus agreeing with previous work that showed that SCG3b links with the Haarlem spoligotype 
(Filliol et al., 2006). In addition, Haarlem-specific genotyping confirmed that at least 14 isolates 
within this study can be confidently assigned to the Haarlem sub-lineage of M. tuberculosis. All 
LAM assigned isolates grouped as SCG-5, which correlated well with previous evidence (Filliol et 
al., 2006). The X and T family dominated the dataset, with all X family sub-lineage isolates being 
assigned to SCG-3c or SCG-4, as previously described (Filliol et al., 2006, Gagneux and Small., 
2007). X family-specific genotyping supported the findings of the SNP bar-coding results and 
found a specific association between particular X family spoligotypes, SCG-3c and SCG-4, that 
has not been shown previously. Essentially the study discovered that X family isolates 
harbouring the X1 or X2 spoligotype SNP barcode, exclusively correlated with the SCG-3c group, 
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whilst, X family isolates harbouring the X1 or X3 (X1; X3) spoligotype were exclusively SCG-4 
isolates (See Appendix Table PH1).  
Four isolates were identified as not Euro-American lineage ones. Three represented lineages 2, 
SCG-2, and one represented lineage 1, SCG-1. Both SCG-1 and SCG-2 have been described 
previously as correlating with PGG1 (Filliol et al., 2006). Unfortunately, the SCG of one isolate, 
BK21, could not be fully determined due to the lack of sequence data; it could either be a SCG-
2 or SCG-3a strain. However, BK21 was assigned to PGG1 and further analysis found it had a SNP 
barcode pattern associated with the lineage 2 Beijing sub-lineage and cgMLST analysis clustered 
it with Lineage 2 and it also contained Beijing-specific polymorphisms thus making it likely to 
have been part of SNP cluster group 2. Hence, these isolates demonstrated how the use of 
multiple methods can aid phylogenetic classification of isolates.  
In the context of the outbreaks included in this study, identifying the PGG and SCG groups of 
outbreak isolates and the spoligotype families and major lineages they associate to provides the 
first insight into the characteristics of the strains that compose the outbreak isolates. The 
dominance of the PPG2 and PGG3 groups provided the first indication that the outbreaks within 
this study were composed of strains of a more modern nature and are associated to the Euro-
american major lineage. In addition, the SCG analysis highlighted that the isolates of these 
outbreaks are associated to particular spoligotype clades. The SCG results supported the Euro-
american association first indicated by the PGG results and provided further information, 
showing that outbreak isolates correlated to the spoligotype families T, X and Haarlem. The SCG 
analysis showed that the outbreak isolates within this database included those associated to the 
Haarlem genotype which is known to include virulent strains (Mardassi et al., 2005, Marais et 
al., 2006, Khanipour et al., 2016). These robust classical SNP set analyses provided the first 
pieces of evidence that the outbreaks within this study were composed of physiologically 
modern Euro American lineage tuberculosis strains and indicated that a portion of outbreak 
isolates are associated to a genotype of known virulence (Haarlem genotype). 
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As stated previously, gene-by-gene MLST methods have proved useful in clinical outbreak 
resolution and epidemiological investigations of human pathogens such as MRSA and 
Campylobacter, as well as M. tuberculosis itself (Sheppard et al., 2012, Maiden et al., 2013). 
Specifically, the Ridom SeqSphere gene-by-gene cgMLST scheme has been used previously to 
look at tuberculosis outbreaks (Kohl et al., 2014), and heralds the advent of a portable, 
standardised database platform for the use of WGS data in tuberculosis research. However, the 
method has not been used previously for classification of M. tuberculosis into well-defined 
phylogenetic lineages. The cgMLST analysis provided confident assignments for 50 out of 57 
Welsh M. tuberculosis isolates according to statistical analysis, and statistical analysis found that 
48 of them had 100% probability of being Euro-American lineage 4 isolates, correlating well with 
the robust SNP barcode results. The association of isolates BK25 and BK21 to lineage 2 was not 
statistically supported, despite their clustering positions in the cgMLST phylogeny indicating an 
association with lineage 2 (figure 3.6). However, the PGG, SCG and SNP barcode results all 
supported the assignment of BK21 and BK25 to lineage 2 and further genotyping confirmed the 
presence of lineage 2 Beijing specific SNP`s within them. Therefore, the evidence suggests that 
currently, further results are needed to confirm the associations proposed by the cgMLST 
analysis and further work is needed to develop the cgMLST method and the way it is interpreted 
if it is to be used in a widespread manner for phylogenetic assignments as a standalone method.  
This study also presents the first phylogenetic tree containing all seven major M. tuberculosis 
lineages constructed based on a gene-by-gene method (Appendix figure PH1), as opposed to 
SNP mapping-based methods (Homolka et al., 2012, Gagneux et al., 2012, Comas et al., 2013). 
The structure of the resulting phylogeny broadly matched that seen for the same isolates (Comas 
et al., 2013), as in that study, lineages 1, 5 and 6 harboured the most ancestral positions in the 
phylogeny. Furthermore, cgMLST showed that lineage 7 isolates harboured an intermediate 
position between the “ancient lineages” (1, 5, and 6), and the modern lineages (2, 3 and 4), 
supporting its intermediate evolutionary position described previously (Comas et al., 2013, 
108 
 
Yimer et al., 2015). Consistent with Comas et al (2013), lineages 2 and 3 isolates shared a closer 
relationship with each other than with lineage 4 isolates. Therefore, despite using a separate set 
of genomic data, the evolutionary positions of each lineage according to cgMLST was consistent 
with other studies of a similar nature which used in-house SNP mapping pipelines for the 
construction of their phylogenies (Wirth et al., 2008b, Gagneux et al., 2012, Firdessa et al., 2013, 
Stucki and Gagneux., 2013, Comas et al., 2013). 
To confirm the lineage and sub-lineage results, specific genotyping markers for the Beijing, 
Haarlem, X family, LAM and lineage 1 sub-lineages were also investigated and supported the 
SNP bar-coding, PGG and SCG results. Specifically, strain-specific genotyping supported all LAM, 
Haarlem and X family assignments made by both SNP bar-coding. The results also showed that 
isolates LL9, BK21 and BK25 harboured Beijing strain-specific polymorphisms, supporting their 
assignment as lineage 2 isolates by SNP bar-coding.  
Additionally, strain-specific genotyping showed isolates LL9 and BK21 to be closely related to 
the Bmyc10 Beijing family of strains, which are the predominant group of globally disseminated 
Beijing strains (Mestre et al., 2011). BK25 was identified as more closely related to the ancient 
Beijing genotype Bmyc25, which again is disseminated globally and renowned as the causative 
agent of virulent outbreaks of M. tuberculosis (Caminero et al., 2001). Thus, two separate Beijing 
strains are present within this dataset, with BK25 potentially being of high virulence and worth 
further investigation.  
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3.5: Conclusions and future perspectives 
This chapter has described the use of classical PGG, SCG, robust SNP bar-coding, novel cgMLST 
analysis and strain-specific genotyping to analyse the phylogenetic make-up of M. tuberculosis 
isolates from across South West Wales. The isolate collection was found to be dominated by 
Euro-American lineage isolates, with lineages 1 and 2 also being present, but in low numbers. 
The isolates consisted of a diverse collection of Euro-American sub-lineages, which were not 
clearly dominated by a single group. T family, X family and the Haarlem family made up a large 
proportion of the dataset, with the Haarlem isolates being particularly prevalent within the 
outbreak-assigned cases. The dominance of the Euro-American lineage, as established by the 
SNP barcode, was supported by all analyses, including the novel cgMLST method. Although 
successfully providing assignment, with 100% confidence, to 50 isolates within this study, the 
cgMLST could not provide confident assignment to 7 isolates which were assigned to lineages 
and sub-lineages by SNP car-coding.  
This study provided only a snapshot of the M. tuberculosis diversity seen within Wales. Extending 
the number of samples would provide further data on the phylogenetics of M. tuberculosis 
across Wales in future. In addition, M. tuberculosis samples should be taken from across the 
country. The discovery of numerous Haarlem sub-lineage strains, and some Beijing strains also, 
was an interesting finding and further investigation into the epidemiology of such isolates in 
Wales would be worthwhile.  
  
110 
 
In conclusion, this study was the first to use a gene-by-gene method for phylogenetic analysis of 
M. tuberculosis isolates, clearly demonstrating the potential of cgMLST to provide a more 
convenient alternative to SNP mapping methods for phylogenetic analysis and global 
tuberculosis surveillance, especially as WGS of M. tuberculosis becomes more widespread in the 
future. Further work into perfecting the method for phylogenetic purposes is required to reduce 
the anomalies found in this study. In summary, the use of multiple WGS-based methods has 
provided an accurate and reliable snapshot of the phylogenetic diversity seen within South West 
Wales and demonstrated a novel use for cgMLST M. tuberculosis typing.  
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Chapter 4 
Analysis of an outbreak of M. tuberculosis in the 
Llwynhendy area of South West Wales using 
Whole Genome Sequencing. 
112 
 
4.1: Introduction 
Between 2009 and 2011, 11 cases of M. tuberculosis infection were reported in the Llwynhendy 
region of South West Wales. Each isolate was genotyped by MIRU-VNTR at the Public Health 
Wales Molecular Unit, Cardiff, using standard methods (section 2.1). Of the 11 isolates, nine had 
an identical MIRU-VNTR pattern and were deemed to be part of an outbreak related to a local 
public house. The remaining two isolates were originally excluded from the outbreak 
investigation as they differed in MIRU-VNTR type from the outbreak strains, although one did 
have strong epidemiological links to the outbreak, with the other being linked based only on 
geography and chronology.  
4.1.1: Epidemiology of Cases 
On 11th August 2010 the landlord of a Llwynhendy public house was diagnosed with pulmonary 
tuberculosis (LL1). The landlord had had symptoms of active disease since January 2010 but did 
not seek medical attention until later that year. He was part of a pool team that travelled to 
various public houses within the nearby Llanelli and Gorseinon areas, which were also included 
in the epidemiological investigation. Screening of contacts during August 2010 showed that the 
landlord’s wife (LL2) had contracted clinical tuberculosis, with a positive culture obtained in 
October 2010. She was a teaching assistant at a local primary school and, in addition, worked as 
a part-time chef at the public house. Public health authorities continued to investigate recent 
cases that might relate to the public house ones. Further investigations and contact tracing 
identified a neighbour (LL4) of the public house with tuberculosis and the mother-in-law of the 
landlord. The mother-in-law regularly socialised and holidayed with the landlord and his wife 
but did not frequent the public house and no further epidemiological links were found with 
anyone else within the local area. 
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Retrospective analysis identified another potential case connected with the public house 
outbreak. LL5 was an elderly lady diagnosed with tuberculosis in March 2010, with onset of 
symptoms dating back to November 2009, who regularly visited the public house, but did not 
live in its immediate area (LL5 is labelled green in figure 4.1). In addition, she also visited public 
houses in the Gorseinon region just east of Llwynhendy, where another outbreak of tuberculosis 
was being investigated (Chapter 6). A further two cases (LL6, LL7) were reported in late 2010. 
Both had visited the Llwynhendy public house around the time of the initial outbreak. 
Epidemiological investigations also identified another case (LL9) diagnosed in May 2010 who 
resided close to the public house. This individual was a recent immigrant who had only arrived 
in the UK in 2009. Another individual (LL10) from the Burry Port area, approximately 6 miles 
west of Llwynhendy (Figure 4.1), was diagnosed with tuberculosis in February 2011. In this case, 
the individual died from tuberculosis the same month, thus the epidemiological investigation 
was limited, but it was able to establish that the individual did commute to public houses within 
the Llanelli and Llwynhendy area. A final pub-related case (LL11) was identified in September 
2011. Epidemiological investigation showed that LL11 lived near the public house during the 
outbreak, prior to moving to a different part of the region. However, the individual still visited 
the public house once a week. 
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Figure 4.1: A map showing the locations of where potential cases associated with the 
Llwynhendy outbreak resided across South West Wales. Cases LL1, LL2, LL3, LL4, LL7 and 
LL11 all resided next to the public house are represented by a house symbol; and LL5, LL8 
and LL9 are shown as a green person. The 2 cases shown in blue were associated with the 
nearby Gorseinon outbreak. mi=miles, km=kilometres. Figure constructed using National 
Geographic MapMaker (https://mapmaker.nationalgeographic.org/#/).  
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All the isolates described above were typed using MIRU-VNTR and an identical pattern was 
obtained for LL1, LL2, LL3, LL4, LL5, LL6, LL7 and LL11 (Figure 4.2). In addition, the MIRU-VNTR 
typing matched an isolate from an individual (LL8), diagnosed in November 2010 that lived in 
Bridgend, 40 miles east of Llwynhendy (Figure 4.1). Despite the identical MIRU-VNTR pattern, 
epidemiological investigations could find no link between LL8 and the Llwynhendy outbreak. The 
recent immigrant LL9’s isolate also did not match the outbreak strains despite the close 
geographic association, so the epidemiological team concluded that this was an unrelated case 
brought into the area from the patient’s country of origin. LL10, the Burry Port case, also did not 
match the main outbreak according to MIRU-VNTR.  Two Gorseinon outbreak cases (GO8 and 
GO9, discussed further in Chapter 6), were thought to have a potential epidemiological link to 
LL5 despite being diagnosed in 2007 and 2008, but were found to have isolates with different 
MIRU-VNTR types. A summary of the epidemiological information on each case is outlined in 
Table 4.1, with LL1 (the landlord) suspected as the most likely source of the outbreak and 
potentially was a super-spreader.  
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Figure 4.2: Diagram showing the epidemiological relationship between each isolate with a 
confirmed or potential epidemiological link to the outbreak. Isolate LL9 had a different 
MIRU-VNTR type and no epidemiological link to the public house or any other isolate 
within the outbreak is excluded from this diagram. Different colours indicate different 
MIRU-VNTR types.  
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Table 4.1: Overview of the basic epidemiology and MIRU-VNTR results on the Llwynhendy 
tuberculosis outbreak cases, colour coded according to MIRU-VNTR including the two 
isolates from the Gorseinon outbreak. 
Isolate Location 
Date of 
Onset/ 
Diagnosis 
Attended 
the public 
house? 
Comments 
MIRU-VNTR 
match? 
LL1 Llwynhendy 
Jan-10/Aug-
10 
Yes Public house landlord Yes 
LL2 Llwynhendy Aug-10 Yes Wife of landlord Yes 
LL3 Llwynhendy Apr-11 No 
Mother-in-law of 
landlord 
Yes 
LL4 Llwynhendy Aug-10 Yes 
Neighbour and regular of 
the public house 
Yes 
LL5 Llangennech 
Nov- 
2009/Mar-
2010 
Yes 
Weekly regular of the 
public house, also 
connections with public 
houses associated with 
the Gorseinon outbreak 
Yes 
LL6 Llwynhendy Late 2010 Yes 
Frequented the public 
house 
Yes 
LL7 Llwynhendy Late 2010 Yes 
Frequented the public 
house 
Yes 
LL8 Bridgend Nov-10 No 
No epidemiological 
association with the 
outbreak 
Yes 
LL9 Llwynhendy May-10 No 
Recent immigrant 
residing close to the 
public house. 
No 
LL10 Burry Port Feb-11 Unknown 
Potentially linked to the 
outbreak public house 
No 
LL11 Llanelli Sep-11 Yes 
Frequented the public 
house and recently 
moved from Llwynhendy 
to Llanelli 
Yes 
GO8 Gorseinon 
Oct-2006/ 
Jan-2007 
No Potentially linked to LL5 No 
GO9 Gorseinon 
Feb- 
2007/April 
2008 
No Potentially linked to LL5 No 
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4.1.2: Chapter aims 
There were several aims in this chapter. The primary aim was to resolve the epidemiology of the 
Llwynhendy outbreak using WGS data, cgMLST and in silico functional prediction software to 
highlight physiological features of the polymorphisms found within the WGS of the outbreak 
isolates. Particular attention was given to the LL10 (Burry Port case) and LL8 (Bridgend case) with 
regards to their inclusion and exclusion from the outbreak, which were disputed by contact 
tracing. The relationship between LL5 and the two epidemiologically-associated cases from the 
separate Gorseinon outbreak (GO8 and GO9) were also resolved. The second aim was to identify 
the source case of this outbreak and exploit WGS data to provide evidence for a potential super-
spreader.   
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4.2: Methods 
4.2.1: Sample collection and gathering of epidemiological information 
Isolate DNA was obtained as described in section 2.1. The collection of each Llwynhendy related 
sample was carried out as described in section 2.1. The Epidemiological information described 
in the introduction was obtained from face-to-face interviews with a nurse from the original 
PHW contact tracing investigation team and from documents produced during the outbreak 
investigation.  
4.2.2: DNA sequencing 
DNA from each isolate was sequenced using an Illumina MiSeq platform as described in section 
2.2. The quality of the sequences produced was represented by Ridom SeqSphere as the 
percentage of “good targets”. The higher the percentage of good targets, the better the initial 
sequencing and the more genes were successfully aligned to the cgMLST scheme genes. 
4.2.3: Core genome MLST  
 The cgMLST within this analysis was based on the 2891 gene M. tuberculosis scheme created 
by the Ridom SeqSphere software and published previously (Kohl et al., 2014). The number of 
“good targets” varied with the inclusion of certain sequenced isolates with sub-optimal level of 
quality (sections 2.3 and 2.3.1). The isolate NPTB6, from the Neath Port Talbot outbreak was 
also included in this analysis, because the phylogenetic results presented in chapter 3 (figure 
3.4) assigned NPTB6 to the same sub-lineage as the Llwynhendy outbreak isolates. The resulting 
neighbour-joining and minimum-spanning trees were produced using the Ridom SeqSphere 
software. The threshold for direct transmission was set at 12 allelic differences as described 
previously in section 2.3 (Kohl et al, 2014, Walker et al., 2013). 
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4.2.4: Whole Genome Sequence SNP mapping 
Traditional SNP mapping was carried out by using the conserved signature indels (CSI) 
phylogeny application provided by the Centre of Genomic epidemiology online server, as 
described in section 2.5. 
4.2.5: Functional analysis 
Functional analysis of each non-synonymous mutation found within each isolate was carried 
out using a Provean algorithm, for identifying the significance of amino acid changes within 
proteins, as defined in section 2.5.3.  
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4.3 Results 
4.3.1 Initial Sequencing results  
Nine of the original 13 isolates included in this analysis aligned successfully to over 90% of the 
cgMLST scheme targets (Table 4.2), and thus were deemed reliable for further analysis. These 
were isolates LL1, 2, 3, 4, 5, 8, 9, GO8 and LL11. Isolates LL6, LL7, LL10 and GO9 aligned to less 
than 90% of the cgMLST scheme targets. Including these isolates would have reduced the 
number of genes within the cgMLST scheme and thus any conclusions on relationships between 
the isolates would not be valid according to the parameters set in this study for the cgMLST 
analysis (see section 2.3.1). Therefore, cgMLST analysis was only applied to those with good 
quality sequences (LL1, LL2, LL3, LL4, LL5, LL8, LL9, GO8 and LL11). 
Table 4.2: The percentage of good targets present in each isolate following sequencing. 
  
Isolate % Good Targets 
GO8 98.9 
GO9 67.5 
LL1 99.3 
LL2 92.3 
LL4 97.9 
LL3 97.7 
LL5 92.6 
LL6 8.2 
LL7 18.4 
LL8 99.2 
LL9 98.2 
LL10 58.1 
LL11 90.3 
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4.3.1.1: cgMLST 
Results of the cgMLST analysis on the 9 Llwynhendy isolates and NPTB6 are shown in Figure 4.3. 
Five isolates (LL1, LL2, LL3, LL4 and NPTB6) were found to share fewer than 12 allelic differences 
indicating that they were part of an outbreak complex. A further five isolates had >200 allelic 
differences with all other isolates in the analysis, thus were as not part of the same outbreak. 
These included 3 isolates with a matching MIRU-VNTR to the public house outbreak (LL5, LL8 
and LL11), the Gorseinon isolate GO8 and the suspected un-linked case LL9. The minimum 
spanning tree in Figure 4.3 showed that LL1 was central to the outbreak, being the closest 
relative to each isolate within the dataset. With regards to the number of allelic differences 
between each isolate within the outbreak complex individually (Table 4.3), only the relationship 
between isolate LL2 and NPTB6 exceeded 12 (the threshold for direct transmission), indicating 
that isolates from the outbreak had diverged recently. Appendix table LL1 provides a matrix of 
the allelic differences between all isolates within figure 4.3. 
LL10 (the case form Burry Port) was not included in the analysis because only 58.1% sequence 
alignment with the cgMLST had been obtained. However, for interest, when sequence data for 
LL10 were included it appeared within the outbreak complex, separated by 3 allelic differences 
(Appendix figure LL1).   
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Figure 4.3: A minimum spanning tree showing the number of allelic differences across the cgMLST scheme. Isolates are colour -coordinated to 
their MIRU-VNTR profile. Branch distances are not to scale. Numbers alongside branches represent the number of allelic differences between 
any two given isolates. The clouded region represents the isolates within the outbreak complex that share less than 12 alleli c differences. 
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Table 4.3: Distance matrix showing the number of allelic differences between each of the 
isolates represented in the outbreak complex defined in Figure 4.3. The greater the red 
intensity the more different the isolates are from each other. The greater the intensity of 
blue in the cells the more closely related the isolates are. 
Number of allelic differences  
Isolate NPTB6 LL1 LL2 LL3 LL4 
NPTB6 0 7 13 9 11 
LL1 7 0 8 2 4 
LL2 13 8 0 10 12 
LL3 9 2 10 0 6 
LL4 11 4 12 6 0 
 
4.3.1.2: Neighbour joining analysis of the outbreak complex 
A neighbour joining phylogeny was produced (Figure 4.4) based on only those five isolates that 
formed the outbreak complex defined in Figure 4.3. The neighbour joining tree showed LL1 to 
be ancestral to each isolate. Thus, in addition to being the central isolate within the outbreak, 
isolate LL1 also holds the most ancestral position within the phylogeny and appears to represent 
the source case. An early branching point separated isolates NPTB6 and LL2 from the cluster 
containing isolates LL1, LL3 and LL4, and suggests that an intermediate case, was the common 
ancestor of LL2 and NPTB6, and is likely to have been missed from in this analysis and would 
have held a position between the source case, LL1, and isolates NPTB6 and LL2.  
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Figure 4.4: Neighbour joining tree constructed using the core genome MLST scheme. The figure contains only the outbreak compl ex subset 
defined in Figure 4.3. The scale bar indicates the genetic divergence relevant to branch length measured in units of allelic differences across 
2891 genes defined in the cgMLST scheme.  
 
126 
 
4.3.2 Analysis of individual allelic differences 
Through analysing each individual allelic difference, it was possible to obtain more information 
with regards to the pattern of transmission that occurred amongst this closely related complex. 
A transmission pattern was established by examining at which point certain allelic differences 
occurred (Table 4.4). Analysis of individual allelic differences supported the results shown in 
Figure 4.3, indicating that cases LL3 and LL4 were directly infected by LL1, as each carried unique 
allelic differences in relation to LL1 and thus could not have been infected by one another. 
Interestingly, an allelic difference at Rv2195 was present in LL2 and NPTB6 but not in isolates 
LL1, LL3 and LL4 (Table 4.4). The observation corroborates that seen in Figure 4.4, where LL2 and 
NPTB6 have branched off from LL1, suggesting that the transmission between isolate LL1 and 
the subsequently more divergent LL2 and NPTB6 isolates was missing an intermediate case that 
harboured the Rv2195 allele.  
Table 4.4: A matrix highlighting each allelic difference between each isolate and the source 
isolate, LL1.  Cells are coloured green where the allelic difference is unique to the isolate, 
and red represents an allelic difference that occurred in more than one isolate in relation 
to LL1. 
Isolate LL1 
LL3 Rv0932c Rv3594             
LL4 Rv0103c Rv0126 Rv0551c Rv2137c         
NPTB6 Rv0133 Rv0663 Rv0959 Rv2678c Rv3635 Rv2195     
LL2 Rv1069c Rv1921c Rv2117 Rv2153c Rv2393 Rv2682c Rv3705A Rv2195 
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4.3.3: Traditional SNP mapping  
Traditional SNP mapping was applied to the five outbreak complex isolates (LL1, LL2, LL3, LL4 
and NPTB6) identified in Figure 4.3. The genomic distances between each given isolate in terms 
of SNPs across the whole genome of each outbreak associated isolate are shown in Figure 4.5 
and Table 4.5. SNPs were extracted using the CSI phylogeny application (see methods sections 
4.2.4 and 2.5,1 for more details). In each case, the (arbitrary) 12 SNP threshold for direct 
transmission was exceeded. Thus, based on this parameter no isolate can be deemed as being 
outbreak-related, according to this WGS SNP mapping result. However, the pattern matched 
that of the cgMLST results in Figure 4.3. As in the cgMLST phylogeny, isolate LL1 holds the 
ancestral position within the phylogeny and shows a closer relationship with LL3 and LL4. Also, 
as in the cgMLST phylogeny, isolates NPTB6 and LL2 are the most distantly related isolates and 
have a different branching point to isolates LL1, LL3 and LL4 again suggesting the presence of an 
intermediate case. Therefore, although the divergence between the isolates in the traditional 
SNP mapping results is greater, the conclusion on the pattern of relationships between the 
isolates is the same.  
 
Figure 4.5: A neighbour joining tree based on the WGS data obtained from the conserved 
signature indels (CSI) phylogeny analysis (see methods section 4.2.4 and 2.5.1 for more 
details) of the outbreak complex subset. The scale bar indicates the genetic divergence 
relevant to branch length measured in units of nucleotide differences per site across the 
WGS of each isolate. 
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Table 4.5: The number of SNPs present between each isolate defined as being part of the 
outbreak complex in Figure 4.3. The greater the red intensity the more different the 
isolates are from each other; the greater the intensity of blue the more closely related 
they are. 
  Number of SNPs across the Whole Genome  
Isolate NPTB6 LL1 LL2 LL3 LL4 
NPTB6 0 25 72 31 49 
LL1 25 0 59 14 30 
LL2 72 59 0 67 81 
LL3 31 14 67 0 36 
LL4 49 30 81 36 0 
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4.3.4: Functional analysis of the allelic differences within the Llwynhendy outbreak isolates. 
Allelic differences were found in 20 loci and the functional effect of each in isolates LL1, LL2, LL3, 
LL4 and NPTB6, according to Provean functional prediction software (section 4.2.5 and 2.5.3), is 
summarised in Tables 4.6a and 4.6b. The closest relative to LL1 was LL3, sharing two allelic 
differences within loci Rv0932c and Rv3594. According to Provean analysis, the allelic difference 
at locus Rv0932c had no effect on the respective protein function. The allele carried by LL3 for 
gene Rv3594 contained mutations at six different base positions (Table 4.6b). Each mutation 
was non-synonymous and according to Provean analysis the effect on the protein was not 
deleterious. LL4 harboured 4 allelic differences relative to LL1 (Rv0126, Rv0551c, Rv2137c and 
Rv0103c), one of which was synonymous and three were non-synonymous, with its RV2137c 
allele having a mutation that caused a deleterious effect on its respective protein (hypothetical 
protein). The most divergent isolate from LL1 was LL2 with eight allelic differences; one was a 
synonymous mutation in RV2153c and the remaining 7 were non-synonymous (Rv1069c, 
Rv1921c, Rv2117, Rv2195, Rv2393, Rv2682c and Rv3705A). According to Provean functional 
prediction, the effect of each non-synonymous allelic difference in LL2 was neutral. NPTB6 had 
7 allelic differences relative to LL1 (Rv0133, Rv0422c, Rv0663, Rv0959, Rv2678c, Rv2678c and 
Rv2195). These were non-synonymous mutations, with five (Rv0133, Rv0422c, Rv0663, Rv0959, 
Rv2678c and Rv2195) harbouring mutations predicted to have a deleterious effect on their 
protein functions. Isolates NPTB6 and LL2 both have a common allelic difference from LL1, at 
the Rv2195 locus. However, the mutation does not affect the function of the encoding protein.  
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Table 4.6a: A detailed matrix based on the allelic differences between LL1, LL2, LL3, LL5 and NPTB6. The matrix includes the allele number for 
each isolate as designated by the cgMLST scheme, allelic difference are synonymous or non -synonymous, SNP nucleotide (nt) and amino acid 
(aa) changes, and position of nucleotide (nt) changes. “X” refers to the deletions of the given nucleotide base or amino acid. The final two 
columns refer to the Provean results: Provean score ≤-2.0 = deleterious mutation, >-2.0 = neutral mutation.  
  
Allele number relevant to the 
cgMLST scheme 
 
Locus GenBank product 
LL
1
 
LL
2
 
LL
4
 
LL
3
 
N
P
TB
6
 Non-
synonymous 
/Synonymous 
SNP (nt) Position nt 
change 
aa 
change 
Provean 
score 
Functional 
effect 
Rv0103c 
cation-transporter P-type 
ATPaseB 
3 3 374 3 3 Synonymous G>C 1350 None None None 
Rv0126 
trehalose synthase/amylase 
TreS 
1 1 166 1 1 
Non-
synonymous 
A>G 1780 T>A 0.444 Neutral 
Rv0133 GCN5-like N-acetyltransferase 1 1 1 1 132 
Non-
synonymous 
deletion 
ACC>XXX 282-284 TP>XX -11.847 Deleterious 
Rv0422c 
hydroxymethylpyrimidine/  
phosphomethylpyrimidine 
kinase 
1 1 1 1 104 
Non-
synonymous 
A>G 652 T>A 2.26 Neutral 
Rv0551c fatty-acid--CoA ligase FadD8 1 1 270 1 1 
Non-
synonymous 
C>A 62 A>E 0.049 Neutral 
Rv0663 arylsulfatase AtsD 33 33 33 33 408 
Non-
synonymous 
C>A 729 H>Q -7.973 Deleterious 
Rv0932c 
phosphate ABC transporter 
substrate-binding lipoprotein 
PstS 
1 1 1 151 1 
Non-
synonymous 
ACC>GGT 333-335 P>V 0.141 Neutral 
Rv0959 hypothetical protein 1 1 1 1 354 
Non-
synonymous 
A>C 407 D>A -5.257 Deleterious 
Rv1069c hypothetical protein 1 271 1 1 1 
Non-
synonymous 
T>G 532 F>V 3.071 Neutral 
Rv1921c lipoprotein LppF 1 214 1 1 1 
Non-
synonymous 
C>A 291 S>R -1.979 Neutral 
Rv2117 hypothetical protein 1 48 1 1 1 
Non-
synonymous 
G>A 281 R>H -0.16 Neutral 
Rv2137c hypothetical protein 1 1 73 1 1 
Non-
synonymous 
G>A 190 G>R -7.765 Deleterious 
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Allele number relevant to the 
cgMLST scheme 
      
Locus GenBank product 
LL
1
 
LL
2
 
LL
4
 
LL
3
 
N
P
TB 6
 
Non-
synonymous 
/Synonymous 
SNP (nt) Position nt 
change 
aa 
change 
Provean 
score 
Functional 
effect 
Rv215
3c 
UDP-N-acetylglucosamine-N-acetyl 
muramyl-(pentapeptide) 
pyrophosphoryl-undecaprenol-N-
acetylglucosamine transferase 
17 225 17 17 17 Synonymous C>A 306 none none none 
Rv219
5 
ubiquinol-cytochrome C reductase 
rieske iron-sulfur subunit 
3 1 3 3 1 
Non-
synonymous 
G>A 40 A>T 0.029 Neutral 
Rv239
3 
Ferrochelatase 1 95 1 1 1 
Non-
synonymous 
A>G 116 E>G -0.118 Neutral 
Rv267
8c 
uroporphyrinogen decarboxylase 1 1 1 1 167 
Non-
synonymous 
G>A, 814 G>S -5.981 Deleterious 
Rv268
2c 
1-deoxy-D-xylulose 5-phosphate 
synthase 
1 213 1 1 1 
Non-
synonymous 
G>T 659 R>L -1.795 Neutral 
Rv359
4* 
hypothetical protein 1 1 1 95 1             
Rv267
8c 
transmembrane protein 1 1 1 1 277 
Non-
synonymous 
C>A 788 A>E -2.085 Neutral 
Rv370
5A 
proline-rich protein 1 123 1 1 1 
Non-
synonymous 
C>A 292 P>T -1.528 Neutral 
*Rv3594 analysis contains 6 mutations that are presented in Table 4.6b.  
Table 4.6b: Mutations observed within the Rv3594 gene of LL3 *represents a stop codon, and X represents the absence of that b ase or amino 
acid at that position. The columns are the same as in Table 4.6a but exclude the column for each isolates’ allelic numbers.  
Nucleotide 
position(s) 
Mutation(s) Non-synonymous 
/Synonymous 
Amino acid 
change 
Amino acid 
position 
Provean score Functional 
effect 
812 C>G Non synonymous P>R, 271 -0.698 Neutral 
816 X>G(insertion) Non synonymous X>R, 272 -0.26 Neutral 
819 A>G Non synonymous *>W, 273 0.565 Neutral 
821 C>X(deletion) Non synonymous H>X, 274 0.404 Neutral 
826-827 TA>GG Non synonymous V>G 276 0.016 Neutral 
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4.4: Discussion 
This chapter described methods for resolving whether 11 M. tuberculosis isolates from the 
Llwynhendy region of South West Wales were part of the same outbreak. In addition to 
evaluating the results of MIRU VNTR typing against WGS, this study also aimed to evaluate the 
epidemiological links made by the contact tracing team. Specifically, the study used a 
combination of cgMLST, WGS SNP mapping, detailed evaluation of each mutation, and a 
physiological prediction-based method to evaluate the Llwynhendy outbreak. The application of 
traditional SNP mapping provided evidence supporting the conclusions of cgMLST analysis, with 
the resulting phylogeny and pattern of genomic distances between isolates being similar. 
However, the number of SNPs seen between isolates through mapping was substantially greater 
than that seen by cgMLST analysis. This greater amount of divergence in SNP mapping in 
comparison with the cgMLST scheme was documented in a previous study (Kohl et al., 2014), 
although to a lesser degree. Unlike that study, the results presented here found a level of 
divergence that exceeded the 12 SNP threshold, indicating that there was no direct association 
between any isolate in this study. Due to the strong epidemiological links, especially between 
isolates LL1, LL2, LL3 and LL4, together with the cgMLST conclusions that showed LL1, LL2, LL3 
and LL4 to be closely related, it seems likely that the SNP mapping results seen here are not 
reliable. However, although the threshold provides a consistent parameter for analysing the 
outbreak status of isolates, it is arbitrary in its nature as it was developed elsewhere and based 
originally on different data and this should be considered when interpreting outbreak relations 
(Walker et al., 2013). In addition, as the actual pipeline used in the Kohl et al (2014) study was 
not disclosed publicly, a reliable comparison between the results presented in this chapter and 
other studies that have used in-house pipelines (Gardy et al., 2011, Walker et al., 2013, Walker 
et al., 2015), cannot be done due to the uncertainty that the parameters used were the same. 
This raises the issue of the need for standardized methods for M. tuberculosis outbreak 
investigations. However, the data presented here supports previous studies that found cgMLST 
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schemes provide a standardized method for analysis of a threshold for outbreak inclusion and 
exclusion which is reproducible across WGS datasets (Sheppard et al., 2012, Maiden et al, 2013).  
The results presented here show for the first time the application of sequencing carried out 
directly from M. tuberculosis boilate samples for outbreak investigation. Boilate extraction has 
previously and justifiably been criticized for its impure/lower yield of DNA, compared to other 
extraction methods used for sequencing (Aldous et al., 2005). The major advantages of using a 
boilate extraction for WGS are the lower cost, ease and speed (Aldous, et al,2005), particularly 
as the cost of sequencing and slow growth of M. tuberculosis are two key barriers in outbreak 
investigation. Boilate extraction using TE buffer has been documented to cost around 0.03$ a 
sample, one hundred times cheaper than the Infection Diagnostics, Inc (IDI) lysis tube extraction 
method which has been documented to yield the most and best quality DNA (Aldous et al., 
2005). This study provides proof in principle that combined with cgMLST this may be a useful 
cost-effective approach where resources are tight.  
Detailed evaluation of each mutation has not been described for other WGS-based 
investigations (Gardy, J et al., 2011, Walker T.M et al., 2013, Kohl, T.A et al., 2014, Walker, T.M 
et al., 2015). Provean analysis was used to predict the functional effect each mutation had on 
genes which differed amongst the outbreak isolates (Choi and Chan, 2015). If the amino acid 
change is neutral and so does not cause a functional difference, then clinically the mutation is 
probably not relevant. Out of a total of 25 mutations across the outbreak, 23 were non-
synonymous. Isolate LL2, despite carrying the most allelic differences, was physiologically 
identical to LL1. Allelic differences in LL4 also had no effect on its proteins. Therefore, in terms 
of both physiology and genomic relation, LL4 was the most similar to LL1.  NPTB6 contained the 
greatest number of deleterious allelic differences and thus had the potential to be the most 
different from LL1 in terms of physiology. The mutation in the RV0133 gene of NPTB6 is 
predicted to have a deleterious effect on an acetyltransferase protein which is a known 
membrane protein (Lew et al., 2011). The literature reports this gene to be non-essential to the 
growth of the H37Rv reference strain (Sassetti et al., 2003), and so the mutation of Rv0133 in 
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NPTB6 may not confer any clinically-relevant physiological change. Similarly, the mutation in 
Rv0663 is also reported to be non-essential to M. tuberculosis growth and unrelated to  virulence 
factors (Sassetti et al., 2003). NPTB6 did carry a deleterious mutation in its Rv2678c gene. The 
Rv2678c gene, hemE, is an essential gene for in vitro growth of the H37Rv reference strain 
(Sassetti et al., 2003). It has been identified as being a protein that can mediate drug resistance 
to isoniazid, ofloxacin, and ethambutol (Raman and Chandra, 2008). The protein produced by 
Rv2678c is a uroporphyrinogen decarboxylase and has been identified as a potential co-protein 
for inhibition of resistance amongst bacteria and is noted as a high confidence drug target 
(Raman and Chandra, 2008). Co-proteins are used by the resistome of bacteria as 
communication pathways between the drug target and resistance machinery. Simultaneous 
inhibition of the co-protein (often referred to as a co-target) and the primary protein for 
resistance aids the binding of the respective drug to the target binding site and allows the drug 
to become effective once again (Raman and Chandra, 2008). Therefore, the deleteriously 
mutated hemE gene in NPTB6 suggests NPTB6 lacks the ability to resist drugs via this protein. 
The mutations seen in Rv0959 in NPTB6 and Rv2137 were in hypothetical proteins, neither of 
which had known functions and thus no physiological information could be gleaned 
(TubercuList, 2017). In summary, Provean analysis has shown that each outbreak isolate was 
physiologically either identical or very similar.  
The contact tracing team raised the issue of a possible super--spreader related to the public 
house being central to the Llwynhendy outbreak. Such a question cannot be answered by MIRU-
VNTR typing, as stated previously (Walker et al., 2013a, Walker et al,. 2013b). This study found 
that WGS supported the outbreak team’s assumption that a super-spreader was present within 
the outbreak, and that LL1 was the likely candidate. The gene-by-gene analysis produced a 
phylogeny with a star-like structure (Figure 4.3), a feature previously shown to represent the 
presence of a super-spreader within an outbreak (Liu et al., 2006, Hirsh et al., 2004, Walker et 
al., 2013c, Kohl et al., 2014). The phylogeny showed cases LL2, LL4 and LL3 to originate from LL1 
(the landlord) at the centre of the phylogeny. The data agreed with previous work that showed 
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the published cgMLST scheme developed by Ridom SeqSphere can identify a potential super-
spreader, as can traditional SNP mapping (Walker et al., 2013 Kohl et al., 2014). Multiple factors 
are known to contribute to super-spreading such as immune suppression, late diagnosis/failure 
to diagnose, co-infection with another agent, airflow dynamics and delayed treatment (Stein et 
al., 2011). LL1 had onset of symptoms eight months prior to his hospital admission for treatment 
and this delay is likely to have contributed to his ability to infect a disproportionate number of 
secondary cases (Riley et al., 2003, Stein et al., 2011). More rapid case reporting has been shown 
to reduce the rate of secondary cases from super-spreading cases (Stein et al., 2011).  
The phylogenetic analysis described in Chapter 3 (Figure 3.4) led to the inclusion of isolate NPTB6 
in this analysis of the Llwynhendy outbreak. The cgMLST went on to suggest that the origin for 
NPTB6`s infection was the Landlord, case LL1. Although there was genomic evidence of a direct 
link between LL1 and NPTB6, the isolates were separated by a relatively larger geographical 
distance. At the time of the outbreak, no epidemiological evidence of links between NPTB6 and 
the Llwynhendy outbreak was sought, due to the geographical distance between the two 
outbreaks, and it having a different MIRU-VNTR type. Therefore, it would be interesting to 
investigate retrospectively the potential epidemiological links between NPTB6 and LL1. The 
findings of this analysis support previous claims that phylogenetic classification can provide data 
that is clinically relevant within tuberculosis outbreaks (Gutacker et al., 2002, Filiol et al., 2006, 
Coll F et al., 2014). 
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4.5 Conclusion 
WGS, through cgMLST analysis, was used to investigate a TB outbreak in Llwynhendy, South 
West Wales. Four out of 11 cases considered part of the outbreak by MIRU-VNTR were found 
not to be according to WGS. WGS also identified an isolate, NPTB6, as clonally related to the 
outbreak. This association had not been detected by MIRU-VNTR typing or epidemiological 
investigation and was only picked up by WGS because prior phylogenetic analysis had identified 
a similarity. Additionally, WGS analysis allowed the construction of a transmission chain and 
identification of a super-spreader. Provean analysis of the amino acid changes that occurred 
because of the DNA SNP mutations within the outbreak isolates highlighted the potential 
advantages WGS analysis provides in addition to strain typing and outbreak resolution. To 
summarize, 5 isolates were confirmed to be part of a direct transmission chain within the 
Llwynhendy outbreak in South West Wales, and the study established LL1 (the landlord) as the 
likely origin of the outbreak and potential super-spreader.  
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Chapter 5 
Resolution of an outbreak of Mycobacterium 
tuberculosis in the Neath Port Talbot area of South 
Wales using Whole Genome Sequencing. 
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5.1 Introduction  
On the 11th of September 2006 an outbreak of tuberculosis in the Sandfields area of Port Talbot, 
South Wales, came to the attention of Public Health Wales. The outbreak involved eight cases 
with cultured isolates and appeared to be circulating amongst individuals who frequented five 
local public houses within the Sandfields area, with one public house, Public House X, having 
connections to several cases in the outbreak. The outbreak sparked a review by Public Health 
Wales of tuberculosis case records in the area and continued until 2011. Over this period a 
further five cases were reported and molecular typing, through MIRU-VNTR profiling, was 
carried out on each isolate.  
5.1.1 Epidemiology and Typing of Neath Port Talbot Outbreak Cases 
Contrary to the assumptions of the outbreak investigation team based on contact tracing data, 
the isolates did not show a single MIRU-VNTR pattern, despite geographical, chronological and 
epidemiological connections between several of the cases. Two MIRU-VNTR profiles were 
identified within the isolate collection (Table 5.1), thus the outbreak investigation team assigned 
the isolates as either “A” or “B” strains according to their MIRU-VNTR profile (Table 5.1). In 
addition, isolate NPTB2, harboured a further polymorphism at the ETR C locus (Table 5.1, isolate 
coloured green), which was not present in other “A” or “B” isolates.  
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Table 5.1: A descriptive summary of each outbreak case and their MIRU-VNTR patterns, generated by the PHW molecular unit. NPTA isolates 
are highlighted in blue; and NPTB isolates are in red, except for nptb2, coloured  green as it differs from the other NPTB isolates at locus ETRC.  
Case 
Date of 
Diagnosis 
(month-
year) 
Onset of 
disease 
(month-
year) 
Attended 
Public House 
X 
Strain 
MIRU-VNTR profiles 
ET
R
A
 
ET
R
B
 
ET
R
C
 
ET
R
D
 
ET
R
E 
M
IR
U
2 
M
IR
U
1
0 
M
IR
U
1
6 
M
IR
U
2
0 
M
IR
U
2
3 
M
IR
U
2
4 
M
IR
U
2
6 
M
IR
U
2
7 
M
IR
U
3
9 
M
IR
U
4
0 
NPTA1 May-04 May-04 Yes (landlord) A 3 2 4 3 3 2 3 1 2 5 1 3 3 2 2 
NPTA2 Apr-05 Apr-05 Unknown A 3 2 4 3 3 2 3 1 2 5 1 3 3 2 2 
NPTA3 Jun-05 Jun-05 Unknown A 3 2 4 3 3 2 3 1 2 5 1 3 3 2 2 
NPTA4 Nov-05 Nov-05 Yes A 3 2 4 3 3 2 3 1 2 5 1 3 3 2 2 
NPTA5 Jun-06 Jun-06 Yes A 3 2 4 3 3 2 3 1 2 5 1 3 3 2 2 
NPTA6 Aug-06 Aug-06 Yes A 3 2 4 3 3 2 3 1 2 5 1 3 3 2 2 
NPTA7 Feb-07 Nov-06 Yes** A 3 2 4 3 3 2 3 1 2 5 1 3 3 2 2 
NPTA8 Apr-07 Apr-07 Unknown A 3 2 4 3 3 2 3 1 2 5 1 3 3 2 2 
NPTB1 Oct-05 Oct-05 Unknown B 3 2 4 3 3 2 3 1 2 5 1 5 3 2 4 
NPTB2 Feb-06 Feb-06 Unknown B 3 2 3 3 3 2 3 1 2 5 1 5 3 2 4 
NPTB3 Nov-06 Mar-06 Unknown B 3 2 4 3 3 2 3 1 2 5 1 5 3 2 4 
NPTB4 Jan-07 Jan-07 No B 3 2 4 3 3 2 3 1 2 5 1 5 3 2 4 
NPTB5 Jun-09 Jun-09 No B 3 2 4 3 3 2 3 1 2 5 1 5 3 2 4 
NPTB6 Oct-11 2007-2011 Unknown B 3 2 4 3 3 2 3 1 2 5 1 5 3 2 4 
**NPTA7 did not admit to frequenting Public House X, but information acquired during contact tracing suggested that he did. 
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5.1.2 Proposed transmission chain 
The index case, that had pulmonary tuberculosis, was the landlord of Public House X. This case 
was identified in May 2004 (NPTA1) and contact tracing of close contacts and the pub’s regular 
customers was carried out promptly. Contact tracing at the time detected no other cases. The 
landlord believed he had caught the infection from workers who had been visiting the public 
house before and at the time of his infection. However, between April 2005 and September 
2006, a further 5 cases of pulmonary tuberculosis (NPTA2, NPTA3, NPTA4, NPTA5, NPTA6) were 
identified in persons with connections to the public house (Table 5.1). NPTA5 stated that they 
did not frequently visit the public house, whilst NPTA6 was a woman who was a regular at Public 
House X and at other public houses within the area. She also lived and socialised frequently with 
people in sheltered accommodation. In September 2006, Public Health Wales assembled the 
Neath Port Talbot (NPT) outbreak team. In early 2007, another male was diagnosed with 
pulmonary tuberculosis (NPTA7) within the outbreak area, with a MIRU-VNTR matching that of 
the NPTA strains. This case had an onset of tuberculosis-related symptoms several months prior 
to his diagnosis. Despite being known to other cases as being a regular at Public House X, he 
denied that this was the case. At this point all isolates had a matching MIRU-VNTR profile, 
classifying them as belonging to outbreak A (Table 5.1). 
In November 2006, a case of tuberculosis (NPTB3) was diagnosed in the same area, with disease 
onset likely to have been several months prior to diagnosis. However, NPTB3 had a MIRU-VNTR 
profile that differed at two loci from the ‘A’ strains (Table 5.1). In early 2007, the estranged wife 
of NPTB3 was diagnosed with pulmonary tuberculosis (NPTB4), and with the same MIRU-VNTR 
type. Thus, the contact tracing team were confident that NPTB3 and NPTB4 shared a direct 
transmission event, and an MIRU-VNTR profile was assigned as Neath Port Talbot ‘B’ (NPTB). 
Retrospective investigations identified case NPTB2, diagnosed in February 2006, as possibly 
being part of the NPTB outbreak; although NPTB2 showed a single locus difference (ETRC) from 
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the other ‘B’ genotype cases (Table 5.1). In April 2007, a further NPTA case (NPTA8) was 
identified in the area although there was no apparent epidemiological link between the case 
and any public house or other case within the area.  A further ‘B’ strain case (NPTB5) was then 
diagnosed in June 2009 in Pontypool, 50 miles away from the outbreak area, but there were no 
apparent epidemiological connections between NPTB5 and the NPT outbreak despite the MIRU-
VNTR match. The contact tracing team considered it unlikely that the case was directly linked to 
the NPT cases. Further retrospective typing identified another case from the area (NPTB1), 
diagnosed in May 2005. NPTB1 was then deemed the earliest isolate in the ‘B’ outbreak as the 
identification of NPTB1 showed that chronologically ‘A’ and ‘B’ strains had co-existed. In 
addition, further contact tracing also found NPTB1 to have an indirect link with Public House X, 
as her husband was a regular at the pub.  At this stage, the contact tracing team began to 
question the heterogeneity of the ‘A’ and ‘B’ genotypes. The team felt it likely that evolution 
had occurred between cases, changing the MIRU-VNTR profile at two loci, and that probably the 
‘B’ isolates were directly related to the ‘A’ ones. In October 2011, a further and final MIRU-VNTR 
‘B’ type strain was identified (NPTB6). This case had been exposed twice to TB over the previous 
four years (2007-2011) and was a close childhood friend of the landlord of Public House X 
(NPTA1). By 2011, fourteen isolates had been reported to be connected to the NPT outbreak 
with 8 of type ‘A’ and 6 of type ‘B’. Figure 5.1 below provides a diagrammatic view of the 
epidemiological connections relative to public house X. 
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Figure 5.1: Diagram showing the epidemiological relationship between each isolate with a 
confirmed or indirect epidemiological link to the outbreak. Hard connecting li nes 
represent a direct epidemiological link. The dashed connecting lines represent an indirect 
link. The public house labelled within the figure represents public house “X”.  
 
In addition to being sceptical about the presence of two separate outbreaks, the outbreak team 
also questioned NPTB5`s inclusion in the ‘outbreak’, as the case was geographically and 
epidemiologically separate from the other outbreak isolates. It was also believed that a “super 
spreader” was likely to be present within the outbreak, with NPTA6 or NPTA1 being the most 
likely candidates. The team desired further confirmation that NPTA1, the landlord, was the 
source of the outbreak and that the Public House X was central to the outbreak, but classical 
molecular typing could not answer these questions.  
  
• MIRU-VNTR=NPTA 
• MIRU-VNTR=NPTB 
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5.1.3: Aims 
The primary aim of this study was to use WGS data to resolve the uncertainties surrounding the 
Neath Port Talbot M. tuberculosis outbreak(s) and identify the source case and any potential 
super spreaders within this outbreak(s). Both the established cgMLST scheme and an in-house 
cgMLST scheme was used to resolve whether the NPTA and NPTB outbreaks were actually one 
large outbreak, and whether NPTB5 was wrongly included in the outbreak by MIRU-VNTR. A 
novel ancestral dating method was introduced to provide evidence on the origin of outbreak 
isolates, whilst also elucidating the presence of micro-evolution within the outbreaks. As stated 
in chapter 4 and shown in chapter 3 (figure 3.4), NPTB6 clusters as the same sub lineage as the 
isolates from the Llwynhendy outbreak (Chapter 4). Previous cgMLST analysis in chapter 4 also 
showed NPTB6 to have a direct relation to isolates of the Llwynhendy outbreak (chapter 4). Thus, 
within this chapter, we aim to confirm the exclusion of NPTB6 from the Neath Port Talbot 
outbreak 
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5.2 Methods 
5.2.1: Sample collection and epidemiological information 
Isolate DNA was obtained as described in section 2.1. The collection of each Neath Port Talbot 
related sample was carried out as described in section 2.1. The Epidemiological information 
described in the introduction was obtained from face-to-face interviews with a nurse from the 
original PHW contact tracing investigation team and from documents produced during the 
outbreak investigation.  
5.2.2: DNA Sequencing 
A total of 14 isolates (Table 5.1) were sequenced initially, as described in section 2.2, through a 
Nextera XT protocol. Isolates were also processed by ancient DNA based BEST methods (Section 
2.13.1 and 2.13.2).   
5.2.3: Phylogenetic filtering of original dataset 
The robust SNP barcode, presented in Chapter 3, Figure 3.4, provided a phylogenetic 
classification for each of the 14 outbreak-associated isolates included in the Neath Port Talbot 
outbreaks.  A further three background isolates (BK1, BK2 and BK3) also clustered clonally as T 
family isolates and were included in further downstream analysis. 17 isolates (the 14 Neath Port 
Talbot isolates and the 3 T family background cases) were included in further analysis. 
5.2.4: Core genome MLST (cgMLST) analysis 
5.2.4.1: Established cgMLST scheme 
A cgMLST scheme developed by Ridom seqSphere (Junemann et al., 2013) (section 2.3.1.), based 
on 2981 core genes was used to analyse the relationship between each of the 17 isolates 
selected following phylogenetic filtering. The 17 isolates include 3 background ones with 
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phylogenetic associations in addition to the 14 previously defined Neath Port Talbot outbreak 
isolates. 
5.2.4.2: In-house core genome MLST (cgMLST) scheme 
An in-house cgMLST was developed containing all genes present across the 16 isolates (section 
2.3.2) Each NPT isolate sequence was included in the “cgMLST definer” application, which used 
M. tuberculosis H37Rv as a reference genome. NPTA6 was removed from the final in-house 
cgMLST scheme as its inclusion significantly reduced the number of genes that could be 
included. The resulting in-house core genome MLST scheme consisted of 2562 loci, present in 
high quality across each isolate. 
 
5.2.5:  SNP analysis 
5.2.5.1: Extraction of individual mutations  
Using the method described in section 2.5.2, single nucleotide polymorphisms (SNPs) were 
extracted from 2981 core genes from the consensus sequence of outbreak 1 and outbreak 2 
(defined in Figure 5.2 by the core genome MLST threshold of 12 allelic differences, see methods 
section 2.3.1). 
5.2.5.2: Prediction Functional Genomic  
The prediction of the functional effect of each mutation present within the dataset was carried 
out using the Provean software, described in section 2.5.3. 
5.2.6: WGS SNP mapping 
The published Centre of Genomic Epidemiology online server (Kaas et al., 2014) was used to 
produce a WGS SNP mapping phylogeny for the outbreak isolates using the conserved signature 
indels (CSI) phylogeny pipeline (section 2.5).  
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5.2.7: Ancestral dating 
Ancestral dating was carried out as described in section 2.4. SNPs were extracted from the 
consensus of the largest outbreak (outbreak 1) and the individual isolates of the smaller 
outbreak 2.  A total of 90 SNPs was concatenated, and their ancestral dating was calculated as 
described in section 2.4. A cgMLST common across NPTB2, NPTB4 and the consensus of the 
NPTA outbreak was used, with BEAST software indicating the date of the most recent common 
ancestor (TMRCA) between the two outbreaks. 
5.2.8:  Statistical calculation of average variation between cgMLST schemes 
The number of allelic differences between each isolate and the remaining isolates within the 
dataset was taken from both the established and in house core genome MLST results and the 
average number of differences each isolate had across the whole dataset was calculated using 
MS Excel (2013). These values were then used to determine the average amount of variations 
seen across the dataset for both cgMLST schemes. An unpaired T-test was used to calculate 
the P Value for whether the amount of variation seen in the results of the in house cgMLST 
scheme and Established cgMLST scheme is different. See section 2.15 for further details. 
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5.3 Results 
5.3.1 Outbreak resolution using the cgMLST scheme 
The results of the cgMLST are presented in Figure 5.2 and include those from three background 
isolates (BK1, BK2 and BK3) analysed as they were assigned the same sub-lineage in the 
phylogenetic analysis shown in Figure 3.4. The use of the established cgMLST scheme, revealed 
that there were technically isolates from two outbreaks present within the NPT dataset, but 
their composition did not correlate with the MIRU-VNTR typing defined outbreaks, NPTA and 
NPTB (Table 5.1). The outbreaks defined by cgMLST contained 9 isolates in outbreak 1 and 2 in 
outbreak 2.   In outbreak 1 there were six NPTA isolates, one NPTB isolate (NPTB1) and BK2, 
previously thought of as an unrelated background case. NPTA3 showed 16 allelic differences 
from its closest relative (NPTA7) and thus according to the definition of no more than 12 allelic 
differences (Walker et al., 2013, Kohl et al., 2014) could not be directly linked to the outbreak. 
Five isolates showed no evidence of direct transmission with any other isolate within the 
dataset: these included three NPTB isolates (NPTB2, NPTB5 and NPTB6), and two background 
ones (BK1 and BK3).  
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Figure 5.2: A minimum spanning tree of 17 cases constructed using Ridom SeqSphere 
software and based on a 2891 cgMLST scheme. Blue=NPTA, Red=NPTB, 
Green=Background. Isolates sharing less than 12 allelic difference are classed as direct 
transmission links and are thus part of a clonal outbreak and are grouped according with 
light blue = outbreak 1, and red=outbreak 2.  
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According to cgMLST, NPTA7 was the source case within this outbreak, having a direct link with 
seven out of the nine outbreak 1 cases, suggesting that NPTA7 was the potential super-spreader. 
Isolates NPTB3 and NPTB4 were similar enough to indicate direct transmission and make up 
outbreak 2. No other NPTB isolate showed any direct link with any other NPTB isolate, with 
NPTB1 in fact appearing to be directly linked with the NPTA outbreak isolates.   
5.3.2 Mutation breakdown 
The SNPs relevant to the consensus of allelic differences between outbreaks 1 and 2 were 
extracted for analysis as described in sections 2.7 and 5.2.5. The proportion of synonymous to 
non-synonymous mutations seen between the consensus sequence of Outbreaks 1 and 2 (Figure 
5.2) showed a predominance of the latter between the two outbreaks (Table 5.3). Twenty-two 
of a total of 31 mutations were non-synonymous.  
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Table 5.2: Synonymous and non-synonymous mutations, by gene, between the consensus 
sequences of outbreaks 1 and 2. The dS/dN ratio is the ratio of synonymous to non-synonymous 
mutations seen between the two outbreaks. Only genes present across each of the isolates in 
outbreak 1 and 2 are compared. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.3.3 Functional Analysis 
Of the 22 non-synonymous mutations in outbreak 1 and 2 isolates, a Provean algorithm, 
(sections 2.5.3 and 5.2.5.2), predicted 7 to have a deleterious effect on their respective protein 
(negative score), and 15 non-synonymous mutations that had no predicted effect on their given 
protein (positive score), thus classified as neutral mutations (Table 5.3).
Composition of Variants 
Synonymous Non-synonymous 
Rv0259c Rv0695 
Rv0272c Rv0696 
Rv0275c Rv0913c 
Rv0397A Rv0933 
Rv1858 Rv0987 
Rv2141c Rv1171 
Rv2875 Rv1304 
Rv3586 Rv1411c 
Rv3675 Rv1482c 
 Rv1551 
 Rv1688 
 Rv1931c 
 Rv2207 
 Rv2284 
 Rv2536 
 Rv2694c 
 Rv2737c 
 Rv2911 
 Rv2990c 
 Rv3090 
 Rv3554 
 Rv3802c 
Total:9 Total:22 
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Table 5.3: Functional analysis on the non-synonymous mutation genes between outbreak 1 
and outbreak 2.  aa change column - codon position, outbreak 1 allele and outbreak 2 allele. aa 
- amino acid; * - stop codon. 
Functional effect of non-synonymous variants 
Gene Product aa 
change 
Provean 
Score 
Effect 
Rv0695 mycofactocin system creatinine amidohydrolase 
family protein MftE 
216,P,A -7.567 Deleterious 
Rv0696 mycofactocin biosynthesis glycosyltransferase 
MftF 
16,G,R 2.037 Neutral 
Rv0913c Dioxygenase 376,D,A 1.215 Neutral 
Rv0933 phosphate ABC transporter ATP-binding protein 
PstB 
150, W,* -21 Deleterious 
Rv0987 adhesion component ABC transporter permease 139,G,R -0.196 Neutral 
Rv1171 hypothetical protein 124,V,I 0.505 Neutral 
Rv1304 ATP synthase subunit A 222,F,L -3.742 Deleterious 
Rv1411c lipoprotein LprG 157,R,G -3.9 Deleterious 
Rv1482c hypothetical protein 23,R,S 2.067 Neutral 
Rv1551 acyltransferase PlsB 566,S,F -5.741 Deleterious 
Rv1688 3-methyladenine DNA glycosylase 116,A,T -1.272 Neutral 
Rv1931c transcriptional regulator 114,P,T 0.832 Neutral 
Rv2207 nicotinate-nucleotide-dimethylbenzimidazol 
phosphoribosyltransferase 
105,A,T 1.548 Neutral 
Rv2284 esterase LipM 276,G,D 5.47 Neutral 
Rv2536 transmembrane protein 155,E,K -1.404 Neutral 
Rv2694c hypothetical protein 2,G,E -0.304 Neutral 
Rv2737c recombinase A 522,S,P -0.007 Neutral 
Rv2911 penicillin-binding protein DacB2 97,*,Q -8.19 Deleterious 
Rv2990c hypothetical protein 139,D,G -5.611 Deleterious 
Rv3090 alanine/valine-rich protein 17,G,V 1.056 Neutral 
Rv3554 electron transfer protein FdxB 16,P,T 0.047 Neutral 
Rv3802c membrane protein 259,W,R 7.128 Neutral 
Total:22 
Interestingly stop codons were identified in Rv2911 of outbreak 1 strains, and in Rv0933 of 
outbreak 2 strains. The presence of these is likely to cause truncations across the remainder of 
the gene, thus explaining how the mutations at Rv2911 and Rv0933 confer the most negative 
Provean analysis values of -8.19 and -21 respectively. 
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5.3.4 Outbreak resolution using an in-house core genome MLST scheme 
The in-house cgMLST scheme included 2562 genes and the generated phylogeny results are 
presented in Figure 5.3.  Isolate NPTA6 only aligned succesfully to 66 % of the potential in-house 
cgMLST “targets” and since its inclusion substantially reduced the number of genes that could 
be analysed to 1919 genes it was excluded. Again the threshold for outbreak inclusion was <12 
allelic differences (Kohl et al., 2014, Walker et al., 2013). Compared to the results shown in 
Figure 5.2, it has slightly different features with regards to the relation of NPTB1 and NPTA7 to 
outbreak 1, but as a whole has the same phylogenic shape as seen using the published cgMLST 
scheme (Figure 5.2). In contrast to that result, the phylogeny has NPTA8 as the central isolate 
while NPTA7 appears to have no direct relationship to the outbreak cases. In addition NPTB1, 
which was outbreak- related in Figure 5.2, showed a higher level of divergence and exceeded 
the 12 allelic difference threshold for direct transmission within outbreak 1.  
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Figure 5.3: A minimum spanning tree generated by in-house cgMLST and based on 2562 
genes present with high quality scores across each isolate within the dataset. Blue = NPTA 
,Red = NPTB, Green = background. Numbers adjacent to branches represent the number 
of allelic differences between given isolates. 
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5.3.5 Comparison between the in-house and established cgMLST schemes 
The average number of allelic differences seen between strains for the two cgMLST schemes are 
shown in Figure 5.4.  Across the isolates included in the established and in-house cgMLST 
analyses respectively, the in-house cgMLST scheme showed fewer differences between strains 
with an average 97 allelic differences per strain compared with an average 109 per strain for the 
established scheme. However, the variation (amount of allelic differences) between isolates was 
not significantly different (P>0.05) in one cgMLST scheme over the other (see section 5.2.8). 
Thus despite using a different set of core genes, the resulting relationships between isolates on 
average are not significantly different when using either the in house or established cgMLST 
scheme.  
 
 
 
 
 
 
 
 
 
 
Figure 5.4:  A graph showing the average number of allelic differences across the total 
set of isolates. 
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5.3.6 Whole Genome Sequence SNP mapping 
The SNP mapping shown in Figure 5.5a and Table 5.4, highlight the degree of divergence seen 
between the outbreak isolates when analysed using the published Centre of Genomic 
Epidemiology  SNP mapping protocol (section 2.5 and 5.2.7). The neighbour- joining phylogeny 
in Figure 5.5a does not include isolate NPTB6 as it had an excesive amount of genomic variation, 
diverging by over 700 SNPs with every isolate in the dataset, as presented in Table 5.4. The 
amount of divergence within the phylogeny exceeds that seen within the cgMLST, with no 
isolates sharing fewer than 12 SNPs and thus could not be classified as an oubtreak complex. 
However, the overall structure of genomic relationships emulates that seen in the cgMLST 
results (Figure 5.2 and Figure 5.5b), although the inclusion of NPTB6 in the cgMLST results should 
be considered when analyzing Figure 5.5b. As in the cgMLST analysis, the results in Figure 5.5a 
showed that the NPTA and NPTB isolates cluster separately. The NPTA cluster holds an ancestral 
position within the phylogeny and the NPTB isolates branch off at a later point in Figure 5.5a. As 
in the cgMLST analysis, NPTB1 and BK2 again cluster with the NPTA isolates (Figure 5.5a and 
5.5b). 
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a) 
 
 
 
 
 
 
 
 
 
 
 
b) 
Figure 5.5: Neighbour- joining phylogenies constructed from a total of 1391 SNPs. (a)  traditional 
WGS SNP mapping, and (b) cgMLST analysis derived from results presented in MST format in 
Figure 5.2. Blue = NPTA, Red = NPTB, Green = background. The scale bar for (a) represents the 
genomic distance measured in nucleotide differences across 1391 loci, and for (b) is measured 
in units of allelic differences.
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Table 5.4. A correlating distance matrix to figure 5.5, produced by traditional WGS SNP mapping  described in section 5.2.7. Red=NPTB isolates, 
Blue= NPTA isolates. The darker blue the cell the more closely related the isolates are. The darker red the cell the more div ergent the isolates. 
 Number of SNP`s across the Whole Genome 
Isolate NPTA1 NPTA2 NPTA3 NPTA4 NPTA5 NPTA6 NPTA7 NPTA8 NPTB1 NPTB2 NPTB3 NPTB4 NPTB5 NPTB6 BK2 
NPTA1 0 28 62 30 42 230 94 21 67 161 94 151 159 720 26 
NPTA2 28 0 60 28 40 230 94 21 67 155 141 149 161 720 18 
NPTA3 62 60 0 66 78 266 132 59 103 191 177 189 193 754 60 
NPTA4 30 28 66 0 42 232 94 29 69 161 147 157 167 726 28 
NPTA5 42 40 78 42 0 242 106 43 79 169 155 167 175 734 42 
NPTA6 230 230 266 232 242 0 296 229 269 361 347 356 365 922 230 
NPTA7 94 94 132 94 106 296 0 95 133 223 209 219 229 786 96 
NPTA8 21 21 59 29 43 229 95 0 68 158 144 146 158 717 17 
NPTB1 67 67 103 69 79 269 133 68 0 196 182 194 200 759 69 
NPTB2 161 155 191 161 169 361 223 158 196 0 146 160 168 727 157 
NPTB3 94 141 177 147 155 347 209 144 182 146 0 20 120 711 143 
NPTB4 151 149 189 157 167 356 219 146 194 160 20 0 130 719 147 
NPTB5 159 161 193 167 175 365 229 158 200 168 120 130 0 729 161 
NPTB6 720 720 754 726 734 922 786 717 759 727 711 719 729 0 718 
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The phylogeny and distance matrix (Figure 5.5 and Table 5.4 respectively) also show NPTA6 to 
be the most divergent isolate within the phylogeny, with over 200 SNPS with every other isolate. 
The closest relationship within the phylogeny was between isolates BK2 and NPTA8 with 17 
SNPs. In support of the cgMLST results, WGS also showed NPTB3 and NPTB4 clustered more 
closely with each other (sharing 20 SNPs) than they do to any other NPTB isolate. These NPTB 
isolates differed from all the NPTB isolates by over 100 SNPs. Within the NPTA strain cluster, 
NPTA6 was the most divergent and NPTA7 the next most. NPTA7’s closest relations were NPTA8, 
NPTA4, NPTA1 and NPTA2, with 94 SNPs. Isolate NPTB1 clustered within the NPTA isolates, 
rather than the other NPTB isolates, and showed a closer relation to isolates NPTA1, NPTA2, 
NPTA8, NPTA54 and NPTA5 than to NPTA7. Thus, the SNP mapping results support previous 
findings in this study that NPTB1 was more closely related to the NPTA isolates than to the NPTB 
isolates, with which it shared a clonal MIRU-VNTR profile. The closest relationships between the 
NPTA isolates are between NPTA1, NPTA2 and NPTA8 equally with 23 SNPs. NPTA4 and NPTA5 
then also share fewer than 50 SNPs with NPTA1, NPTA2 and NPTA8. NPTA3 does show at least 
60 SNPs with each other NPTA isolate and thus along with NPTA7 is less clonally related to the 
other NPTA isolates.  The SNP mapping method provided a similar phylogenetic structure to that 
seen previously, although the level of divergence was greater than that seen with the cgMLST 
analysis. 
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5.3.7 Ancestral dating 
The results so far all provided evidence for the presence of two separate outbreaks, despite also 
showing discrepancies in the status of NPTB5, NPTB1, NPTB2 and NPTB6. However, the original 
phylogenetic analysis in Figure 3.4 indicated that the NPTA and NPTB outbreak isolates were of 
the same sub-lineage. To investigate the possibility that both outbreaks were caused by the 
same circulating strain, with unreported cases causing direct transmission links, a previously 
defined ancestral reconstruction method was used (section 5.2.8 and section 2.4). Figure 5.6 
depicts the chronological divergence that has occurred between the two outbreaks and how 
long ago both outbreaks shared their most recent common ancestor.  
 
 
 
 
 
 
 
 
 
Figure 5.6: A phylogenetic tree based on the ancestral reconstruction and dating of the 
most recent common ancestor (TMRCA) of both NPTA and NPTB outbreaks. A consensus 
sequence of NPTA outbreak strains was produced and aligned to the corresponding 
cgMLST sequences of both NPTB3 and NPTB4. Red = divergence of NPTB isolates; Blue = 
divergence of NPTA outbreak isolates from TMRCA of both. Values are scaled in years.  
 
 
TMRCA 
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The data indicated that it was 4.38 years since NPTA and NPTB isolates shared a common 
ancestor. As can be seen by the lower branch length numbers, the NPTA isolates are of a closer 
relation to TMRCA (3.30 years of divergence) than the NPTB ones (4.38 years of divergence). 
NPTB2 and NPTB4 last shared a common ancestor 0.02 years before their divergence to their 
current state. Thus, the two outbreaks diverged from each other around 4.38 years before their 
current state and NPTB2 and NPTB4 isolates share a very recent common ancestor. 
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5.4: Discussion 
This chapter has described how through WGS of M. tuberculosis boilate samples it was possible 
to apply phylogenetics, cgMLST methods, SNP mapping and ancestral sequence dating to 
analyse the Neath Port Talbot outbreak. This study supports previous ones that have shown the 
higher resolution of WGS data provides over MIRU-VNTR typing (Walker et al., 2013b, Walker et 
al., 2013a, Roetzer et al., 2013). 
One aim of this study was to evaluate whether a phylogenetic method could aid epidemiological 
investigation within a tuberculosis outbreak. The phylogenetic characterisation of tuberculosis 
isolates into respective lineages and sub-lineages has been shown previously to provide clinically 
relevant data in terms of vaccines and antibiotic resistance risks (Filliol et al., 2006, Comas et al., 
2009, Homolka et al., 2012, Feuerriegel et al., 2014). Phylogenetics has also been used 
epidemiologically in other infectious diseases, such as Ebola and respiratory syncytial virus 
(Dudas and Rambaut, 2014, Nabeya et al., 2017). In this current study, phylogenetic analysis 
confirmed that all the outbreak isolates except NPTB6, were clustered within the same sub-
lineage, the Euro-American T family. The results within this chapter further confirms NPTB6`s 
wrongful inclusion as being part of the Neath Port Talbot outbreak. In addition, the SNP barcode 
method seen in figure 3.4(chapter 3) identified three further apparently unrelated local isolates 
that clustered within this phylogeny; substantiating that phylogenetic characterisation may be 
useful in tuberculosis outbreak investigation.  
A previous study highlighted how a novel gene-by-gene cgMLST scheme could provide a more 
standardised method for outbreak resolution over the more traditional SNP typing methods 
(Kohl et al., 2014). This method has already been applied to Campylobacter spp. (Sheppard et 
al., 2012), Salmonella spp. (Maiden et al., 2013), Legionella spp. (Moran-Gilad et al., 2015) and 
Neisseria meningitidis  (Agnememel et al., 2016) outbreaks.  An advantage of gene-by-gene 
MLST methods is that unlike SNP mapping, they do not rely on high quality genomes,  and can 
thus provide analysis where only partial sequence data are available (Sheppard et al., 2012, 
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Maiden et al., 2013), as was the case in this study. Through the use of this established cgMLST 
scheme (Kohl et al., 2014), the relationship between the NPT outbreak isolates was resolved, 
and in accordance with the MIRU-VNTR results, two outbreaks were confirmed, although they 
did not correlate completely with those generated by MIRU-VNTR. The cgMLST analysis 
confirmed that each of the NPTA cases was directly linked, except for NPTA3. The cgMLST 
analysis also confirmed that the cases were directly linked to Public House X, as assumed by 
initial contact tracing team. However, in the cases of NPTB, cgMLST analysis found only two out 
of the six NPTB isolates to be directly related and found NPTB1 to cluster with the main NPTA 
outbreak, confirming the link between NPTB1 and the Public House X, as proposed by the 
contact tracing team. The close genomic relationship and contact tracing links between the 
NPTA isolates (the main outbreak) and NPTB1 may have resulted from microevolution, which 
refers in this context to the gradual evolution of a single clonal strain during an outbreak (Walker 
et al., 2013, Liu et al., 2015, Takiff and Feo., 2015), altering the MIRU-VNTR typing results, as 
postulated in previous studies (Walker et al., 2013b, Takiff and Feo., 2015).  
Previous studies have highlighted that WGS can identify super spreaders and that this is 
indicated by a star-like phylogeny (Kohl et al., 2014;Walker et al 2013). In agreement with those 
studies, the cgMLST result in this one also generated a star-like phylogeny. However, the contact 
tracing teams assumed the super-spreaders were NPTA1 and NPTA6, but this was not shown by 
cgMLST, which indicated NPTA7 was the most likely source case and super-spreader. A super-
spreader is validated epidemiologically as a case that has disproportionally infected more 
secondary cases than others infected with the same disease(Galvani et al., 2005, Stein et al, 
2011). Epidemiological investigation had identified that NPTA7 was likely to have frequented 
Public House X (although he did not admit to it), and had identified that NPTA7 had numerous 
social contacts, including family members, who also frequented the pub. 
One of the key potential advantages of WGS over other typing methods is that its application is 
not restricted to typing and epidemiological applications. The data have the potential to provide 
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information on the physiological properties of isolates within a given outbreak. Bioinformatic 
tools and databases have and are being developed to predict the functional effect that variations 
between genomes have on the phenotype for a given sample (Bromberg and Rost, 2007, Wong 
and Zhang, 2014, Johnson et al., 2005, Thomas et al., 2003). One particular tool, called Provean 
(Choi and Chan, 2015), allows prediction of whether non-synonymous mutations have 
deleterious effects on a given protein; and has been previously used in studies on virulence in 
the tuberculosis reference strains H37Rv and H37Ra (Jena et al., 2014), the prediction of colistin 
resistance genes in Klebsiella pneumoniae (Olaitan et al., 2014), and in the analysis of host 
adaptation in Salmonella enterica (Octavia et al., 2017). In this current study, a total of 31 allelic 
differences between the outbreak 1 and outbreak 2 isolates were identified, 22 were non-
synonymous and 9 were synonymous. Although the information on synonymous mutations 
between the outbreaks is useful in terms of understanding the natural evolution between the 
two outbreaks (Kimura, 1984, Hurst, 2002, Li, 2014), the properties of the non-synonymous 
mutations may yield more information on the physiological differences between the outbreak 
isolates, which may be clinically relevant. 
Provean analysis on the 22 non-synonymous mutations found only ones in seven genes 
conferred a deleterious effect on their respective protein (Table 5.4); 5 of which were clinically 
relevant. RV1411c produces a TLR-2 ligand that inhibits human macrophage class II antigen 
processing, allowing the organism to avoid recognition by CD4+ T-cells (Gehring et al., 2004). 
Rv0695 encodes the protein MftE which is part of the myofactin system (Lew et al., 2011)  shown 
to be essential for in vitro growth on cholesterol (Lew et al., 2011, Griffin et al., 2011), and for 
the ability of M. tuberculosis to use cholesterol as a carbon source in order to  persist within 
animal tissue (Griffin et al., 2011). Recent studies have highlighted that statins are associated 
with reduced risk of active tuberculosis infection (Lai et al, 2016).  
A further three mutations were found which have a possible influence on drug susceptibility. 
Rv0933 is a cell wall gene encoding an ABC transporter (efflux pump; Lew et al., 2011, Pang et 
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al., 2013), and its hypothetical function is to enable phosphate transportation across the cell 
wall which is essential to the survival of M. tuberculosis (Betts et al., 2002). A previous study 
showed that in rifampicin mono-resistant clinical samples, a high level of Rv0933 expression was 
seen (Pang et al., 2013). Rv1304 is an ATP synthase subunit and is an essential gene for in vitro 
growth and in vivo in a mouse host (Lew et al., 2011). It is situated and expressed within the Sig1 
regulon, a sigma factor (Lee et al., 2012), and its loss of function has been shown to correlate 
with isoniazid resistance which does not hinder fitness (Lee et al., 2012). Lastly, a deleterious 
functional mutation was detected in the DacB2 gene, Rv2911. The deletion of DacB2 has been 
shown to cause a hyper-virulent phenotype, whereby the bacteria survive and grow at a 
significantly higher rate within macrophages than wild type isolates (Bourai et al., 2012). Recent 
in vitro evidence has shown the potential efficacy of a combination of a carbapenem and 
amoxicillin-clavulanic acid in treating tuberculosis infection, through the inhibition of DacB2 by 
meropenem (Diacon et al., 2016, Kumar et al., 2012). Hence, functional prediction of non-
synonymous mutations may therefore be conferring potentially clinically useful information, not 
least in terms of therapy. Although all the isolates in this study were known to be phenotypically 
sensitive to standard anti-tuberculosis treatment, having been tested at PHW WCM, it is 
interesting to consider that a subset of isolates may have increased susceptibility to beta-
lactams, and this is something that could be tested in future to investigate whether previous 
reports on the function of DacB2 can be corroborated. A previous study highlighted how WGS 
data will be an important future tool for M. tuberculosis drug susceptibility and resistance 
detection (Walker et al., 2015). This current study showed that Provean functional analysis 
provided clinically relevant evidence for not only antibiotic susceptibility, but also sheds light on 
other clinical feature, such as the ability to metabolise cholesterol.   
The in-house cgMLST scheme confirmed the presence of two separate outbreaks and results 
correlated with those obtained using the established cgMLST scheme previously defined, 
showing minor contrasts for isolates NPTB1 and NPTA7. Certain genes within the in-house 
cgMLST scheme, such as the pe/ppe genes, are known to be polymorphic. The ppe/pe genes 
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encode secreted cell surface proteins involved in host immune evasion and antigen variation 
(McEvoy et al., 2012, Gutacker et al., 2002). It has been shown previously that non-synonymous 
mutations are 3.0 and 3.3 times more likely, in pe and ppe genes respectively, than in other ones 
(McEvoy et al., 2012, Gutacker et al., 2002). Other studies have removed such loci from their 
alignment analysis due to their polymorphic properties (Stucki and Gagneux., 2013) and this 
includes the established cgMLST scheme used here (Kohl et al., 2014). This may at least partly 
explain the discrepancies in degree of divergence seen between the two methods. 
 In line with previous studies, the SNP mapping produced results that reflected the pattern seen 
in the cgMLST analyses (Kohl et al., 2014). However, in contrast to previous studies (Walker et 
al., 2013b;Kohl et al, 2014), the number of SNPs far exceeded the previously published 12 SNP 
threshold for direct transmission. As stated in Chapter 4, the SNP calling pipeline used in this 
study (see section 5.2.6 and 2.5) is likely to be based on parameters that are not identical to the 
publications from which the 12 SNP threshold was derived as the exact pipeline is not presented 
by the original Walker et al (2013) publication (Walker et al; 2013a). Therefore the application 
of this threshold may not to be suitable for outbreak associations made by the WGS SNP 
mapping, highlighting the non-standardized nature of SNP calling pipelines (Sheppard et al., 
2012, Maiden et al., 2013). The effective use of cgMLST typing in this study provides promise in 
providing a standardized platform for the widespread use of WGS data for outbreak 
investigation. 
Despite this study providing evidence for the presence of two separate outbreaks, phylogenetic 
analysis found isolates from both outbreaks to be of the same sub-lineage and epidemiological 
analysis also suggested a single, larger outbreak. Ancestral dating methods showed that both 
outbreaks shared a recent common ancestor of less than 5 years previously and were probably 
caused by a single endemic circulating T family strain, thus suggesting that isolates from both 
outbreaks 1 and 2 derive from the same origin, and possibly due to microevolution of a 
circulating T family strain. Investigation into intermediate cases that may be responsible for the 
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divergence seen between both outbreaks, should be carried out in future work following this 
study. A study of a tuberculosis outbreak in Germany with the prominent “Hamburg clone” used 
BEAST ancestral reconstruction (Ansari et al, 2016) to assess the clonality of a large outbreak, 
spaced over a large period of time, where the interpretation of the genomic results was found 
to be complicated by microevolution (Roetzer et al., 2013a). Ancestral dating methods have also 
been applied to other infectious agents for identification of the evolution of a certain trait, 
outbreak investigation or species origin in the SARS outbreak (Jombart et al., 2014), Salmonella 
enterica (Hawkey et al., 2013) and Yersinia pestis (Whittles and Didelot, 2016) respectively. Such 
information cannot be obtained via MIRU-VNTR typing, thus this study’s results supports the 
ability of ancestral dating to elucidate confusions within outbreak resolution and along with 
phylogenetic grouping, provide convincing evidence with regards to outbreak origin, as stated 
in previous studies (Ansari and Didelot, 2016; Roetzer et al., 2013a).  
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5.5 Conclusion 
Using WGS data, an outbreak of tuberculosis in Neath Port Talbot, in which epidemiology and 
molecular typing by MIRU-VNTR were inconsistent with one and other, was resolved. Although 
original cgMLST analysis showed evidence of two separate outbreaks, the introduction of 
ancestral dating indicated that the two “outbreaks” were likely to be one continuous one caused 
by the same endemic strain that had micro-evolved over time, with intermediate cases likely to 
have been missed form this investigation. The phylogenetic clonality, seen in the robust SNP 
barcode results in Chapter 3 provides further support to the presence of one outbreak caused 
by a circulating strain. The results also confirm Public House X as being central to the outbreak, 
and the presence of a super-spreader, with NPTA7 being the most likely super-spreader 
according to the established cgMLST scheme results. The results also confirm exclusion of isolate 
NPTB6 from the Neath Port Talbot outbreak. For future work identification, culturing and 
sequencing of missing intermediate cases should be carried out and followed by further genomic 
analysis including these missing isolates in addition to those already in this dataset. 
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Chapter 6 
The study of a M. tuberculosis outbreak in 
Gorseinon, South Wales, using a novel ancient 
DNA library build and sequencing protocol. 
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6.1: Introduction 
During 2003-2004, an outbreak of tuberculosis was identified centred on a public house in the 
Gorseinon area of South West Wales. Another outbreak arose in a school in the same area in 
2007. In addition, in 2008, a further outbreak occurred in the Townhill area of nearby Swansea. 
MIRU-VNTR typing showed that both the Gorseinon pub and school outbreak isolates shared 
identical patterns, with the Townhill outbreak isolates differing by one locus (MIRU16) from the 
Gorseinon outbreak isolates (Table 6.1 below). Due to the proximity of the Townhill outbreak to 
the other two in both time and place, and the existence of at least one case with contacts to the 
Townhill as well as the Gorseinon outbreak, the investigation team suspected that all three 
outbreaks might be part of the same one, and that micro-evolution had caused the slight 
divergence between the MIRU-VNTR types. To investigate this, WGS was applied to a subset of 
13 isolates from the outbreaks.  
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Table 6.1: Epidemiological data for each isolate of the 13 isolates included within this dataset.  
Case 
Date of 
Diagnosis 
Date of 
symptom 
onset 
Outbreak MIRU-VNTR Notes 
GO1 Jun-03 Apr-03 Gorseinon public house 
The first Gorseinon case only frequented Public House M and only declared direct contact with 
GO3. Potential link with GO1,TH2 and TH3. 
GO2 Nov-03 Nov-03 Gorseinon public house Linked to 3 - 4 public houses in Gorseinon, was not in direct contact with many except for GO4. 
GO3 Feb-04 Mar-03 Gorseinon public house 
Barman at Public House M for 3 years. Potential super-spreader in the Gorseinon outbreak and 
potential Townhill link (TH2, TH1 and TH3). Direct contact with all public house cases. 
GO4 Jul-04 Feb-03 Gorseinon public house 
Potential super-spreader in the Gorseinon outbreak and potential Townhill link (TH2). Direct 
contact with all public house cases. 
GO5 Aug-04 Jul-04/03 Gorseinon public house Potentially infectious for a year prior to diagnosis. 
GO6 May-05 Feb-05 Gorseinon public house Gorseinon outbreak secondary case. 
GO7 Oct-08 Jan-08 Gorseinon Public house Potential link case between Gorsienon and Townhill. 
GS1 Apr-08 Feb-07 Gorseinon school outbreak Potential link between Gorseinon school and public house outbreaks. 
TH1 Mar-08 Oct-06 Townhill Original Townhill outbreak case and potential super-spreader. 
TH2 Dec-02 Jul-02 Townhill Thought to be the main link between the Gorseinon and Townhill outbreaks. 
TH3 Jan-07 Oct-06 Townhill Potential link to Gorseinon outbreak. 
GO8 Oct-08 Jul-08 Unique 
Contrasting MIRU-VNTR and epidemiological data, either a background strain or a link case between 
Townhill and Gorseinon outbreaks. 
GO9 Feb-04 Aug-02 Unique Closely related through epidemiology to the public house outbreak. 
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6.1.2: Background 
6.1.2.1: Gorseinon public-house associated outbreak (2003-2004 and 2007) 
On 10th February 2004, Public Health officials noted that the number of cases of M. tuberculosis 
reported in the Gorseinon area of South West Wales was higher than expected. In addition, all 
the cases were found to drink regularly at a public house (M) in Gorseinon. GO1 was the first 
case diagnosed (notified June 2003), with onset of disease occurring in April 2003. GO1 was a 
customer at Public House M and another one in the Gorseinon area, with evidence of direct 
contact with another case from the area (GO3). Case GO2 was notified in December 2003, with 
onset of symptoms one month earlier. This person was a customer at three public houses in 
Gorseinon, including Public House M, and had direct contact with GO3 and GO4. Case GO3, a 
barman in Public House M, was notified in February 2004, having symptoms going back to at 
least December 2003, and potentially as far back as spring 2003. He had direct contact with at 
least six other M. tuberculosis cases within the area that visited Public House M (GO1, GO2, GO4, 
GO5, GO6 and GO7). Case GO4 was notified in July 2004, with onset of disease in February or 
March 2003, was considered highly infectious, and had direct contact with each of the original 
three cases, especially GO3. At this point, it was postulated that GO3 and GO4 might represent 
potential ‘super-spreaders’ within the public house outbreak, as both had direct links to multiple 
cases. Case GO5 was diagnosed in August 2004, although the Public Health team believed that 
this individual had had active pulmonary TB for a year prior to diagnosis. In May 2005, GO6 was 
diagnosed with pulmonary tuberculosis, with symptom onset probably in February 2005. All 
these cases had identical MIRU-VNTR typing patterns. A summary of the MIRU-VNTR profiles for 
each isolate is shown in Table 6.2.  
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Table 6.2: A table showing the MIRU-VNTR profiles across 15 loci seen for each of the 13 
isolates within this dataset. 
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Outbreak 
Townhill 3 2 3 3 3 2 5 3 2 5 1 5 3 2 3 
Gorseinon 
Pub 
3 2 3 3 3 2 5 4 2 5 1 5 3 2 3 
Gorseinon 
school 
3 2 3 3 3 2 5 4 2 5 1 5 3 2 3 
Isolates 
TH1 3 2 3 3 3 2 5 3 2 5 1 5 3 2 3 
TH2 3 2 3 3 3 2 5 3 2 5 1 5 3 2 3 
TH3 3 2 3 3 3 2 5 3 2 5 1 5 3 2 3 
GS1 3 2 3 3 3 2 5 4 2 5 1 5 3 2 3 
GO1 3 2 3 3 3 2 5 4 2 5 1 5 3 2 3 
GO2 3 2 3 3 3 2 5 4 2 5 1 5 3 2 3 
GO3 3 2 3 3 3 2 5 4 2 5 1 5 3 2 3 
GO4 3 2 3 3 3 2 5 4 2 5 1 5 3 2 3 
GO5 3 2 3 3 3 2 5 4 2 5 1 5 3 2 3 
GO6 3 2 3 3 3 2 5 4 2 5 1 5 3 2 3 
GO7 3 2 3 3 3 2 5 4 2 5 1 5 3 2 3 
GO8 3 2 4 3 3 2 4 3 2 5 1 5 3 2 3 
GO9 3 2 4 3 2 2 5 3 2 5 2 5 3 2 2 
 
The second cluster of cases in the Gorseinon area was identified in 2007. GS1 worked as a dinner 
lady in a Gorseinon school and was diagnosed in April 2007, with symptom onset being in 
February of that year. She had the same MIRU-VNTR genotype as the 2003-04 pub cases (Table 
6.2) and also frequented Public House M. The identification of case GS1 led to an extension of 
the outbreak investigation into the local school with 67 children being screened. Seven had 
positive tuberculin skin tests and 4 needed prophylactic treatments. GS1 had been seen by a 
medical practitioner three times prior to her diagnosis and been wrongly diagnosed with 
pleurisy. The final case related to this public house (GO7) was identified in October 2008. This 
individual was closely linked to GO3 and had contact with GO4, with symptom onset in January 
2008. Case GO7 worked in Public House M alongside GO3 and went on to work with GO3 at 
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other public houses in Townhill, Swansea. GO7 was friendly with the spouse of GO3 sleeping 
regularly in their home and was a close friend of GO4`s daughter. The Public Health team were 
uncertain whether GO7 had been infected by GO3 or GO4, as all had identical MIRU-VNTR types. 
A diagrammatic view of the epidemiological connections associated with the public house 
outbreak in Gorseinon can be seen in Figure 6.1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: A diagrammatic view of the epidemiological connections between all isolates 
associated with the public house outbreak in Gorseinon. Isolates in pink, GO3 and GO4, 
represent potential “super spreaders” within the outbreak, and isolates in grey do not 
share a common MIRU-VNTR profile to the outbreak.  
 
A further two cases (GO8 and GO9) were linked epidemiologically with the Gorseinon outbreak 
and included in the investigation. However, the MIRU-VNTR profiles of GO8 and GO9 did not 
match those of the other Gorseinon isolates or one another. Case GO8 admitted to frequenting 
Public House M during the outbreak but was not diagnosed until October 2008. Although GO9 
was diagnosed in August 2004, the individual had onset of symptoms two years earlier in April 
2002. Case GO9 was considered potentially involved in the Gorseinon public house and/or 
school outbreaks but appeared to have no direct contacts with other cases. Due to lack of direct 
epidemiological links for GO8 and GO9 and the fact that neither of the isolates shared the same 
MIRU-VNTR pattern as the outbreak isolates, they were not considered part of the outbreak. 
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6.1.2.2: Townhill outbreak (2006-2008) 
In 2008, an outbreak of M. tuberculosis occurred in the Townhill region of Swansea. The first 
case, TH1, was initially admitted to hospital in March 2008 with a suspected chest infection but 
was found to be suffering from tuberculosis. TH1 had been severely symptomatic for a 
prolonged period prior to hospital admission, with coughing, weight loss and night sweats going 
back as far as October 2006. He or she was considered to have been highly infectious for some 
time. TH1 had disseminated tuberculosis with lung cavities and tuberculomas in the brain and 
had a history of drug and alcohol abuse. Contact tracing identified numerous contacts. Thirteen 
cases were found among the contacts - 8 latent and 5 with active infection. Retrospective case-
finding identified another Townhill-related case (TH3), diagnosed in January 2007. Patient TH3 
resided in the Gendros area of Swansea, about a mile from Townhill and 3.2 miles from 
Gorseinon (Figure 6.1), but contact tracing documented that TH3 visited public houses in both 
the Townhill and Gorseinon region during the two outbreaks. Initially no apparent direct links 
were identified between TH1 and TH3. However, detailed contact tracing of GO3 revealed that 
he regularly met and socialised with TH3 and GO1 in Public House M. With no direct link to TH1 
and with close regular contact with cases of the Gorseinon outbreak, it was believed initially that 
TH3 was part of that outbreak.  
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Figure 6.2: A map showing the distances between the 9 Gorseinon and 3 Townhill outbreak 
cases. One ‘Townhill’ case resided in the adjacent Gendros area. Further details on the 
construction of the map, are described in section 2.14. 
 
When compared to the Gorseinion public house outbreak, MIRU-VNTR typing showed that the 
Townhill outbreak isolates differed by one locus (MIRU16). The MIRU-VNTR typing of the TH3 
isolate was identical to that of TH1, showing the same single polymorphism at locus MIRU16. It 
was at this point that contact tracing began to further investigate links between the Gorseinon 
and Townhill outbreaks. In November 2008, further retrospective investigations found that the 
uncle of TH1, TH2, was diagnosed with open tuberculosis in December 2002. The onset of 
symptoms for TH2 was in July 2002 and thus he was potentially infectious for six months. TH2 
also claimed to have been exposed to tuberculosis during time spent in prison between 1989 
and 1990. Initial screening in 2002, focused on immediate family (son and wife) and a next-door 
neighbour, meaning TH1 was not screened during the time of TH2`s contact tracing 
investigation. It was found that TH2 regularly visited numerous public houses in Swansea, 
Townhill and Gorseinon and regularly socialised and drank at Public House M at the time of the 
Gorseinon outbreak. TH2 said he drank in Gorseinon with aman who lived opposite him in 
Townhill, who was diagnosed with tuberculosis years earlier. Furthermore, another neighbour 
of TH2 regularly drank, smoked marijuana and consumed other drugs with TH2 around this time, 
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and was also diagnosed with tuberculosis, but the isolate was un-culturable. TH2 also smoked 
marijuana with TH1. In addition, TH2 was found to socialise heavily with people from the 
Gendros area where TH3 resided. Thus, the contact tracing team concluded that the Gorseinon 
and Townhill outbreaks must be linked, despite the one locus difference in MIRU-VNTR typing. 
Retrospective contact tracing also found further epidemiological links between isolates from the 
Gorseinon and Townhill outbreaks. It was found that cases GO3, GO4, GO7 and GO9 all had links 
with the Townhill area. In particular, it was found that GO4 had an estranged wife who was 
associated with the Townhill outbreak. GO1 had frequented the same public houses as TH2 and 
thus was a potential link, and furthermore, there was evidence that the potential super-spreader 
GO3 had contact with both TH1 and TH2. During the Townhill outbreak, GO7 had contact with a 
doorman in the Townhill area and thus, despite having matching MIRU-VNTR to the Gorseinon 
public house outbreak and strong links to potential super-spreader GO4, GO7 was considered a 
potential link case between the two outbreaks. GO9 frequented public houses in the Townhill 
area during 2008 in addition to Public House M in Gorseinon. A diagrammatic view of the 
epidemiological connections related to the Townhill cases is shown in Figure 6.3. The Public 
Health team concluded that the outbreaks of Gorseinon and Townhill were probably linked in 
some way and that the small amount of divergence seen in the MIRU-VNTR profiles of both 
outbreaks must be due to micro-evolution of the strain, with TH2 being deemed the most likely 
case to link the two outbreaks. 
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Figure 6.3: A diagrammatic view of the epidemiological connections between the Townhill 
isolates TH1, TH2 and TH3 and the potentially linked Gorseinon isolates GO1 and GO3 . 
Solid lines refer to confirmed direct contact between the cases; dashed lines refer to 
potential, but not confirmed contact between cases. 
 
6.1.3: Aims  
There were four aims to the work presented this chapter. Firstly, WGS was carried out on the 13 
isolates and the previously established gene-by-gene cgMLST typing method used to identify the 
source case and any super-spreaders within the outbreaks. Secondly the relationship between 
the Gorseinon and Townhill outbreaks was investigated using genomic data. Thirdly, the 
outbreaks were further analysed using novel in silico spoligotyping (Brudey et al., 2006), and 
their evolutionary relationship elucidated using BEAST ancestral dating (Jombart et al., 2014). 
The final aim was to support or refute the conclusions from the gene-by-gene cgMLST and assess 
whether this analysis provided a useful alternative to SNP mapping methods for using WGS in 
clinical studies. 
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6.1.4: DNA sequencing problems 
For 9 of the isolates studied, significant difficulties were experienced in obtaining sequence data 
from the available DNA. The samples were provided in boilate form. Although boilate extraction 
does release DNA, it is crude, inconsistent and has been documented to yield DNA of lower 
integrity, in low quantity and of poorer quality in comparison with other extraction methods 
(Aldous et al., 2005, Timms et al., 2015). 
As might be expected, poor sample quality has a negative effect on the standard Nextera XT 
library preparation (Tyler et al., 2016), which was used for analysis of the Gorseinon samples. 
The Nextera XT library preparation is widely used and established within  microbial genomics 
(Tyler et al., 2016). Given the clinical importance of generating WGS data to resolve this 
outbreak, solutions to this problem would be very beneficial. In this regard, lessons might be 
learnt from the field of palaeogenomics, which routinely attempts to generate genome-scale 
data from samples that are highly fragmented, contaminated with non-target DNA, and often 
contain residual chemical impurities (Pääbo., 1989,  Lindahl, 1993.,  Dabney et al., 2013,. 
Schubert et al 2014, Orlando et al, 2015, Carøe C et al, 2017). For example, recent developments 
within palaeogenomic methodologies have allowed WGS data to be obtained from a wide range 
of samples, spanning ancient humans and hominids (Rasmussen, Morten, et al, 2010 Green, 
Richard E., et al, 2010), mammals (Miller W.,et al, 2008, Orlando L., et al, 2013, Skoglund P,. et 
al 2015, Palkopoulou E., et al 2015, Mak, S.S.T., et al 2017), plants (Jaenicke-Despres, Viviane, et 
al, 2003., Li, Chunxiang, et al, 2011., Wales, N., et al, 2013.,) and even pathogens (Verena J. 
Schuenemann et al, 2013) – many of which contain DNA with fragment lengths of <80bp.  We 
therefore hypothesised that the application of ancient DNA (aDNA), which refers to DNA derived 
from ancient specimens such as fossils that is often degraded significantly (M Stoneking, 1995), 
library preparation and sequencing protocols might overcome the impossibility of retrieving 
genomic data from the low purity and low-quality DNA of crude M. tuberculosis boilate samples. 
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The Geogenetics Gilbert group at the University of Copenhagen is renowned for research into 
the molecular analysis and sequencing of degraded ancient DNA (Grealy, A., Phillips et al, 2017., 
Carøe C et al, 2018) A European Microbiology Organisation research grant made it possible to 
visit the Gilbert group and use the ancient DNA sequencing facilities at the University of 
Copenhagen to obtain usable sequence from nine of the samples. 
An ancient DNA library build method, termed the BEST library building protocol (Carøe C et al., 
2017),was employed on the assumption that the boiled samples would contain DNA in a similarly 
fragmented state to that from ancient samples (Carøe C et al., 2017). The small fragment size of 
the target DNA is a feature that is sometimes incompatible with standard sequencing equipment 
such as the Nextera XT protocol used in the previous chapters (Nextera XT, Illumina, 2010). 
These standard methods use a library preparation step which targets amplicons of a certain 
consistent size of over 300bps (Illumina, 2015), whilst the ancient DNA method targets 
fragments as small as 50bps (Carøe C et al., 2017).  The use of a library preparation method 
which originates from museum based paleogenomic research has not previously been 
attempted in the clinical setting with regards to outbreaks of infectious disease. 
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6.2: Methods 
6.2.1:  Standard Sequencing and assembly 
The 13 isolates were supplied in boilate form by PHW WCM, Cardiff, Wales, as described in 
section 2.1. DNA sequencing was carried out directly on these samples. Genomic DNA libraries, 
genome sequencing and genome assembly were carried out as described in section 2.2. The 
percentage of reference genome coverage was calculated through submission of isolate 
sequences to the CSI phylogeny web-server version 1.3 
(https://cge.cbs.dtu.dk/services/CSIPhylogeny/). The percentage of core genome MLST 
coverage was calculated using the Ridom SeqSphere software as described in previous chapters. 
6.2.2: Ancient DNA sequencing protocol 
Briefly, isolates were purified using the extraction protocol described in  Section 2.13.1, before 
being subjected to the BEST ancient DNA library building protocol and sequencing described in 
Section 2.13.2 (Carøe C et al, 2017).  
6.2.3 Core Genome MLST 
A previously established gene-by-gene cgMLST typing method (Kohl et al., 2014) was used, as 
described in Sections 2.3 and 2.3.1. Typing was performed successfully on 11 of the sequenced 
isolates (TH1, TH2, GO1, GO2, GO3, GO4, GO5, GO6, GO7 and GO9). 
6.2.4: Extended gene–by-gene MLST. 
In addition to the core genes used in the cgMLST, the Ridom SeqSphere also included an 
accessory genome scheme consisting of 755 genes. Through including the accessory genes to 
the core genome MLST, a gene-by-gene MLST scheme containing 3646 genes was used for the 
resolution of relations between the 11 remaining outbreak isolates, see section 2.3.3 for further 
description. 
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6.2.5: WGS SNP mapping  
Traditional SNP mapping was carried out by using the conserved signature indels (CSI) phylogeny 
application provided by the Centre of Genomic epidemiology online server, as described in 
section 2.5. 
6.2.6 In silico spoligotype 
In silico spoligotyping was carried out using the Python-based SpolTyping (Xia et al., 2016) in 
silico software as described in Methods section 2.6.  
6.2.7: Ancestral dating 
This was carried out as described in section 2.4. SNPs present between the consensus sequence 
of ‘outbreak 1’ isolates and TH1, TH2 and GO1 of ‘outbreak 2’ were extracted using the “extract 
SNVs from target groups” application within the Ridom SeqSphere software. Outbreak 1 and 2 
isolates were as defined by the cgMLST scheme (see results in figure 6.4a). The extraction was 
based on loci from the cgMLST, and missing alleles were ignored. Indels and SNPs within 10 bps 
of each other were removed from the analysis, thus a total of 132 SNPs were concatenated.   
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6.3: Results 
6.3.1: Standard sequencing  
Unfortunately, standard sequencing failed to provide any sequence data for 11 of the 13 isolates 
associated with the Gorseinon and Townhill outbreaks (Table 6.3). The heat-to-kill process may 
have denatured and fragmented the DNA within the samples to a level whereby downstream 
molecular processing was not possible using standard sequencing protocol. Sequence data could 
only be obtained for isolates GO8 and GO9 (Table 6.3). Further attempts to clean up and 
sequence isolates TH3 and GS1 resulted in the loss of those samples, leaving 11 for further 
analysis. 
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Table 6.3: Basic sequencing results for the 13 Gorseinon and Townhill outbreak isolates. 
Included in the table are the number of contigs produced, the largest contig followed by 
the total length of the reference genome that was covered by sequencing results, the 
percentage of the cgMLST genes present and the percentage of the reference genome 
covered according to the CSI phylogeny algorithm provided by the Centre for Genomic 
Epidemiology (Kaas et al., 2014). 
 
Standard sequencing results 
Sample ID #contigs 
Largest 
contig 
Total 
length 
% of 
cgMLST 
% of reference 
genome covered* 
GO1 0 0 0 0 0 
GO2 0 0 0 0 0 
G03 0 0 0 0 0 
GO4 0 0 0 0 0 
GO5 0 0 0 0 0 
GO6 0 0 0 0 0 
GO7 0 0 0 0 0 
GS1 0 0 0 0 0 
TH1 0 0 0 0 0 
TH2 0 0 0 0 0 
TH3 0 0 0 0 0 
GO8 143 228436 4353711 98.89 99.41 
GO9 1514 20613 4163985 67.45 94.11 
 
6.3.2: Ancient DNA sequencing  
Ancient DNA sequencing was carried out successfully on the remaining 9 samples: TH1, TH2, 
GO1, GO2, GO3, GO4, GO5, GO6 and GO7 (Table 6.4), providing a total length for each isolate of 
over 4 370 000 bps. The sequence in each case provided data for >99% of the core genes used 
in the cgMLST scheme. In addition, sequence data were obtained from all isolates that covered 
>98% of the reference genome according to the CSI phylogeny software of the Centre for 
Genomic Epidemiology. 
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Table 6.4: Sequencing results from 9 Gorseinon and Townhill outbreak isolates that failed 
to sequence using the standard sequencing protocol, obtained using the ancient DNA 
protocol.  
 
Ancient DNA sequencing results 
Sample ID #Contigs 
Largest 
contig 
Total 
length 
% of 
cgMLST 
% of reference 
genome covered 
TH1 797 174895 4397736 99.52 98.27 
TH2 276 171547 4372794 99.34 98.18 
GO1 271 174836 4379530 99.52 98.45 
GO2 250 174750 4375457 99.52 98.07 
GO3 1296 211047 4574259 99.52 98.26 
GO4 230 257745 4379980 99.41 98.15 
GO5 230 228152 4380862 99.45 98.50 
GO6 248 210603 4384763 99.48 98.36 
GO7 247 174721 4374335 99.52 98.50 
 
6.3.3: In silico spoligotyping 
Following ancient DNA sequencing, WGS was now available for a final set of 11 isolates from 
these 2 outbreaks, and 10 of the 11 isolates were successfully spoligotyped in silico (table 6.5) 
as described in section 6.2.6 and 2.6. SpolTyping software could not process the sequence data 
provided for GO9 as the quality of its sequence data did not meet that required by the software 
(Xia et al., 2016). All 10 successfully predicted isolates that could be assigned to the lineage 4 
Euro-American and Haarlem H1 phylogenetic lineage and spoligotype clade respectively. Within 
this, three different spoligotypes were found, correlating to three separate international types. 
Two Gorseinon public house cases (GO2 and GO4) were of international type 742. This 
spoligotype differs by one locus from that of isolates GO3, GO5, GO6, GO7 and GO8, which were 
all international type 47. GO1 did not have the same spoligotype pattern as any other Gorseinon 
public house outbreak isolate but had the same spoligotype pattern and international type as 
Townhill outbreak cases TH1 and TH2.   
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Table 6.5: In silico spoligotyping results for each of the Gorseinon and Townhill-associated 
outbreak isolates, showing the predicted spoligotype (produced by SpolDB4), 
international spoligotype (SITVIT database), lineage assignment and clade assignment 
(both outputted from the TB-insight online server). 
 
Spoligotype clade assignment 
Isolate 
Predicted 
Spoligotype 
International 
spoligotype 
Lineage Clade 
GO3 777777774020771 47 Euro-American H1 
TH1 777777770000000 46 Euro-American H1 
TH2 777777770000000 46 Euro-American H1 
GO1 777777770000000 46 Euro-American H1 
GO2 777777770020771 742 Euro-American H1 
GO4 777777770020771 742 Euro-American H1 
GO5 777777774020771 47 Euro-American H1 
GO6 777777774020771 47 Euro-American H1 
GO7 777777774020771 47 Euro-American H1 
GO8 777777774020771 47 Euro-American H1 
GO9 110100020400000* Unsuccessful Unsuccessful Unsuccessful 
 
6.3.4: cgMLST analysis 
The cgMLST-based phylogenies are shown in Figures 6.4 and showed the presence of two 
outbreaks within the dataset, separated by 124 allelic differences (Figure 6.4). The cgMLST 
analysis showed each of the Gorseinon public house outbreak cases GO2, GO3, GO4, GO5, GO6 
and GO7 formed one clonal outbreak, ‘outbreak 1’. Isolates GO2 and GO6 were identical, and 
GO3, GO4 and GO7 differed from them by only one allelic difference (Table 6.4a). The largest 
divergence seen within outbreak 1 was 3 allelic differences between GO5 and isolates GO2, GO4 
and GO6 (Figure 6.4a). Outbreak 2 was represented by isolates TH1, TH2 and GO1. A clonal 
complex was also observed in outbreak 2, containing TH1 and GO1, with TH2 diverging from 
them both by 4 allelic differences (Figure 6.4ba).  
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Figure 6.4: cgMLST-based phylogenies of the 11 successfully sequenced isolates. a) A 
minimum spanning tree containing each of the 11 sequenced isolates. Numbers represent 
the number of allelic differences between isolates, however the branch lengths between 
isolates does not represent a measure of divergence. b) A neighbour-joining phylogenetic 
tree based on the 2891 core genes that comprise the cgMLST. Townhill cluster is coloured 
pink with the Gorseinon cluster coloured purple. The scale bar highlights the genetic 
divergence relevant to branch length measured in units of allelic differences per site 
across the cgMLST scheme of the 11 isolates included in the figure. 
 
 
 
 
 
a 
b 
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Both GO8 and GO9 substantially exceeded the 12-allelic difference threshold for direct 
transmission from any of the other cases within this dataset. Therefore, according to the 
cgMLST, they were not outbreak-related isolates, a result consistent with the MIRU-VNTR 
results. The neighbour-joining phylogeny produced from the cgMLST analysis provided further 
information on the evolutionary relationships of the isolates. The neighbour joining tree above 
(Figure 6.4b), shows that the Gorseinon cluster (GO2, GO3, GO4, GO5, GO6 and GO7) harbours 
a more ancestral position within the tree than the Townhill cluster (GO1, TH1 and TH2) following 
on from the branching off of both clusters.  
The shorter branch length indicated a more ancestral position for the Gorseinon public house 
cluster (purple) relative to cases TH1, TH2 and GO1. Interestingly, although having a short branch 
length, TH2 branched off before TH1 and GO1, suggesting it was ancestral to both isolates.  
6.3.5: Extended gene-by-gene analysis 
The introduction of 755 additional accessory genes not specified as part of the cgMLST scheme, 
see section 6.2.4 for details, resulted in a minimum spanning tree with the same pattern as 
cgMLST alone, (Figure 6.5), with the only differences being in the number of allelic differences 
between the two outbreaks: with 154 allelic differences for extended gene-by-gene analysis of 
outbreak 1 instead of 124 for cgMLST and within outbreak 2, 5 allelic differences instead of 4. 
The addition of 755 genes also increased the divergence seen for isolates GO8 and GO9. 
Outbreak resolution was not impacted by the addition of the accessory genes.  
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Figure 6.5: A minimum spanning tree of the 11 isolates, based on the cgMLST scheme and 
755 accessory genes. Numbers represent the number of allelic differences between 
isolates, and the branches between isolates do not represent a measure of divergence.  
6.3.5.2: Whole Genome SNP mapping  
WGS SNP mapping using the Centre for Genomic Epidemiology software (see section 6.2.5 and 
2.5 for more details), provided more resolution than any of the previous methods, with all 
isolates showing at least 4 SNP differences between one and other (Figure 6.6a; Table 6.6). The 
results found that GO1 was central to outbreak 2 and to be the intermediate isolate between 
TH1 and TH2, whilst GO3 was identified as the central case within outbreak 1. Again, GO8 and 
GO9 were found to be clearly divergent from the rest of the isolates. As in the previous cgMLST 
neighbour-joining tree (Figure 6.4b), the neighbour-joining one here (Figure 6.6b) showed 
outbreak 1 isolates harboured an ancestral position to TH1, TH2 and GO1, with TH2 branching 
off at a slightly ancestral position to isolates TH1 and GO1. 
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a 
 
b 
 
Figure 6.6: Phylogenetic analysis results from WGS SNP mapping. a) A minimum spanning 
tree based on a total of 1123 SNPs across 11 isolates related to the Gorseinon and Townhill 
outbreaks. Clusters are highlighted by colour with the threshold for cluster inclusion being 
<12 SNPs. The numbers seen adjacent to the branches between isolates are the number 
of SNPs that differ between two given isolates. b) A neighbour-joining phylogeny showing 
Townhill cases in pink, Gorseinon outbreak cases in purple and the non-matching G08 and 
GO9 in black. The scale bar (figure 6.6b) highlights the genetic divergence relevant to 
branch length measured in units of nucleotide differences per site across the Whole 
Genome sequences of the 11 isolates. 
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Table 6.6: A table showing the number of SNPs between each isolate found in the WGS SNP mapping phylogeny shown in Figure 6.4a. Cells 
within the table are related to the number of SNPs between isolates. The redder the cell  the more SNPs, the bluer the cell the fewer SNPs. 
Whole Genome SNP mapping 
Isolate TH1 GO6 GO7 TH2 GO1 GO2 GO3 GO4 GO5 GO8 GO9 
TH1 0 201 199 18 5 197 197 197 197 538 823 
GO6 201 0 10 201 200 8 6 9 10 511 794 
GO7 199 10 0 201 198 8 8 8 12 511 794 
TH2 18 201 201 0 15 197 197 198 203 544 829 
GO1 5 200 198 15 0 196 196 196 196 537 822 
GO2 197 8 8 197 196 0 4 6 8 509 794 
GO3 197 6 8 197 196 4 0 4 6 507 792 
GO4 197 9 8 198 196 6 4 0 10 509 794 
GO5 197 10 12 203 196 8 6 10 0 509 794 
GO8 538 511 511 544 537 509 507 509 509 0 680 
GO9 823 794 794 829 822 794 792 794 794 680 0 
min: 4 max: 829 
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6.3.6: Ancestral dating  
To determine the relationship between outbreaks 1 and 2, ancestral dating of the isolates was 
carried out (Sections 2.4 and 6.2.7). The most recent common ancestor (TMRCA) refers to the 
last time either outbreaks (or isolates) shared an identical sequence. A diagrammatic 
representation of the distance in terms of evolutionary chronology between outbreak 1 and 
outbreak 2 isolates as defined by cgMLST is shown in Figure 6.7. The phylogeny was rooted at 
6.001, meaning that the TMRCA between outbreak 1 and 2 isolates existed 6.001 years prior to 
their current state. The phylogeny also showed that the TMRCA of all three outbreak 2 isolates 
diverged from the TMRCA of the whole phylogeny (phylogeny root) 5.755 years before diverging 
into the three isolates, TH1, TH2 and GO1. In addition, the results found that TH2 diverged from 
TH1 and GO1 0.246 years previous, with TH1 and GO1 diverging from each other more recently, 
around 0.0387 years prior to their current state. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          
 
  
 
  
   
     
 
  
 
 
 
  
 
 
 
      
TMRCA Figure 6.7: An ancestral dating 
phylogeny based on the consensus 
sequence of outbreak 1 and the three 
outbreak 2 isolates. Numbers refer to 
the years of divergence between each 
node, defined by BEAST software. The 
longer the branch length the greater the 
amount of divergence there is between 
the isolates. 
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6.4: Discussion 
The application of an ancient DNA-based library building and sequencing method has allowed 
the analysis of isolates associated with the outbreaks across the Gorseinon and Townhill regions 
of South Wales, where traditional WGS failed. WGS analysis confirmed the presence of two 
outbreaks within the dataset correlating with the MIRU-VNTR results and that isolate GO1 had 
a clonal relationship with the Townhill isolates, in contrast with MIRU-VNTR data, supporting 
the assumption that both outbreaks were connected. WGS results confirmed isolates GO8 and 
GO9 to be unrelated to the outbreak, agreeing with the results of MIRU-VNTR. Ancestral 
sequence reconstruction and dating showed that the isolates of both outbreaks shared a TMRCA 
six years previously. The evidence presented also supported the hypothesis of micro-evolution 
proposed by the contact tracing team and a direct relationship between the Townhill and 
Gorseinon cases.  
The DNA used had been extracted from boilate samples of M. tuberculosis, and previous studies 
have highlighted how boilate extractions, although cheap and easily carried out, provide DNA of 
the lowest quantity and quality in comparison with other extraction methods (Aldous et al., 
2005, Tyler et al., 2016, Cruz., 2017). The standard Nextera XT protocol used in this current study 
has been shown previously to produce poor or no sequencing results when the starting sample 
is of poor quality (Tyler et al., 2016). 
 Ancient DNA specialised library building and sequencing methods have been developed to 
overcome problems of sample contamination, low DNA starting quantity and integrity. They 
have allowed, for example, the sequencing of Neanderthal, cave bear and mammoth fossil 
samples (Meyer et al., 2007, Dabney et al., 2013,. Lindahl, 1993) with the oldest successfully 
sequenced sample being DNA from a horse discovered in 700,000 year old permafrost (Orlando 
et al., 2013, Dabney et al., 2013). Following the application of the BEST ancient DNA library 
preparation, it was possible to sequence the DNA from 11 of the boilates (Carøe C et al., 2017).  
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Importantly, this is the first clinical application of this ancient DNA sequencing protocol, and 
despite not being the method of first choice, it has the potential to be extremely useful in cases 
where DNA sequencing is critical and available DNA quality is poor. 
One of the aims was to identify the source case and potential super-spreader(s) within this 
dataset. Previous studies have highlighted the use of WGS data for the identification of super-
spreaders within an outbreak, which cannot be identified by MIRU-VNTR or other typing 
methods (Walker et al., 2013b, Witney et al., 2016). Super-spreaders represent cases which have 
a higher propensity to cause secondary cases and represent highly infectious individuals (Lloyd-
Smith et al., 2005, Stein., 2011, Walker et al., 2013b). They have been associated with outbreaks 
of M. tuberculosis within schools (Ewer et al., 2003) and have also been described as central to 
some community-based outbreaks (Walker et al., 2013b). Due to the evolution of M. 
tuberculosis being by descent, the presence of a super-spreader within a cluster of outbreak 
cases is characterised by a star-like phylogenetic structure (Walker et al., 2013b, Kohl et al., 
2014). Within the Gorseinon outbreak cluster, isolates GO3 and GO4 were considered the most 
likely super-spreaders epidemiologically, being regulars in the public houses in the area and GO4 
having been highly infectious. In addition, contact tracing identified GO5 as being potentially 
infectious for a year prior to diagnosis and treatment and thus GO5 was also deemed to have 
the potential to have caused multiple secondary cases.  
However, in both the cgMLST and WGS SNP mapping results (Figures 6.3a and 6.5a), a star-like 
structure was present within the phylogenies. Gene-by-gene based cgMLST identified isolates 
GO2 and GO6 as the central cases, which differed from what the contact tracing team suspected. 
The use of a WGS SNP calling method also produced a star-like structure but identified GO3 as 
the super-spreader central to the outbreak, causing direct transmission to each of the five 
secondary cases within outbreak 2. As stated, GO3 was considered, along with GO4, the most 
likely super-spreader in the public house outbreak according to the epidemiological data. Thus, 
use of the WGS SNP calling method supported at least some of the epidemiological assumptions. 
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However, the WGS SNP calling method determined that GO4 and GO5 were not super-spreaders 
despite their epidemiological status as being potentially highly infectious. In addition, the WGS 
SNP calling results confirmed the status of GO6 and GO7 as secondary cases within the outbreak 
and found that GO7 was infected by GO3 and not GO4 (a question arising from contact tracing 
prior to typing). A previous study has highlighted the increased resolution WGS SNP calling 
phylogenies provide in comparison with cgMLST analysis (Kohl et al., 2014). This study supported 
those conclusions. However this study also contrasts with the study by Kohl et al (2014), which 
found that despite providing lower resolution, cgMLST provided an adequate alternative to WGS 
SNP mapping in terms of matching the epidemiological conclusions on transmission events and 
super-spreader identification. Here, in contrast, cgMLST failed to assign a distinct super-
spreader and was not in agreement with transmission events as identified by the SNP mapping 
and epidemiological data, in terms of both the central role GO3 played within the outbreak and 
the secondary role GO2 and GO6 had within the outbreak. Thus, despite showing a similar 
overall outbreak structure, this study found that, for the identification of a super-spreader, the 
gene-by-gene cgMLST method and WGS SNP calling gave conflicting results.  The inferior 
accuracy of the cgMLST found here also contrasts with the results in other publications which 
support the use of gene-by-gene WGS MLST methods (such as the cgMLST used here) as an 
adequate alternative to SNP mapping for analysing outbreak transmission ( Sheppard et al., 
2012, Maiden et al., 2013). 
Despite TH2`s epidemiological links with the Gorseinon area during the outbreak, no genomic 
evidence of direct transmission between this person and any of the Gorseinon public house 
cases was found. The TH2 isolate differed from the others in outbreak 2 by at least 15 SNPs. 
With TH1 being the nephew of TH2 and both being in regular contact, the epidemiological links 
between the two are overwhelming. A previous study based on Clostridium difficile nosocomial 
outbreaks highlighted how the transmission chain missed intermediate cases which then 
skewed the true genomic distances and subsequent clinical relationship between isolates within 
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an outbreak, the study applied ancestral dating to WGS data which in turn highlighted the likely 
presence of such cases (Didelot et al., 2012). Due to the overwhelming epidemiological 
evidence, it is likely that intermediate cases between TH2 and TH1 must have been missed which 
in turn caused the excessive divergence documented by WGS SNP mapping. Unfortunately, the 
2 isolates that could have been the intermediate cases could not be included in the study as 
isolate TH3 could not be sequenced and the other isolate was unculturable.  
In-silico spoligotyping showed that each isolate belonged to the Euro-American lineage H1 
Haarlem spoligotype. Diversity was seen with regards to the octal pattern and international 
types given to each isolate and the results supported those from the WGS data results that 
showed isolates TH1, TH2 and GO1 to be part of a separate clonal complex (outbreak 2). In-silico 
spoligotyping also supported the cgMLST and epidemiological conclusions which categorise TH2 
as being part of a direct transmission chain with isolates TH1 and GO1. This is consistent with 
the hypothesis that the reason for the divergence seen in the WGS SNP calling was due to an 
unidentified intermediate case between TH2 and isolates TH1 and GO1. 
Isolates GO2 and GO4 had a different octal pattern and international type from isolates GO3, 
GO5, GO6 and GO7 despite being part of the same clonal complex according to cgMLST and WGS 
SNP calling methods. It has been documented previously that micro-evolution of the Direct 
Repeat (DR) locus responsible for spoligotype designation, can mask the true epidemiological 
relationships between clinically-related isolates (Fang et al., 1998, Warren et al., 2002). With 
both cgMLST and WGS SNP calling methods in agreement that GO2 and GO4 are directly related 
to isolates GO3, GO5, GO6 and GO7, and with there being only one locus difference between 
the two octal codes for GO2 and GO4 in comparison with the other outbreak 1 isolates, it is 
plausible that micro-evolution of the DR locus may be responsible for the divergence seen. 
Isolate GO8 harboured the exact same spoligotype octal pattern and international type as 
isolates GO3, GO5, GO6 and GO7 despite being divergent in the WGS based result. Therefore, 
despite not being directly related to any of the isolates within this dataset, the correlating in 
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silico spoligotype indicates that isolate GO8 may have potentially been infected by the same 
circulating strain that infected GO3, GO5, GO6 and GO7. Micro-evolution of the DR-locus has 
been shown to occur mainly within the sub-families of spoligotypes (Warren et al., 2002, Van 
Embden et al., 2000, Fang et al., 1998). In terms of providing a phylogenetic assignment above 
sub-family level the in silico spoligotyping provided reliable results. However, this integrity is not 
matched when spoligotyping was used to define direct evolutionary relationships between 
related clinical isolates. Thus it is not reliable for epidemiological conclusions when used alone 
(Warren et al., 2002).  
One of the original assumptions by the contact tracing team was that the Townhill and 
Gorseinon public house outbreaks were caused by the same circulating strain of M. tuberculosis 
that had micro-evolved. In silico spoligotyping provided evidence that supported the presence 
of an endemic circulating strain in the Gorseinon and Townhill areas supporting the contact 
tracing assumptions. To further assess the possibility of a endemic circulating strain causing both 
outbreaks, an ancestral dating method (Wohl et al., 2016, Jombart et al., 2014) was used to 
estimate the date of divergence between the consensus sequence of ‘outbreak 1’ and isolates 
TH1, TH2 and GO1 of ‘outbreak 2’. The use of such methods has previously aided infectious 
disease investigation for identification of the evolution of a certain trait, for a previous outbreak 
of severe acute respiratory syndrome (SARS) (Jombart et al., 2014), outbreak resolution for 
Salmonella enterica (Hawkey et al., 2013), identification of missing cases of M. tuberculosis 
(Bjorn-Mortensen et al., 2016), or species origin of Yersinia pestis (Whittles and Didelot, 2016). 
The results found TH2 to be the ancestral isolate of TH1 and GO1, which correlates to the 
ancestral position TH2 has within the cgMLST and WGS SNP calling phylogenies. This ancestral 
position of isolate TH2 was also supported by the epidemiological data that showed TH2 to be 
the earliest clinical isolate within outbreak 2 (although date of clinical presentation does not 
necessarily reflect date of infection in tuberculosis). In addition, the phylogeny also showed GO1 
and TH1 to have diverged from TMRCA 0.0387 years prior to their isolation, which correlates to 
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the close genetic relationship seen in the results.  The data predicted that the transmission chain 
that linked ‘outbreak 1’ and ‘outbreak 2’ dated back 5.755 years prior to the isolation of case 
TH2. The divergence observed between the two outbreaks could be explained by the lack of 
intermediate cases between the estimated dates of the TMRCA of both outbreaks. 
 Previous studies have highlighted how ancestral dating techniques can elucidate more on 
confusions within outbreak resolution (Roetzer et al., 2013a., Ansari and Didelot, 2016). Through 
the use of ancestral dating, which was further supported by in silico spoligotyping and strong 
epidemiological data, this study concludes that the divergence of TH1 from TH2 was likely 
because of missing cases and thus supports previous studies which uses ancestral dating on WGS 
data to elucidate and help resolve outbreaks where original SNP mapping is questionable 
(Roetzer et al., 2013a., Ansari and Didelot, 2016).  This result extends on from Chapter 5 of this 
thesis which also highlights how ancestral dating aided outbreak understanding whereby 
genomic divergences seem to unrealistically exceed epidemiological expectations. 
6.5: Conclusion 
This study has described the first use of an ancient DNA sequencing protocol for clinically 
relevant outbreak isolates that could not be sequenced by standard protocols. The data 
presented were broadly in agreement with MIRU-VNTR typing, namely that based on cgMLST 
and SNP mapping parameters there were two separate outbreaks that occurred separately. 
However, the application of in silico spoligotyping and ancestral reconstruction suggested that 
the Public Health team was correct in assuming that all isolates were related, as the origin of 
both outbreaks emerged only 6.001 years earlier than the final case and all isolates spoliogtyped 
identically as H1 Haarlem strains. The data also supported epidemiological conclusions that a 
super-spreader was present amongst the cases and suggests that GO3 was the most likely super-
spreader, which is supported by the epidemiological data on this investigation. In contrast to 
work in previous chapters, WGS SNP mapping provided results that correlated with the 
epidemiological data, whereby cgMLST analysis provided results that could be questioned based 
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on epidemiological data. For future work, it is the potentially missing intermediate cases that 
warrant further investigation. 
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Chapter 7 
General Discussion 
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The work carried out for this thesis aimed to provide an in-depth analysis of M. tuberculosis 
outbreaks and phylogenetics primarily using WGS and gene-by-gene MLST analysis software 
developed and published by Ridom SeqSphere (Jünemann, S et al, 2013). Previous studies have 
shown that the use of a gene-by-gene MLST analysis for WGS data works well (Sheppard et al., 
2012, Maiden et al., 2013, Kohl et al., 2014, Bratcher H.B, 2014). However, the authors 
emphasised the need for the provision of the raw data in a uniform and standardised format. 
With affordable WGS allowing multiple microbial genomes to be sequenced and analysed, 
refining the way data are analysed and used for clinical outbreak resolution will inevitably be an 
issue for application in clinical practice. Previous studies, using traditional SNP mapping pipelines 
have provided excellent resolution of M. tuberculosis outbreaks, going above and beyond earlier 
typing methods with regards to confirming outbreak clusters (Gardy et al., 2011, Walker et al., 
2013, Walker et al., 2015,), identifying outbreak source cases (Walker et al., 2018), identification 
of super-spreaders (Takiff and Feo, 2015), highlighting direct transmission events and more 
(Walker et al., 2013, Witney et al., 2016). These studies have confirmed the advantages of using 
WGS data for outbreak resolution and investigation. However, there are limitations as identified 
in the present study; the use of “in-house” SNP mapping pipelines across various published 
studies has meant that the widespread use of WGS in clinical practice is challenging due to the 
lack of a uniform and standardised format for bioinformatic analysis on large WGS datasets.  
Analysis of three outbreaks in South West Wales using cgMLST allowed for adequate resolution 
of each one, supporting the results of a previous study that used this method for M. tuberculosis 
outbreak resolution (Kohl et al., 2014). However, for the Llwynhendy and Gorseinon outbreaks, 
certain discrepancies were found with regards to cgMLST conclusions. Previous studies have 
highlighted that WGS gene-by-gene MLST methods allow isolates,  for which only partial 
sequence data were obtained (Sheppard et al., 2012), to be included in the downstream 
bioinformatic analysis (Sheppard et al., 2012). However, the results of the Llwynhendy outbreak 
analysis highlighted that where a parameter was set, such as the 12-allelic difference threshold, 
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isolates with partial sequence data could not be included confidently, such as for LL10.  The 
cgMLST indicated that LL10 showed little divergence from the other isolates associated with the 
Llwynhendy outbreak, however only 1466 genes (51%) of the 2891 cgMLST scheme could be 
analysed for LL10. Whether or not this divergence would exceed the threshold when all 2891 
genes were present is not known. Therefore, although partial sequence data for isolates can be 
analysed using the cgMLST scheme, doing so cannot provide a conclusive result, only that LL10 
may be worth re-sequencing (Sheppard et al., 2012, Kohl et al., 2014). Although the 
compromised cgMLST analysis provided evidence for LL10`s inclusion in the outbreak, re-
sequencing and the cost that goes with it would still be needed to make any valid conclusions; 
thus this method would not save time or money in clinical practice. Inevitably, for WGS data to 
be used clinically in a widespread manner for M. tuberculosis, a threshold defining outbreak 
resolution is needed for successful standardisation. In short, the emphasis should be placed on 
consistent high-quality sequencing of outbreak isolates rather than focusing on being “able” to 
use partial sequence data, a strategy which has been suggested previously (Sheppard et al., 
2012, Maiden et al., 2013).  
In contrast, for the Gorseinon outbreak (Chapter 6), cgMLST successfully resolved conflicts 
between MIRU-VNTR typing and traditional epidemiological conclusions. The cgMLST clarified 
that two outbreaks were present; that isolate GO1 despite having the Gorseinon MIRU-VNTR 
type actually clustered as a Townhill outbreak isolate and confirmed suspicions that isolates GO8 
and GO9 were not directly related to the either the Gorseinon or Townhill outbreaks. However, 
the cgMLST analysis could not define a specific case as the likely source case or super-spreader 
as postulated by the original contact tracing team. In fact, the results for the Gorseinon outbreak 
largely supported those seen by Kohl et al, (2014), in finding that the cgMLST method provided 
adequate resolution of the outbreak but was inferior to the resolution provided by traditional 
SNP mapping. SNP mapping did reveal the presence of GO3 as the super-spreader within the 
outbreak, a conclusion which was supported by the traditional epidemiological data.  
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Although the traditional SNP mapping method provided superior resolution for the Gorseinon 
outbreak, its application for the Llwynhendy and Neath Port Talbot outbreaks (Chapter 4 and 5 
respectively) was inconsistent and provided results that were unlikely according to the 
epidemiology.  In these cases, the cgMLST analysis was superior to traditional SNP mapping.  
Thus, within the present study of three outbreaks, there were inconsistent results from using 
WGS traditional SNP mapping for outbreak resolution, based on the published parameter of 12 
SNPs for outbreak association defined by Walker et al (2013). Within this study, the published 
CSI phylogeny SNP mapping programme available on the Centre of Genomic Epidemiology 
online server, applying the standard default parameters to each isolate of each outbreak, was 
used. A major flaw in the application of traditional SNP mapping with regards to consistency was 
identified. The resolution of the outbreaks within this study was based on using a 12 SNP 
threshold defined in previous studies (Walker et al., 2013, Kohl et al, 2014).  However, the 
studies that originally defined the threshold did not define the specific computational pipeline 
or sequence quality parameters used to call the SNP`s from their WGS data and rather refer to 
their pipeline as “in-house”. Therefore, as the detailed parameter`s used in those studies are 
unknown, the 12 SNP threshold applied for the traditional WGS SNP mapping across this thesis 
is not reliable, as the threshold was calculated based on an “in-house” pipeline as stated by 
Walker et al (2013) which may differ from the CSI phylogeny pipeline used in this study. The 
inconsistency in the computational pipelines used to call SNP`s from sequence data across 
different datasets is a flaw in traditional SNP mapping in terms of its widespread use in outbreak 
resolution. 
 
In contrast, the 12 allelic difference threshold applied for each outbreak was derived from a 
published set of 2891 core genes used in a previous study (Kohl et al, 2014) and commercially 
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available using the Ridom seqSphere software (Jünemann S et al., 2013). Understanding the 
exact parameters for SNP mapping is essential for consistent outbreak resolution.  
The SNP mapping analysis, carried out using the CSI phylogeny pipeline, was based on SNPs 
across the WGS of each outbreak isolate, thus parameters to exclude more polymorphic regions 
of the genome were not included in the analysis. The basis to exclude such sites was not defined 
by Walker et al (2013), which first defined the 12 SNP threshold. However, through comparison 
of the WGS SNP mapping with both an in-house constructed cgMLST and an established cgMLST 
scheme, it could be concluded that the discrepancies observed between the SNP mapping and 
the established cgMLST analysis were likely to be caused by the inclusion of polymorphic loci 
within the SNP mapping analysis. Within M. tuberculosis, polymorphic loci refer to hyper variable 
loci whereby the rate of divergence is disproportionally higher than the rest of the loci in the 
genome, these loci notoriously include genes of the PPE and PE gene family which accumulate 
non-synonymous mutations 3 times that of  the rest of the genome (Gutacker et al., 2002, 
McEvoy et al., 2012). This is a point to consider with regards to the use of WGS gene-by-gene 
MLST methods as an alternative to WGS SNP mapping.  
In addition, the application of the 12 SNP “cut-off” thresholds may also be invalid for our 
outbreaks for reasons relating to the inconsistency of the pipeline used. Previous research has 
emphasised that, due to the relatively slow but variable molecular clock of M. tuberculosis 
(Bryant et al, 2013), the use of a simple SNP threshold as a “cut-off” point of any kind may not 
be applicable to this organism in terms of confirming transmission events alone (Bryant et al, 
2013), a concept supported by the work in this thesis. Instead of providing evidence of direct 
links between isolates for the Llwynhendy and Neath Port Talbot outbreaks, the SNP mapping 
results mirrored those in the original Gardy et al (2011) SNP mapping study where the pattern 
of divergence between outbreak isolates in the phylogenies produced by WGS SNP mapping 
aided the original epidemiological data to resolve discrepancies with MIRU-VNTR typing and 
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identified the presence of super-spreaders (Gardy et al., 2011), rather than being used as a 
standalone method for outbreak resolution.  
The outbreaks in Llwynhendy and Neath Port Talbot are more divergent genomically than the 
Gorseinon one in terms of the WGS SNP mapping of the isolates involved. The polymorphic 
regions, which were not removed from traditional SNP mapping, are likely to have exacerbated 
the genomic distances in the less clonal outbreaks of Llwynhendy and Neath Port Talbot. The 
application of the established cgMLST scheme provided results that were more standardised, 
reproducible and consistent across each outbreak within this study, in contrast to the results 
achieved by traditional SNP mapping. For clinical outbreak resolution, cgMLST results provide 
promise for the use of WGS data in clinical practice which is consistent, presented in a uniform 
format and based on a standardised set of established core genes from which outbreak 
association thresholds can be applied consistently using a single piece of software. 
In addition to using the cgMLST method for resolution of clinical outbreaks, this was the first 
use, to our knowledge, of a gene-by-gene method for providing phylogenetic analysis of M. 
tuberculosis isolates. Such analysis has been carried out routinely through traditional SNP 
mapping for M. tuberculosis (Gutacker et al 2006, Comas et al 2013, Coll et al, 2014). The results 
from this study based on a set of 60 SNPs (Coll et al, 2014) showed a close correlation with the 
initial SNP bar-coding results, clearly highlighting a dominance of Euro-American lineage 4 
isolates among the Welsh ones. However, cgMLST statistically could only provide confident 
assignments to 50 of the 59 M. tuberculosis isolates originally assigned into phylogenetic groups 
by robust SNP bar-coding. In particular, statistical analysis could not provide 100% confidence in 
the associations of isolates BK21 and BK25, with further sub-lineage specific genotyping needed 
to confirm their assignment as lineage 2 Beijing strains as previously postulated by the 60 SNP 
barcode (Coll et al, 2014). Globally, failure to confidently identify M. tuberculosis Beijing strains 
is of concern, with this sub-lineage containing strains often regarded as virulent and highly 
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transmissible (Rad et al 2003, Marais et al 2006, Mestre et al 2011). Within this current study, 
the 60 SNP barcode analysis did provide more reliable and detailed conclusions on the 
phylogenetics of the Welsh isolates, giving both major and sub-lineage classifications. The 60 
SNP barcode also provided a level of standardisation analysing the same 60 loci across any M. 
tuberculosis isolate for which phylogenetic assignment is needed. However, even with a 
standardised set of SNPs, the computational pipeline needed to extract these was based on a 
command line script including a combination of various, user-unfriendly command line steps 
which requires high level computational expertise. The computational complexity and user- 
unfriendly nature of such a pipeline is clinically relevant as the method would be undesirable for 
routine laboratory staff and would require widespread employment or training of 
computational expertise for its routine use across the clinical setting. The cgMLST results did not 
match the integrity of those made by the SNP barcode. However, gene-by-gene MLST analysis 
has the potential to provide phylogenetic classifications which are user-friendly, reproducible 
and uniform. Further research into refining the cgMLST analysis for phylogenetic classification is 
needed. 
This study has provided insights into how WGS data can be used in various applications, other 
than simply for outbreak resolution. In the phylogenetic analysis alone, it was possible to classify 
isolates into PGGs, SNP cluster groups and extract strain-specific polymorphisms to support the 
lineage and sub-lineage assignments made by the application of a robust SNP barcode and the 
cgMLST association results. The same sequence data were used for each of the phylogenetic 
analyses, emphasising that WGS data allow for multiple formats to which phylogenetic 
classifications can be made simultaneously. This contrasts with other typing methods such as 
spoligotyping and MIRU-VNTR typing, where phylogenetic classification is uniformly designated 
and would require further separate protocols, such as PCR amplification of the gyrB and katG 
loci for PGG assignment (Sreevatsan et al., 1997).  
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Various applications of WGS data interpretation can lead to increasing levels of insight to an 
outbreak and the strains of M. tuberculosis within them. The Llwynhendy outbreak was 
presented initially, to provide an introduction into the application of a gene-by-gene based 
cgMLST method for outbreak resolution. In Llwynhendy, the epidemiological questions were 
simple with only the inclusion and exclusion of isolates from an outbreak surrounding the public 
house needing to be resolved. Therefore, the application of the cgMLST alone was satisfactory 
for the resolution of this outbreak. The presence of “two” separate outbreaks in Neath Port 
Talbot provided a more complex scenario and thus ancestral dating was introduced to provide 
a clearer picture. For the Neath Port Talbot outbreak, cgMLST alone did resolve discrepancies in 
the original typing, excluding several “B” isolates as wrongly assigned by MIRU-VNTR and 
including a background isolate previously considered not associated with the outbreak. 
However, cgMLST did confirm the presence of two outbreaks within the dataset. The use of 
ancestral dating provided clarity on the relationship between the “two” outbreaks identified by 
cgMLST, showing that, the isolates had only recently diverged. This supports the original 
hypothesis by traditional epidemiological conclusions that the Neath Port Talbot cases were 
caused by one larger outbreak. The ancestral dating indicated that further work is needed to 
investigate potential intermediate cases not included in the investigation which may bridge the 
genomic distances between isolates of the separate outbreaks.  
The Gorseinon/Townhill outbreak in Chapter 6 showed complexity with the presence of “two” 
outbreaks from two close but distinct areas. The use of ancestral dating provided further insight 
into the outbreaks and highlighted that although both cgMLST and WGS SNP mapping identified 
two; their common ancestor was recent, indicating both were part of a larger outbreak. In 
addition, in silico spoligotyping provided more insight into the demography of the outbreak. As 
stated, all isolates belonged to the H1 Haarlem Euro American spoligotype family, a result that 
correlated with the SNP bar-coding phylogenetic assignment of the Gorseinon isolates carried 
out in Chapter 3. Thus, through addition of in silico spoligotyping it was possible to identify the 
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presence of an endemic H1 Haarlem strain circulating in the Gorseinon and Townhill regions. 
Such evidence provided a more complete picture of the Gorseinon outbreak than the use of 
cgMLST and WGS SNP mapping alone. For resolving outbreaks of a complex nature, the work 
presented provides evidence that additional information through ancestral dating; in silco 
spoligotyping and SNP bar-coding is helpful prior to drawing conclusions on the outbreak.  
For both the Llwynhendy (Chapter 4) and Neath Port Talbot (Chapter 5) outbreaks, functional 
analysis of polymorphisms was carried out. Through introducing in-silico functional prediction 
software to this study, further insights into the physiology of outbreak isolates were potentially 
elucidated. Within the Neath Port Talbot outbreak, Provean functional prediction identified the 
presence of a deleterious mutation within the dacB2 (Rv2195) gene. Inactivation of the DacB2 
protein has been shown in vitro to cause susceptibility of M. tuberculosis to amoxicillin-
clavulanic acid treatment (Kumar et al., 2012 Diacon et al., 2016). This is not to say that 
treatment with this drug would be indicated in this case, but it showed that, in principle, 
information that might be useful for treatment could be obtained. Such physiological 
information cannot be gleaned when typing is carried out by any other molecular typing 
method.    
This study highlights the large amount of information that can be obtained from WGS data and 
its ability to resolve outbreaks in a more accurate manner than classical methods, which have 
been documented previously (Gardy et al, 2011, Walker et al, 2013, Walker et al, 2015). 
Prediction of functional differences caused by polymorphisms, identifying the last common 
ancestor of separate outbreaks, providing phylogenetic conclusions and more can all be carried 
out though analysis and processing of the same raw sequence data. Although outbreak 
resolution is greater using WGS data, it is the wider applications and extensive information 
obtained from the same original raw sequence data which elevates the potential of WGS for 
clinical purposes.  
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The most unique element of my work was the use of an ancient DNA library preparation method 
for the rescue of poor quality sample DNA essential to resolving the Gorseinon outbreak. 
Although ancient DNA library preparation and sequencing protocols have been used to 
investigate pathogens from historical outbreaks, such as the Yersinisa pestis plague of 541 AD 
(Gilbert et al, 2014) and the Philadelphia Vibrio cholerae outbreak of 1849 (Devault et al., 2014), 
no adaptation of such methods has been recorded in the resolution of a modern-day clinical 
tuberculosis outbreak, as far as can be established. The method used has allowed WGS data to 
be obtained from a wide range of samples, spanning ancient humans and hominids (Rasmussen, 
et al, 2010; Green et al, 2010), mammals (Miller et al., 2008, Mak et al., 2017) and plants (Li et 
al., 2011; Wales et al., 2013; Jaenicke-Despres et al., 2003). The adaptation of the method to aid 
the resolution of the Gorseinon outbreak demonstrated successfully how work in another field 
has opened the door for the rescuing of genomic data from modern clinical samples of sub-
optimal quality despite its origins being based on sequencing DNA from museum-based 
specimens. The cost of the ancient DNA library preparation is around £50 (Christian Caroe, 
personal communication), which is over double the cost of the conventional Nextera XT library 
preparation per sample, which stands at around £24 (Christian Caroe, personal communication). 
Therefore, its widespread usage would not be cost-effective. In certain circumstances, such as 
legal cases regarding M. tuberculosis infections or in investigation of characteristics important 
to certain outbreaks, such as drug resistance, it could be justified.  
In conclusion, WGS will soon revolutionise clinical outbreak investigations. This study has 
shown that its applications are above and beyond any other current typing method and 
supports previous studies regarding the inferior resolution provided by MIRU-VNTR typing. 
Developments in the standardisation of WGS data without losing its accuracy, inclusion of 
simultaneous ancestral dating and simultaneous physiological predictions from WGS data will 
be able to truly exploit the WGS data provided. The cost of conventional WGS has fallen to a 
level where it is considered affordable for use in clinical outbreak investigations and for 
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complex cases where poor DNA quality is a problem the ancient DNA library preparation 
method used in this study has potential to rescue important genomic data. Thus, over the next 
few years, WGS for the resolution, surveillance and treatment of M. tuberculosis will no doubt 
become widespread throughout clinical practice. 
 
 
210 
Bibliography  
ABADIA, E., ZHANG, J., RITACCO, V., KREMER, K., RUIMY, R., RIGOUTS, L., GOMES, H., ELIAS, 
A., FAUVILLE-DUFAUX, M., STOFFELS, K., RASOLOFO-RAZANAMPARANY, V., DE VIEDMA, D., 
HERRANZ, M., AL-HAJOJ, S., RASTOGI, N., GARZELLI, C., TORTOLI, E., SUFFYS, P., VAN 
SOOLINGEN, D., REFREGIER, G. & SOLA, C. 2011. The use of microbead-based spoligotyping 
for Mycobacterium tuberculosis complex to evaluate the quality of the conventional 
method: Providing guidelines for Quality Assurance when working on membranes. BMC 
Infectious Diseases, 11, 110. 
  
AGNEMEMEL, A., HONG, E., GIORGINI, D., NUÑEZ-SAMUDIO, V., DEGHMANE, A.-E. & TAHA, 
M.-K. 2016. Neisseria meningitidis Serogroup X in Sub-Saharan Africa. Emerging Infectious 
Diseases, 22, 698. 
  
ALDOUS, W. K., POUNDER, J. I., CLOUD, J. L. & WOODS, G. L. 2005. Comparison of six 
methods of extracting Mycobacterium tuberculosis DNA from processed sputum for testing 
by quantitative real-time PCR. Journal of Clinical Microbiology, 43, 2471-2473. 
  
AL-HAJOJ, S. A., AKKERMAN, O., PARWATI, I., AL-GAMDI, S., RAHIM, Z., VAN SOOLINGEN, D., 
VAN INGEN, J., SUPPLY, P. & VAN DER ZANDEN, A. G. 2010. Microevolution of 
Mycobacterium tuberculosis in a tuberculosis patient. Journal of Clinical Microbiology, 48, 
3813-3816. 
 
ALIX, E., GODREUIL, S. AND BLANC-POTARD, A.B., 2006. Identification of a Haarlem 
genotype-specific single nucleotide polymorphism in the mgtC virulence gene of 
Mycobacterium tuberculosis. Journal of clinical microbiology, 44(6), pp.2093-2098. 
 
ALLAND, D., LACHER, D. W., HAZBÓN, M. H., MOTIWALA, A. S., QI, W., FLEISCHMANN, R. D. 
& WHITTAM, T. S. 2007. Role of large sequence polymorphisms (LSPs) in generating genomic 
diversity among clinical isolates of Mycobacterium tuberculosis and the utility of LSPs in 
phylogenetic analysis. Journal of Clinical Microbiology, 45, 39-46. 
 
AMINIAN, M., COUVIN, D., SHABBEER, A., HADLEY, K., VANDENBERG, S., RASTOGI, N. AND 
BENNETT, K.P., 2014. Predicting Mycobacterium tuberculosis complex clades using 
knowledge-based Bayesian networks. BioMed research international, 2014. 
ANDERSON, J., JARLSBERG, L.G., GRINDSDALE, J., OSMOND, D., KAWAMURA, M., 
HOPEWELL, P.C. AND KATO-MAEDA, M., 2013. Sublineages of lineage 4 (Euro-American) 
Mycobacterium tuberculosis differ in genotypic clustering. The International Journal of 
Tuberculosis and Lung Disease, 17(7), pp.885-891. 
  
ANSARI, M. A. & DIDELOT, X. 2016. Bayesian Inference of the Evolution of a Phenotype 
Distribution on a Phylogenetic Tree. Genetics, 204, 89-98. 
  
ARJOMANDZADEGAN, M., TITOV, L. P., SURKOVA, L. K., FARNIA, P., SHEIKHOLESLAMI, F., 
OWLIA, P., ESHGHINEJAD, A. & FARAZI, A. A. 2012. Determination of principal genotypic 
groups among susceptible, MDR and XDR clinical isolates of Mycobacterium tuberculosis in 
Belarus and Iran. Tuberk Toraks, 60, 153-159. 
  
  
 
 
211 
ASANTE-POKU, A., YEBOAH-MANU, D., OTCHERE, I. D., ABOAGYE, S. Y., STUCKI, D., 
HATTENDORF, J., BORRELL, S., FELDMANN, J., DANSO, E. & GAGNEUX, S. 2015. 
Mycobacterium africanum is associated with patient ethnicity in Ghana. PLoS Neglected 
Tropical Diseases, 9, e3370. 
  
AUGUSTYNOWICZ-KOPEC, E., JAGIELSKI, T., KOZINSKA, M., ZABOST, A. & ZWOLSKA, Z. 2007. 
The significance of spoligotyping method in epidemiological investigations of tuberculosis. 
Pneumonol Alergol Pol, 75, 22-31. 
  
BAKER, L., BROWN, T., MAIDEN, M. C. & DROBNIEWSKI, F. 2004. Silent nucleotide 
polymorphisms and a phylogeny for Mycobacterium tuberculosis. Emerging Infectious 
Diseases, 10, 1568. 
 
BALASUBRAMANIAN, V., WIEGESHAUS, E. & SMITH, D. 1992. Growth characteristics of 
recent sputum isolates of Mycobacterium tuberculosis in guinea pigs infected by the 
respiratory route. Infection and Immunity, 60, 4762-4767. 
  
BARRY, C. E., LEE, R. E., MDLULI, K., SAMPSON, A. E., SCHROEDER, B. G., SLAYDEN, R. A. & 
YUAN, Y. 1998. Mycolic acids: structure, biosynthesis and physiological functions. Progress in 
Lipid Research, 37, 143-179. 
  
BETTS, J. C., LUKEY, P. T., ROBB, L. C., MCADAM, R. A. & DUNCAN, K. 2002. Evaluation of a 
nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein 
expression profiling. Molecular Microbiology, 43, 717-731. 
  
BIFANI, P. J., PLIKAYTIS, B. B., KAPUR, V., STOCKBAUER, K., PAN, X., LUTFEY, M. L., 
MOGHAZEH, S. L., EISNER, W., DANIEL, T. M. & KAPLAN, M. H. 1996. Origin and interstate 
spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. 
JAMA, 275, 452-457. 
  
BISHAI, W. R., DANNENBERG, A. M., PARRISH, N., RUIZ, R., CHEN, P., ZOOK, B. C., JOHNSON, 
W., BOLES, J. W. & PITT, M. L. M. 1999. Virulence of Mycobacterium tuberculosisCDC1551 
and H37Rv in Rabbits Evaluated by Lurie’s Pulmonary Tubercle Count Method. Infection and 
Immunity, 67, 4931-4934. 
  
BJORN-MORTENSEN, K., SOBORG, B., KOCH, A., LADEFOGED, K., MERKER, M., LILLEBAEK, T., 
ANDERSEN, A., NIEMANN, S. & KOHL, T. 2016. Tracing Mycobacterium tuberculosis 
transmission by whole genome sequencing in a high incidence setting: a retrospective 
population-based study in East Greenland. Scientific Reports, 6. 
  
BLASER, M. J. & KIRSCHNER, D. 2007. The equilibria that allow bacterial persistence in 
human hosts. Nature, 449, 843. 
  
  
 
 
212 
BOURAI, N., JACOBS, W. R. & NARAYANAN, S. 2012. Deletion and over expression studies on 
DacB2, a putative low molecular mass penicillin binding protein from Mycobacterium 
tuberculosis H 37 Rv. Microbial Pathogenesis, 52, 109-116. 
 
BRATCHER, H.B., CORTON, C., JOLLEY, K.A., PARKHILL, J. AND MAIDEN, M.C., 2014. A gene-
by-gene population genomics platform: de novo assembly, annotation and genealogical 
analysis of 108 representative Neisseria meningitidis genomes. BMC genomics, 15(1), 
p.1138. 
 
BROMBERG, Y. & ROST, B. 2007. SNAP: predict effect of non-synonymous polymorphisms on 
function. Nucleic Acids Research, 35, 3823-3835.  
 
BROSCH, R., GORDON, S. V., PYM, A., EIGLMEIER, K., GARNIER, T. & COLE, S. T. 2000. 
Comparative genomics of the mycobacteria. International Journal of Medical Microbiology, 
290, 143-152. 
 
BROSCH R, GORDON SV, MARMIESSE M, 2002. A new evolutionary scenario for the 
Mycobacterium tuberculosis complex. Proceedings of the National Academy of Sciences of 
the United States of America. 2002;99(6):3684-3689. doi:10.1073/pnas.052548299. 
 
BRYANT, J.M., SCHÜRCH, A.C., VAN DEUTEKOM, H., HARRIS, S.R., DE BEER, J.L., DE JAGER, V., 
KREMER, K., VAN HIJUM, S.A., SIEZEN, R.J., BORGDORFF, M. AND BENTLEY, S.D., 2013. 
Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome 
sequencing data. BMC infectious diseases, 13(1), p.110. 
  
BRUDEY, K., DRISCOLL, J. R., RIGOUTS, L., PRODINGER, W. M., GORI, A., AL-HAJOJ, S. A., 
ALLIX, C., ARISTIMUÑO, L., ARORA, J. & BAUMANIS, V. 2006a. Mycobacterium tuberculosis 
complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) 
for classification, population genetics and epidemiology. BMC Microbiology, 6, 23. 
 
BYNUM, H., 2012. Spitting Blood: The history of tuberculosis. Oxford University Press.  
CARØE C, G. S., VINNER L, MAK SS, SINDING MH, SAMANIEGO JA ET AL. 2017. Single-tube 
library preparation for degraded DNA. Methods in Ecology and Evolution. 
  
CAWS, M., THWAITES, G., DUNSTAN, S., HAWN, T. R., LAN, N. T. N., THUONG, N. T. T., 
STEPNIEWSKA, K., HUYEN, M. N. T., BANG, N. D. & LOC, T. H. 2008. The influence of host and 
bacterial genotype on the development of disseminated disease with Mycobacterium 
tuberculosis. PLoS Pathogen, 4, e1000034. 
 
CAVE, A.J.E. AND DEMONSTRATOR, A., 1939. The evidence for the incidence of tuberculosis 
in ancient Egypt. British Journal of Tuberculosis, 33(3), pp.142-152. 
  
CHIN, C.-S., SORENSON, J., HARRIS, J. B., ROBINS, W. P., CHARLES, R. C., JEAN-CHARLES, R. R., 
BULLARD, J., WEBSTER, D. R., KASARSKIS, A. & PELUSO, P. 2011. The origin of the Haitian 
cholera outbreak strain. New England Journal of Medicine, 364, 33-42. 
  
CHOI, Y. & CHAN, A. P. 2015. PROVEAN web server: a tool to predict the functional effect of 
amino acid substitutions and indels. Bioinformatics, btv195. 
  
 
 
213 
CHRISTIANSON, S., WOLFE, J., ORR, P., KARLOWSKY, J., LEVETT, P. N., HORSMAN, G. B., 
THIBERT, L., TANG, P. & SHARMA, M. K. 2010. Evaluation of 24 locus MIRU-VNTR genotyping 
of Mycobacterium tuberculosis isolates in Canada. Tuberculosis (Edinb), 90, 31-8. 
 
COLE, S. T., BROSCH, R., PARKHILL, J., GARNIER, T., CHURCHER, C., HARRIS, D., GORDON, S. 
V., EIGLMEIER, K., GAS, S., BARRY, C. E., TEKAIA, F., BADCOCK, K., BASHAM, D., BROWN, D., 
CHILLINGWORTH, T., CONNOR, R., DAVIES, R., DEVLIN, K., FELTWELL, T., GENTLES, S., 
HAMLIN, N., HOLROYD, S., HORNSBY, T., JAGELS, K., KROGH, A., MCLEAN, J., MOULE, S., 
MURPHY, L., OLIVER, K., OSBORNE, J., QUAIL, M. A., RAJANDREAM, M. A., ROGERS, J., 
RUTTER, S., SEEGER, K., SKELTON, J., SQUARES, R., SQUARES, S., SULSTON, J. E., TAYLOR, K., 
WHITEHEAD, S. & BARRELL, B. G. 1998. Deciphering the biology of Mycobacterium 
tuberculosis from the complete genome sequence. Nature, 393, 537-544. 
 
COLDITZ, G.A., BREWER, T.F. AND BERKEY, C.S., 1994. Efficacy of BCG vaccine in the 
prevention of tuberculosis. J. Am. Med. Assoc, 271, p.698702. 
  
COLL, F., MCNERNEY, R., GUERRA-ASSUNÇÃO, J. A., GLYNN, J. R., PERDIGÃO, J., VIVEIROS, 
M., PORTUGAL, I., PAIN, A., MARTIN, N. & CLARK, T. G. 2014. A robust SNP barcode for 
typing Mycobacterium tuberculosis complex strains. Nature Communications, 5. 
 
COLLINS, F. M. & SMITH, M. M. 1969. A Comparative Study of the Virulence of 
Mycobacterium Tuberculosis Measured in Mice and Guinea Pigs 1, 2. American Review of 
Respiratory Disease, 100, 631-639. 
  
COMAS, I., COSCOLLA, M., LUO, T., BORRELL, S., HOLT, K. E., KATO-MAEDA, M., PARKHILL, 
J., MALLA, B., BERG, S. & THWAITES, G. 2013. Out-of-Africa migration and Neolithic co 
expansion of Mycobacterium tuberculosis with modern humans. Nature genetics, 45, 1176-
1182. 
  
COMAS, I., HOMOLKA, S., NIEMANN, S. & GAGNEUX, S. 2009. Genotyping of genetically 
monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the 
limitations of current methodologies. PLoS One, 4, e7815. 
  
  
COSCOLLA, M. & GAGNEUX, S. Consequences of genomic diversity in Mycobacterium 
tuberculosis.  Seminars in Immunology, 2014. Elsevier, 431-444. 
  
CRAMPIN, A. C., MWAUNGULU, J. N., MWAUNGULU, F. D., MWAFULIRWA, D. T., 
MUNTHALI, K., FLOYD, S., FINE, P. E. & GLYNN, J. R. 2010. Recurrent TB: relapse or 
reinfection? The effect of HIV in a general population cohort in Malawi. AIDS (London, 
England), 24, 417. 
  
  
 
 
214 
CRUZ, U. O. S. 2017. Troubleshooting DNA Separations on Agarose Gels [Online]. Available: 
http://bio.classes.ucsc.edu/bio20L/info/content/molbio2/molbio1/troub.htm. 
  
CUBILLOS-RUIZ, A., SANDOVAL, A., RITACCO, V., LÓPEZ, B., ROBLEDO, J., CORREA, N., 
HERNANDEZ-NEUTA, I., ZAMBRANO, M. M. & DEL PORTILLO, P. 2010. Genomic Signatures 
of the Haarlem Lineage of Mycobacterium tuberculosis: Implications of Strain Genetic 
Variation in Drug and Vaccine Development. Journal of Clinical Microbiology, 48, 3614-
3623. 
  
DABNEY, J., KNAPP, M., GLOCKE, I., GANSAUGE, M.-T., WEIHMANN, A., NICKEL, B., 
VALDIOSERA, C., GARCÍA, N., PÄÄBO, S. & ARSUAGA, J.-L. 2013. Complete mitochondrial 
genome sequence of a Middle Pleistocene cave bear reconstructed from ultrashort DNA 
fragments. Proceedings of the National Academy of Sciences, 110, 15758-15763. 
 
DANIEL, T.M., 2006. The history of tuberculosis. Respiratory medicine, 100(11), pp.1862-
1870 
 
DAS, S. D., NARAYANAN, S., HARI, L., HOTI, S. L., THANGATHURAI, R. K., CHARLES, N., 
JAGGARAJAMMA, K. & NARAYANAN, P. R. 2005. Differentiation of highly prevalent IS6110 
single-copy strains of Mycobacterium tuberculosis from a rural community in South India 
with an ongoing DOTS programme. Infection, Genetics and Evolution, 5, 67-77. 
  
DAVID, S., DUARTE, E. L., LEITE, C. Q. F., RIBEIRO, J.-N., MAIO, J.-N., PAIXÃO, E., PORTUGAL, 
C., SANCHO, L. & DE SOUSA, J. G. 2012. Implication of the RD Rio Mycobacterium 
tuberculosis sublineage in multidrug resistant tuberculosis in Portugal. Infection, Genetics 
and Evolution, 12, 1362-1367. 
 
DEFRA,. 2013. Department for Environment Food and Rural  Affairs. Request for 
information: Various Bovine TB costs (2008-2013). URL: 
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment
_data/file/239443/DOC120913-12092013094820.pdf 
  
  
 
 
215 
DE JONG, B. C., HILL, P. C., AIKEN, A., AWINE, T., MARTIN, A., ADETIFA, I. M., JACKSON-
SILLAH, D. J., FOX, A., KATHRYN, D. & GAGNEUX, S. 2008. Progression to active tuberculosis, 
but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. The 
Journal of Infectious Diseases, 198, 1037-1043. 
 
DE LA RUA-DOMENECH, R., 2006. Human Mycobacterium bovis infection in the United 
Kingdom: incidence, risks, control measures and review of the zoonotic aspects of bovine 
tuberculosis. Tuberculosis, 86(2), pp.77-109. 
 
DEMAY, C., LIENS, B., BURGUIÈRE, T., HILL, V., COUVIN, D., MILLET, J., MOKROUSOV, I., 
SOLA, C., ZOZIO, T. AND RASTOGI, N., 2012. SITVITWEB–a publicly available international 
multimarker database for studying Mycobacterium tuberculosis genetic diversity and 
molecular epidemiology. Infection, Genetics and Evolution, 12(4), pp.755-766. 
DEN BOON, S., VERVER, S., LOMBARD, C.J., BATEMAN, E.D., IRUSEN, E.M., ENARSON, D.A., 
BORGDORFF, M.W. AND BEYERS, N., 2008. Comparison of symptoms and treatment 
outcomes between actively and passively detected tuberculosis cases: the additional value 
of active case finding. Epidemiology & Infection, 136(10), pp.1342-1349. 
DIACON, A. H., VAN DER MERWE, L., BARNARD, M., VON GROOTE-BIDLINGMAIER, F., 
LANGE, C., GARCÍA-BASTEIRO, A. L., SEVENE, E., BALLELL, L. & BARROS-AGUIRRE, D. 2016. β-
lactams against tuberculosis—new trick for an old dog? New England Journal of Medicine, 
375, 393-394.  
DORMANDY, T., 1999. The white death: a history of tuberculosis. 
 
DOU, H.Y., TSENG, F.C., LIN, C.W., CHANG, J.R., SUN, J.R., TSAI, W.S., LEE, S.Y., SU, I.J. AND 
LU, J.J., 2008. Molecular epidemiology and evolutionary genetics of Mycobacterium 
tuberculosis in Taipei. BMC infectious Diseases, 8(1), p.170. 
 
DRUMMOND, A. J., SUCHARD, M. A., XIE, D. & RAMBAUT, A. 2012. Bayesian phylogenetics 
with BEAUti and the BEAST 1.7. Molecular Biology and Evolution, 29, 1969-1973.  
DUDAS, G. & RAMBAUT, A. 2014. Phylogenetic analysis of Guinea 2014 EBOV Ebolavirus 
outbreak. PLOS Currents Outbreaks.  
ENGLAND, T. F. 2017. NFU [Online]. Available: http://www.tbfreeengland.co.uk/faqs/how-
much-does-btb-cost/.  
EWER, K., DEEKS, J., ALVAREZ, L., BRYANT, G., WALLER, S., ANDERSEN, P., MONK, P. & 
LALVANI, A. 2003. Comparison of T-cell-based assay with tuberculin skin test for diagnosis 
of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. The Lancet, 361, 
1168-1173. 
 
European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 
2014. Tuberculosis surveillance and monitoring in Europe 2015. 
 
European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 
2017. Tuberculosis surveillance and monitoring in Europe 2017. 
  
FANG, Z., MORRISON, N., WATT, B., DOIG, C. & FORBES, K. 1998. IS6110 transposition and 
evolutionary scenario of the direct repeat locus in a group of closely related 
Mycobacterium tuberculosis strains. Journal of bacteriology, 180, 2102-2109. 
  
 
 
216 
FEIL, E. J. & SPRATT, B. G. 2001. Recombination and the population structures of bacterial 
pathogens. Annual Reviews in Microbiology, 55, 561-590. 
  
FENNER, L., GAGNEUX, S., HELBLING, P., BATTEGAY, M., RIEDER, H. L., PFYFFER, G. E., 
ZWAHLEN, M., FURRER, H., SIEGRIST, H. H. & FEHR, J. 2012. Mycobacterium tuberculosis 
transmission in a country with low tuberculosis incidence: role of immigration and HIV 
infection. Journal of clinical microbiology, 50, 388-395. 
  
FERRO, B. E., NIETO, L. M., ROZO, J. C., FORERO, L. & SOOLINGEN, D. V. 2011. Multidrug-
resistant Mycobacterium tuberculosis, Southwestern Colombia. 
  
FEUERRIEGEL, S., KÖSER, C. U. & NIEMANN, S. 2014. Phylogenetic polymorphisms in 
antibiotic resistance genes of the Mycobacterium tuberculosis complex. Journal of 
Antimicrobial Chemotherapy, 69, 1205-1210. 
  
FILLIOL, I., MOTIWALA, A. S., CAVATORE, M., QI, W., HAZBÓN, M. H., BOBADILLA DEL 
VALLE, M., FYFE, J., GARCÍA-GARCÍA, L., RASTOGI, N., SOLA, C., ZOZIO, T., GUERRERO, M. I., 
LEÓN, C. I., CRABTREE, J., ANGIUOLI, S., EISENACH, K. D., DURMAZ, R., JOLOBA, M. L., 
RENDÓN, A., SIFUENTES-OSORNIO, J., PONCE DE LEÓN, A., CAVE, M. D., FLEISCHMANN, R., 
WHITTAM, T. S. & ALLAND, D. 2006b. Global Phylogeny of Mycobacterium tuberculosis 
Based on Single Nucleotide Polymorphism (SNP) Analysis: Insights into Tuberculosis 
Evolution, Phylogenetic Accuracy of Other DNA Fingerprinting Systems, and 
Recommendations for a Minimal Standard SNP Set. Journal of Bacteriology, 188, 759-772.  
 
FIRDESSA, R., BERG, S., HAILU, E., SCHELLING, E., GUMI, B., ERENSO, G., GADISA, E., KIROS, 
T., HABTAMU, M. & HUSSEIN, J. 2013. Mycobacterial lineages causing pulmonary and 
extrapulmonary tuberculosis, Ethiopia. Emerg Infect Dis, 19, 460-463. 
  
FITZGIBBON, M., GIBBONS, N., ROYCROFT, E., JACKSON, S., O'DONNELL, J., O'FLANAGAN, D. 
& ROGERS, T. 2013. A snapshot of genetic lineages of Mycobacterium tuberculosis in 
Ireland over a two-year period, 2010 and 2011. Euro surveillance: bulletin Européen sur les 
maladies transmissibles, European Communicable Disease Bulletin. 
 
FLYNN, J. L. & CHAN, J. 2001. Tuberculosis: latency and reactivation. Infection and 
Immunity, 69, 4195-4201. 
  
FORD, C. B., SHAH, R. R., MAEDA, M. K., GAGNEUX, S., MURRAY, M. B., COHEN, T., 
JOHNSTON, J. C., GARDY, J., LIPSITCH, M. & FORTUNE, S. M. 2013. Mycobacterium 
tuberculosis mutation rate estimates from different lineages predict substantial differences 
in the emergence of drug-resistant tuberculosis. Nature Genetics, 45, 784-790. 
  
FRITH, J. 2014. History of tuberculosis. Part 1-phthisis, consumption and the white plague. 
Journal of Military and Veterans Health, 22, 29. 
  
FROTHINGHAM, R. & MEEKER-O'CONNELL, W. A. 1998a. Genetic diversity in the 
Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats. 
Microbiology, 144, 1189-1196. 
 
GAGNEUX, S. & SMALL, P. M. 2007. Global phylogeography of Mycobacterium tuberculosis 
and implications for tuberculosis product development. The Lancet Infectious Diseases, 7, 
328-337. 
 
 
217 
  
GAGNEUX, S. 2012. Host–pathogen coevolution in human tuberculosis. Philosophical 
Transactions of the Royal Society of London B: Biological Sciences, 367, 850-859. 
  
GAGNEUX, S., DERIEMER, K., VAN, T., KATO-MAEDA, M., DE JONG, B. C., NARAYANAN, S., 
NICOL, M., NIEMANN, S., KREMER, K. & GUTIERREZ, M. C. 2006. Variable host–pathogen 
compatibility in Mycobacterium tuberculosis. Proceedings of the National Academy of 
Sciences of the United States of America, 103, 2869-2873. 
 
GALVANI, A.P. AND MAY, R.M., 2005. Epidemiology: dimensions of 
superspreading. Nature, 438(7066), p.293. 
  
GARDY, J., JOHNSTON, J., HO SUI, S., COOK, V., SHAH, L., BRODKIN, E., REMPEL, S., MOORE, 
R., ZHAO, Y., HOLT, R., VARHOL, R., BIROL, I., LEM, M., SHARMA, M., ELWOOD, K., JONES, S., 
BRINKMAN, F., BRUNHAM, R. & TANG, P. 2011. Whole-genome sequencing and social-
network analysis of a tuberculosis outbreak. N Engl J Med, 364, 730 - 739. 
  
GEHRING, A. J., DOBOS, K. M., BELISLE, J. T., HARDING, C. V. & BOOM, W. H. 2004. 
Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human 
macrophage class II MHC antigen processing. The Journal of Immunology, 173, 2660-2668.  
 
GHEBREMICHAEL, S., GROENHEIT, R., PENNHAG, A., KOIVULA, T., ANDERSSON, E., 
BRUCHFELD, J., HOFFNER, S., ROMANUS, V. & KÄLLENIUS, G. 2010. Drug resistant 
Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden. PLoS One, 
5, e10893. 
  
GLICKMAN, M. S. & JACOBS, W. R. 2001. Microbial pathogenesis of Mycobacterium 
tuberculosis: dawn of a discipline. Cell, 104, 477-485. 
  
GRANGE, J. 2001. Mycobacterium bovis infection in human beings. Tuberculosis, 81, 71-77.  
 
GREENWOOD, D. 2012. Medical Microbiology, With STUDENTCONSULT online access, 18: 
Medical Microbiology, Elsevier Health Sciences. 
 
GREEN, RICHARD E., ET AL. "A draft sequence of the Neandertal genome." science 328.5979 
(2010): 710-722. 
   
GRIFFIN, J. E., GAWRONSKI, J. D., DEJESUS, M. A., IOERGER, T. R., AKERLEY, B. J. & SASSETTI, 
C. M. 2011. High-resolution phenotypic profiling defines genes essential for mycobacterial 
growth and cholesterol catabolism. PLoS Pathog, 7, e1002251. 
  
GRIMES, C. Z., TEETER, L. D., HWANG, L.-Y. & GRAVISS, E. A. 2009. Epidemiologic 
characterization of culture positive Mycobacterium tuberculosis patients by katG-gyrA 
principal genetic grouping. The Journal of Molecular Diagnostics, 11, 472-481. 
  
GUTACKER, M. M., MATHEMA, B., SOINI, H., SHASHKINA, E., KREISWIRTH, B. N., GRAVISS, E. 
A. & MUSSER, J. M. 2006a. Single-nucleotide polymorphism–based population genetic 
analysis of Mycobacterium tuberculosis strains from 4 geographic sites.  Journal of Infectious 
Diseases, 193, 121-128. 
  
 
 
218 
GUTACKER, M. M., SMOOT, J. C., MIGLIACCIO, C. A. L., RICKLEFS, S. M., HUA, S., COUSINS, D. 
V., GRAVISS, E. A., SHASHKINA, E., KREISWIRTH, B. N. & MUSSER, J. M. 2002. Genome-wide 
analysis of synonymous single nucleotide polymorphisms in Mycobacterium tuberculosis 
complex organisms: resolution of genetic relationships among closely related microbial 
strains. Genetics, 162, 1533-1543. 
  
GUTIERREZ, M. C., AHMED, N., WILLERY, E., NARAYANAN, S., HASNAIN, S. E., CHAUHAN, D. 
S., KATOCH, V. M., VINCENT, V., LOCHT, C. & SUPPLY, P. 2006. Predominance of ancestral 
lineages of Mycobacterium tuberculosis in India. Emerging Infectious Diseases, 12, 1367. 
  
HALL, T. A. BioEdit: a user-friendly biological sequence alignment editor and analysis 
program for Windows 95/98/NT.  Nucleic Acids Symposium Series, 1999. 95-98. 
 
Hawkey J, Edwards DJ, Dimovski K, et al. Evidence of microevolution of Salmonella 
Typhimurium during a series of egg-associated outbreaks linked to a single chicken farm. 
BMC Genomics. 2013;14:800. doi:10.1186/1471-2164-14-800. 
  
HEALTH, N. I. O. 2010. National Library of Medicine–Medical Subject Headings. Available 
from. Accessed May, 15, 2010. 
  
HERMANS, P., VAN SOOLINGEN, D. & VAN EMBDEN, J. 1992. Characterization of a major 
polymorphic tandem repeat in Mycobacterium tuberculosis and its potential use in the 
epidemiology of Mycobacterium kansasii and Mycobacterium gordonae. Journal of 
Bacteriology, 174, 4157-4165. 
  
  
 
 
219 
HERSHBERG, R., LIPATOV, M., SMALL, P. M., SHEFFER, H., NIEMANN, S., HOMOLKA, S., 
ROACH, J. C., KREMER, K., PETROV, D. A. & FELDMAN, M. W. 2008. High functional diversity 
in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol, 6, 
e311. 
 
HERSHKOVITZ, I., DONOGHUE, H.D., MINNIKIN, D.E., BESRA, G.S., LEE, O.Y., GERNAEY, A.M., 
GALILI, E., ESHED, V., GREENBLATT, C.L., LEMMA, E. AND BAR-GAL, G.K., 2008. Detection and 
molecular characterization of 9000-year-old Mycobacterium tuberculosis from a Neolithic 
settlement in the Eastern Mediterranean. PloS one, 3(10), p.e3426. 
 
H HERZOG, B., 1998. History of tuberculosis. Respiration, 65(1), pp.5-15. 
 
HESSELING, A.C., RABIE, H., MARAIS, B.J., MANDERS, M., LIPS, M., SCHAAF, H.S., GIE, R.P., 
COTTON, M.F., VAN HELDEN, P.D., WARREN, R.M. AND BEYERS, N., 2006. Bacille Calmette-
Guérin vaccine—induced disease in HIV-infected and HIV-uninfected children. Clinical 
infectious diseases, 42(4), pp.548-558.  
HIRSH, A. E., TSOLAKI, A. G., DERIEMER, K., FELDMAN, M. W. & SMALL, P. M. 2004. Stable 
association between strains of Mycobacterium tuberculosis and their human host 
populations. Proceedings of the National Academy of Sciences of the United States of 
America, 101, 4871-4876. 
  
HOMOLKA, S., PROJAHN, M., FEUERRIEGEL, S., UBBEN, T., DIEL, R., NUBEL, U. & NIEMANN, S. 
2012. High resolution discrimination of clinical Mycobacterium tuberculosis complex strains 
based on single nucleotide polymorphisms. PLoS One, 7, e39855. 
 
HUARD, R. C., CHITALE, S., LEUNG, M., LAZZARINI, L. C. O., ZHU, H., SHASHKINA, E., HO, J. L. 
(2003). The Mycobacterium tuberculosis Complex-Restricted Gene cfp32 Encodes an 
Expressed Protein That Is Detectable in Tuberculosis Patients and Is Positively Correlated 
with Pulmonary Interleukin-10 . Infection and Immunity, 71(12), 6871–6883. 
http://doi.org/10.1128/IAI.71.12.6871-6883.2003 
 
HURST, L. D. 2002. The Ka/Ks ratio: diagnosing the form of sequence evolution. TRENDS in 
Genetics, 18, 486-487. 
  
ILLUMINA. 2015. Nextera XT Library Prep: Tips and Troubleshooting [Online]. Available: 
https://support.illumina.com/content/dam/illumina- 
support/documents/documentation/chemistry_documentation/samplepreps_nextera/next
era-xt/nextera-xt-troubleshooting-guide.pdf. 
  
JACKSON, C., MOSTOWY, J. H., STAGG, H. R., ABUBAKAR, I., ANDREWS, N. & YATES, T. A. 
2016. Working conditions and tuberculosis mortality in England and Wales, 1890–1912: a 
retrospective analysis of routinely collected data. BMC Infectious Diseases, 16, 215. 
 
JAENICKE-DESPRES, VIVIANE, et al. "Early allelic selection in maize as revealed by ancient 
DNA." Science 302.5648 (2003): 1206-1208. 
  
JENA, L., KASHIKAR, S., KUMAR, S. & HARINATH, B. 2014. Effect of single amino acid 
mutations on function of Mycobacterium tuberculosis H37RV and H37RA by computational 
approaches. The Indian Journal of Tuberculosis, 61, 200-206. 
  
 
 
220 
 
 
KAMERBEEK, J., SCHOULS, L., KOLK, A., VAN AGTERVELD, M., VAN SOOLINGEN, D., KUIJPER, 
S., BUNSCHOTEN, A., MOLHUIZEN, H., SHAW, R. & GOYAL, M. 1997. Simultaneous detection 
and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. 
Journal of Clinical Microbiology, 35, 907-914. 
 
KENDALL, W.B., 1915. Artificial Pneumothorax in the Treatment of Tuberculosis. Canadian 
Medical Association Journal, 5(3), p.206. 
  
  
JEONG, Y. J., LEE, K. S., KOH, W.-J., HAN, J., KIM, T. S. & KWON, O. J. 2004. Nontuberculous 
mycobacterial pulmonary infection in immunocompetent patients: comparison of thin-
section CT and histopathologic findings. Radiology, 231, 880-886. 
  
JOHNSON, M. M., HOUCK, J. & CHEN, C. 2005. Screening for deleterious nonsynonymous 
single-nucleotide polymorphisms in genes involved in steroid hormone metabolism and 
response. Cancer Epidemiology and Prevention Biomarkers, 14, 1326-1329. 
  
JOLLEY, K. A. & MAIDEN, M. C. 2010. BIGSdb: Scalable analysis of bacterial genome variation 
at the population level. BMC Bioinformatics, 11, 595. 
  
JOLLEY, K. A., HILL, D. M., BRATCHER, H. B., HARRISON, O. B., FEAVERS, I. M., PARKHILL, J. & 
MAIDEN, M. C. 2012. Resolution of a meningococcal disease outbreak from whole-genome 
sequence data with rapid Web-based analysis methods. Journal of Clinical Microbiology, 50, 
3046-3053. 
  
JOMBART, T., CORI, A., DIDELOT, X., CAUCHEMEZ, S., FRASER, C. & FERGUSON, N. 2014. 
Bayesian reconstruction of disease outbreaks by combining epidemiologic and genomic 
data. PLoS Comput Biol, 10, e1003457. 
JONSSON, J., HOFFNER, S., BERGGREN, I., BRUCHFELD, J., GHEBREMICHAEL, S., PENNHAG, A. 
& GROENHEIT, R. 2014. Comparison between RFLP and MIRU-VNTR genotyping of 
Mycobacterium tuberculosis strains isolated in Stockholm 2009 to 2011. Plos One, 9, 
e95159. 
  
JUNEMANN, S., SEDLAZECK, F. J., PRIOR, K., ALBERSMEIER, A., JOHN, U., KALINOWSKI, J., 
MELLMANN, A., GOESMANN, A., VON HAESELER, A., STOYE, J. & HARMSEN, D. 2013. 
Updating benchtop sequencing performance comparison. Nat Biotechnol, 31, 294-6. 
  
KAAS, R. S., LEEKITCHAROENPHON, P., AARESTRUP, F. M. & LUND, O. 2014. Solving the 
problem of comparing whole bacterial genomes across different sequencing platforms. PLoS 
One, 9, e104984. 
 
 
221 
KHANIPOUR, S., EBRAHIMZADEH, N., MASOUMI, M., SAKHAEI, F., ALINEZHAD, F., 
SAFARPOUR, E., FATEH, A., NEMATOLLAHI, A. N., TASBITI, A. H. & ZOLFAGHARI, M. R. 2016. 
Haarlem 3 is the predominant genotype family in multidrug-resistant and extensively drug-
resistant Mycobacterium tuberculosis in the capital of Iran: A 5-year survey. Journal of 
Global Antimicrobial Resistance, 5, 7-10. 
 
KIMURA, M. 1984. The neutral theory of molecular evolution, Cambridge University Press.  
KING, H. C., KHERA-BUTLER, T., JAMES, P., OAKLEY, B. B., ERENSO, G., ASEFFA, A., KNIGHT, 
R., WELLINGTON, E. M. & COURTENAY, O. 2017. Environmental reservoirs of pathogenic 
mycobacteria across the Ethiopian biogeographical landscape. PloS One, 12, e0173811. 
  
KOHL, T. A., DIEL, R., HARMSEN, D., ROTHGÄNGER, J., WALTER, K. M., MERKER, M., 
WENIGER, T. & NIEMANN, S. 2014. Whole-genome-based Mycobacterium tuberculosis 
surveillance: a standardized, portable, and expandable approach. Journal of Clinical 
Microbiology, 52, 2479-2486. 
 
KÖSER, C.U., HOLDEN, M.T., ELLINGTON, M.J., CARTWRIGHT, E.J., BROWN, N.M., OGILVY-
STUART, A.L., HSU, L.Y., CHEWAPREECHA, C., CROUCHER, N.J., HARRIS, S.R. AND SANDERS, 
M., 2012. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. 
New England Journal of Medicine, 366(24), pp.2267-2275. 
  
KUMAR, P., ARORA, K., LLOYD, J. R., LEE, I. Y., NAIR, V., FISCHER, E., BOSHOFF, H. I. & BARRY, 
C. E. 2012. Meropenem inhibits D, D‐carboxypeptidase activity in Mycobacterium 
tuberculosis. Molecular microbiology, 86, 367-381. 
  
LARKIN, M. A., BLACKSHIELDS, G., BROWN, N., CHENNA, R., MCGETTIGAN, P. A., 
MCWILLIAM, H., VALENTIN, F., WALLACE, I. M., WILM, A. & LOPEZ, R. 2007. Clustal W and 
Clustal X version 2.0. Bioinformatics, 23, 2947-2948. 
 
LARROUY-MAUMUS, G., BISWAS, T., HUNT, D. M., KELLY, G., TSODIKOV, O. V. & DE 
CARVALHO, L. P. S. 2013. Discovery of a glycerol 3-phosphate phosphatase reveals 
glycerophospholipid polar head recycling in Mycobacterium tuberculosis. Proceedings of the 
National Academy of Sciences, 110, 11320-11325. 
  
LE, V. T. M. & DIEP, B. A. 2013. Selected insights from application of whole genome 
sequencing for outbreak investigations. Current Opinion in Critical Care, 19, 432. 
  
  
 
 
222 
LEE, J.-H., AMMERMAN, N. C., NOLAN, S., GEIMAN, D. E., LUN, S., GUO, H. & BISHAI, W. R. 
2012. Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis. Nature 
communications, 3, 753. 
 
LETUNIC, I. AND BORK, P., 2006. Interactive Tree Of Life (iTOL): an online tool for 
phylogenetic tree display and annotation. Bioinformatics, 23(1), pp.127-128. 
  
LEVITT, I. 2003. TB, Glasgow and the Mass Radiography Campaign in the Nineteen Fifties: A 
Democratic Health Service in Action, University of Glasgow Centre for the History of 
Medicine. 
  
LEW, J., KAPOPOULOU, A., JONES, L. & COLE, S. 2011. TubercuList-10years after. 
Tuberculosis (Edinb), 91, 1 - 7. 
 
LI, H., HANDSAKER, B., WYSOKER, A., FENNELL, T., RUAN, J., HOMER, N., MARTH, G., 
ABECASIS, G. AND DURBIN, R., 2009. The sequence alignment/map format and SAMtools. 
Bioinformatics, 25(16), pp.2078-2079. 
 
LI, H. AND DURBIN, R., 2009. Fast and accurate short read alignment with Burrows–Wheeler 
transform. Bioinformatics, 25(14), pp.1754-1760. 
  
LI, Z. 2014. Detecting the correlated mutations based on selection pressure with Core Mut. 
URL : https://bioc.ism.ac.jp/packages/3.0/bioc/vignettes/CorMut/inst/doc/CorMut.pdf. 
 
Li, Chunxiang, et al. "Ancient DNA analysis of desiccated wheat grains excavated from a 
Bronze Age cemetery in Xinjiang." Journal of Archaeological Science 38.1 (2011): 115-119. 
  
LINDAHL, T. 1993.Instability and decay of the primary structure of DNA. Nature, 362, 709-
715. 
  
LIU, X., GUTACKER, M. M., MUSSER, J. M. & FU, Y.-X. 2006. Evidence for recombination in 
Mycobacterium tuberculosis. Journal of Bacteriology, 188, 8169-8177. 
 
LIU, Q., VIA, L.E., LUO, T., LIANG, L., LIU, X., WU, S., SHEN, Q., WEI, W., RUAN, X., YUAN, X. 
AND ZHANG, G., 2015. Within patient microevolution of Mycobacterium tuberculosis 
correlates with heterogeneous responses to treatment. Scientific reports, 5, p.17507. 
 
LLOYD-SMITH, J. O., SCHREIBER, S. J., KOPP, P. E. & GETZ, W. M. 2005. Superspreading and 
the effect of individual variation on disease emergence. Nature, 438, 355-359. 
  
MAIDEN, M. C., VAN RENSBURG, M. J. J., BRAY, J. E., EARLE, S. G., FORD, S. A., JOLLEY, K. A. & 
MCCARTHY, N. D. 2013. MLST revisited: the gene-by-gene approach to bacterial genomics. 
Nature Reviews Microbiology, 11, 728-736. 
 
MAIDEN, M.C., VAN RENSBURG, M.J.J., BRAY, J.E., EARLE, S.G., FORD, S.A., JOLLEY, K.A. AND 
MCCARTHY, N.D., 2013. MLST revisited: the gene-by-gene approach to bacterial genomics. 
Nature Reviews Microbiology, 11(10), p.728. 
 
MAK, S.S.T., GOPALAKRISHNAN, S., CARØE, C., GENG, C., LIU, S., SINDING, M.H.S., KUDERNA, 
L.F., ZHANG, W., FU, S., VIEIRA, F.G. AND GERMONPRÉ, M., 2017. Comparative performance 
 
 
223 
of the BGISEQ-500 vs Illumina HiSeq2500 sequencing platforms for palaeogenomic 
sequencing. GigaScience, 6(8), pp.1-13. 
  
MANCA, C., TSENOVA, L., BARRY, C. E., BERGTOLD, A., FREEMAN, S., HASLETT, P. A., 
MUSSER, J. M., FREEDMAN, V. H. & KAPLAN, G. 1999. Mycobacterium tuberculosis CDC1551 
induces a more vigorous host response in vivo and in vitro, but is not more virulent than 
other clinical isolates. The Journal of Immunology, 162, 6740-6746. 
  
MARAIS, B. J., VICTOR, T. C., HESSELING, A. C., BARNARD, M., JORDAAN, A., BRITTLE, W., 
REUTER, H., BEYERS, N., VAN HELDEN, P. D. & WARREN, R. M. 2006. Beijing and Haarlem 
genotypes are overrepresented among children with drug-resistant tuberculosis in the 
Western Cape Province of South Africa. Journal of Clinical Microbiology, 44, 3539-3543. 
  
MARCH, F., COLL, P., COSTA, R., RODRÍGUEZ, P., MORENO, C., GARRIGÓ, M. & PRATS, G. 
1996. Usefulness of DR, PGRS, and spoligotyping in the typing of Mycobacterium 
tuberculosis. Comparison with IS6110. Enfermedades Infecciosas y Microbiologia Clinica, 14, 
160-166. 
  
MARDASSI, H., NAMOUCHI, A., HALTITI, R., ZARROUK, M., MHENNI, B., KARBOUL, A., 
KHABOUCHI, N., VAN PITTIUS, N. C. G., STREICHER, E. M. & RAUZIER, J. 2005. Tuberculosis 
due to resistant Haarlem strain, Tunisia. Tuberculosis. 
 
MAZARS, E., LESJEAN, S., BANULS, A.L., GILBERT, M., VINCENT, V., GICQUEL, B., TIBAYRENC, 
M., LOCHT, C. AND SUPPLY, P., 2001. High-resolution minisatellite-based typing as a portable 
approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. 
Proceedings of the national academy of Sciences, 98(4), pp.1901-1906. 
  
MCEVOY, C. R., CLOETE, R., MÜLLER, B., SCHÜRCH, A. C., VAN HELDEN, P. D., GAGNEUX, S., 
WARREN, R. M. & VAN PITTIUS, N. C. G. 2012. Comparative analysis of Mycobacterium 
tuberculosis pe and ppe genes reveals high sequence variation and an apparent absence of 
selective constraints. PloS One, 7, e30593. 
  
MELLMANN, A., HARMSEN, D., CUMMINGS, C.A., ZENTZ, E.B., LEOPOLD, S.R., RICO, A., 
PRIOR, K., SZCZEPANOWSKI, R., JI, Y., ZHANG, W. AND MCLAUGHLIN, S.F., 2011. Prospective 
genomic characterization of the German enterohemorrhagic Escherichia coli O104: H4 
outbreak by rapid next generation sequencing technology. PloS one, 6(7), p.e22751. 
 
MÉRIC, G., YAHARA, K., MAGEIROS, L., PASCOE, B., MAIDEN, M. C., JOLLEY, K. A. & 
SHEPPARD, S. K. 2014. A reference pan-genome approach to comparative bacterial 
genomics: identification of novel epidemiological markers in pathogenic Campylobacter. 
PloS One, 9, e92798. 
  
MESTRE, O., LUO, T., DOS VULTOS, T., KREMER, K., MURRAY, A., NAMOUCHI, A., JACKSON, 
C., RAUZIER, J., BIFANI, P. & WARREN, R. 2011. Phylogeny of Mycobacterium tuberculosis 
Beijing strains constructed from polymorphisms in genes involved in DNA replication, 
recombination and repair. PLoS One, 6, e16020. 
  
MEYER, M., BRIGGS, A. W., MARICIC, T., HÖBER, B., HÖFFNER, B., KRAUSE, J., WEIHMANN, 
A., PÄÄBO, S. & HOFREITER, M. 2007. From micrograms to picograms: quantitative PCR 
reduces the material demands of high-throughput sequencing. Nucleic Acids Research, 36, 
e5-e5. 
 
 
224 
  
MICHAEL, P. 2008. Public Health in Wales (1800-2000). 
  
MILBURN, H., ASHMAN, N., DAVIES, P., DOFFMAN, S., DROBNIEWSKI, F., KHOO, S., 
ORMEROD, P., OSTERMANN, M. & SNELSON, C. 2010. Guidelines for the prevention and 
management of Mycobacterium tuberculosis infection and disease in adult patients with 
chronic kidney disease. Thorax, 65, 559-570. 
 
MILLER, W., DRAUTZ, D.I., RATAN, A., PUSEY, B., QI, J., LESK, A.M., TOMSHO, L.P.,     
PACKARD, M.D., ZHAO, F., SHER, A. AND TIKHONOV, A., 2008. Sequencing the nuclear 
genome of the extinct woolly mammoth. Nature, 456(7220), p.387. 
 
MILLÁN-LOU, M. I., LÓPEZ-CALLEJA, A. I., COLMENAREJO, C., LEZCANO, M. A., VITORIA, M. 
A., DEL PORTILLO, P., OTAL, I., MARTÍN, C. & SAMPER, S. 2013. Global study of IS6110 in a 
successful Mycobacterium tuberculosis strain: clues for deciphering its behaviour and for its 
rapid detection. Journal of Clinical Microbiology, 51, 3631-3637. 
  
MITCHISON, D., BHATIA, A., RADHAKRISHNA, S., SELKON, J., SUBBAIAH, T. & WALLACE, J. 
1961. The virulence in the guinea-pig of tubercle bacilli isolated before treatment from 
South Indian patients with pulmonary tuberculosis: 1. Homogeneity of the investigation and 
a critique of the virulence test. Bulletin of the World Health Organization, 25, 285. 
  
MITCHISON, D., WALLACE, J., BHATIA, A., SELKON, J., SUBBAIAH, T. & LANCASTER, M. 1960. 
A comparison of the virulence in guinea-pigs of South Indian and British tubercle bacilli. 
Tubercle, 41, 1-22. 
  
MORAN-GILAD, J., PRIOR, K., YAKUNIN, E., HARRISON, T., UNDERWOOD, A., LAZAROVITCH, 
T., VALINSKY, L., LUCK, C., KRUX, F. & AGMON, V. 2015. Design and application of a core 
genome multilocus sequence typing scheme for investigation of Legionnaires’ disease 
incidents. Euro Surveillance, 20, 21087. 
  
MOSTOWY, S., COUSINS, D., BRINKMAN, J., ARANAZ, A. & BEHR, M. A. 2002. Genomic 
deletions suggest a phylogeny for the Mycobacterium tuberculosis complex. The Journal of 
Infectious Diseases, 186, 74-80. 
  
MÜLLER, R., ROBERTS, C. A. & BROWN, T. A. Genotyping of ancient Mycobacterium 
tuberculosis strains reveals historic genetic diversity.  Proc. R. Soc. B, 2014. The Royal 
Society, 20133236. 
  
MUSSER, J. M., AMIN, A. & RAMASWAMY, S. 2000. Negligible genetic diversity of 
Mycobacterium tuberculosis host immune system protein targets: evidence of limited 
selective pressure. Genetics, 155, 7-16. 
  
NABEYA, D., KINJO, T., PARROTT, G. L., UEHARA, A., MOTOOKA, D., NAKAMURA, S., NAHAR, 
S., NAKACHI, S., NAKAMATSU, M. & MAESHIRO, S. 2017. The clinical and phylogenetic 
investigation for a nosocomial outbreak of respiratory syncytial virus infection in an adult 
hemato‐oncology unit. Journal of Medical Virology. 
 
NGUYEN, V. 1997. Diagnosis and treatment of disease caused by nontuberculous 
mycobacteria. This official statement of the American Thoracic Society was approved by the 
 
 
225 
Board of Directors, March 1997. Medical Section of the American Lung Association. Am J 
Respir Crit Care Med, 156, S1-S25. 
  
NICOL, M. P., SOLA, C., FEBRUARY, B., RASTOGI, N., STEYN, L. & WILKINSON, R. J. 2005. 
Distribution of strain families of Mycobacterium tuberculosis causing pulmonary and 
extrapulmonary disease in hospitalized children in Cape Town, South Africa. Journal of 
Clinical Microbiology, 43, 5779-5781. 
  
NIEMANN, S., KUBICA, T., BANGE, F., ADJEI, O., BROWNE, E., CHINBUAH, M., DIEL, R., 
GYAPONG, J., HORSTMANN, R. & JOLOBA, M. 2004. The species Mycobacterium africanum 
in the light of new molecular markers. Journal of clinical microbiology, 42, 3958-3962. 
 
NORTH, R. J., RYAN, L., LACOURCE, R., MOGUES, T. & GOODRICH, M. E. 1999. Growth rate of 
mycobacteria in mice as an unreliable indicator of mycobacterial virulence. Infection and 
Immunity, 67, 5483-5485. 
  
OCTAVIA, S., WANG, Q., TANAKA, M. M., SINTCHENKO, V. & LAN, R. 2017. Genomic 
heterogeneity of Salmonella enterica serovar Typhimurium bacteriuria from chronic 
infection. Infection, Genetics and Evolution, 51, 17-20. 
  
OJO, O. O., SHEEHAN, S., CORCORAN, D. G., NIKOLAYEVSKY, V., BROWN, T., O'SULLIVAN, M., 
O'SULLIVAN, K., GORDON, S. V., DROBNIEWSKI, F. & PRENTICE, M. B. 2010. Molecular 
epidemiology of Mycobacterium tuberculosis clinical isolates in Southwest Ireland. Infection, 
Genetics and Evolution, 10, 1110-1116. 
  
OLAITAN, A. O., DIENE, S. M., KEMPF, M., BERRAZEG, M., BAKOUR, S., GUPTA, S. K., 
THONGMALAYVONG, B., AKKHAVONG, K., SOMPHAVONG, S. & PABORIBOUNE, P. 2014. 
Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans 
and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the 
PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. International Journal 
of Antimicrobial Agents, 44, 500-507. 
  
ORGANIZATION, W. H. 2017. Guidelines for the treatment of drug-susceptible tuberculosis 
and patient care, 2017 Update. 
  
ORLANDO, L., GINOLHAC, A., ZHANG, G., FROESE, D., ALBRECHTSEN, A., STILLER, M., 
SCHUBERT, M., CAPPELLINI, E., PETERSEN, B. & MOLTKE, I. 2013. Recalibrating Equus 
evolution using the genome sequence of an early Middle Pleistocene horse. Nature, 499, 74-
78. 
 
PÄÄBO, S., HIGUCHI, R.G. AND WILSON, A.C., 1989. Ancient DNA and the polymerase chain 
reaction: the emerging field of molecular archaeology (Minireview). The Journal of biological 
chemistry, 264(17), pp.9709-9712. 
 
PANG, Y., LU, J., WANG, Y., SONG, Y., WANG, S. & ZHAO, Y. 2013. Study of the rifampin 
monoresistance mechanism in Mycobacterium tuberculosis. Antimicrobial Agents and 
Chemotherapy, 57, 893-900. 
  
 
PARISH, T. & BROWN, A. C. 2009. Mycobacterium: genomics and molecular biology, Horizon 
Scientific Press. 
 
 
226 
  
PARK, Y.-K., BAI, G.-H. & KIM, S.-J. 2000. Restriction Fragment Length Polymorphism Analysis 
of Mycobacterium tuberculosis Isolated from Countries in the Western Pacific Region. 
Journal of Clinical Microbiology, 38, 191-197. 
  
PÉREZ-LAGO, L., COMAS, I., NAVARRO, Y., GONZÁLEZ-CANDELAS, F., HERRANZ, M., BOUZA, 
E. & GARCÍA-DE-VIEDMA, D. 2013. Whole genome sequencing analysis of intrapatient 
microevolution in Mycobacterium tuberculosis: potential impact on the inference of 
tuberculosis transmission. The Journal of Infectious Diseases, 209, 98-108. 
  
PÉREZ-LAGO, L., HERRANZ, M., LIROLA, M. M., BOUZA, E. & DE VIEDMA, D. G. 2011. 
Characterization of microevolution events in Mycobacterium tuberculosis strains involved in 
recent transmission clusters. Journal of Clinical Microbiology, 49, 3771-3776. 
 
PUBLIC HEALTH ENGLAND.2013. Tuberculosis mortality and mortality rate, England and 
Wales, 1913-2013. In: STATISTICS, O. F. N. (ed.). 
 
PUBLIC HEALTH ENGLAND. 2014. Tuberculosis in the UK 2014 report. In: ENGLAND, P. H. 
(ed.). 
 
PUBLIC HEALTH ENGLAND. 2016. Tuberculosis in England: 2016 report. In: ENGLAND, P. H. 
(ed.). 
  
PUBLIC HEALTH WALES. 2014. Tuberculosis in Wales. Annual Report 2014: Data to the end 
of 2013. 
 
PUBLIC HEALTH WALES. 2016. Tuberculosis in Wales. Annual Report 2016: Data to the end 
of 2015. 
 
RAMAN, K. & CHANDRA, N. 2008. Mycobacterium tuberculosis interactome analysis 
unravels potential pathways to drug resistance. BMC Microbiology, 8, 234. 
  
RAMAZANZADEH, R., ROSHANI, D., SHAKIB, P. & ROUHI, S. 2015. Prevalence and occurrence 
rate of Mycobacterium tuberculosis Haarlem family multi-drug resistant in the worldwide 
population: A systematic review and meta-analysis. Journal of research in medical sciences: 
The Official Journal of Isfahan University of Medical Sciences, 20, 78. 
 
RASMUSSEN, MORTEN,.2010. "Ancient human genome sequence of an extinct Palaeo-
Eskimo." Nature 463.7282 (2010): 757-762. 
 
RASIGADE, J.-P., BARBIER, M., DUMITRESCU, O., PICHAT, C., CARRET, G., RONNAUX-BARON, 
A.-S., BLASQUEZ, G., GODIN-BENHAIM, C., BOISSET, S. & CARRICAJO, A. 2017. Strain-specific 
estimation of epidemic success provides insights into the transmission dynamics of 
tuberculosis. Scientific Reports, 7, 45326. 
  
  
 
 
227 
REED, M. B., PICHLER, V. K., MCINTOSH, F., MATTIA, A., FALLOW, A., MASALA, S., 
DOMENECH, P., ZWERLING, A., THIBERT, L. & MENZIES, D. 2009. Major Mycobacterium 
tuberculosis lineages associate with patient country of origin. Journal of Clinical 
Microbiology, 47, 1119-1128. 
  
REILING, N., HOMOLKA, S., WALTER, K., BRANDENBURG, J., NIWINSKI, L., ERNST, M., 
HERZMANN, C., LANGE, C., DIEL, R. & EHLERS, S. 2013. Clade-specific virulence patterns of 
Mycobacterium tuberculosis complex strains in human primary macrophages and 
aerogenically infected mice. MBio, 4, e00250-13. 
  
RIE, A. V., PAGE-SHIPP, L., SCOTT, L., SANNE, I. & STEVENS, W. 2010. Xpert® MTB/RIF for 
point-of-care diagnosis of TB in high-HIV burden, resource-limited countries: hype or hope? 
Expert Review of Molecular Diagnostics, 10, 937-946. 
  
RILEY, S., FRASER, C., DONNELLY, C. A., GHANI, A. C., ABU-RADDAD, L. J., HEDLEY, A. J., 
LEUNG, G. M., HO, L.-M., LAM, T.-H. & THACH, T. Q. 2003. Transmission dynamics of the 
etiological agent of SARS in Hong Kong: impact of public health interventions. Science, 300, 
1961-1966. 
  
RINDI, L., LARI, N. & GARZELLI, C. 2012. Large Sequence Polymorphisms of the Euro-
American lineage of Mycobacterium tuberculosis: a phylogenetic reconstruction and 
evidence for convergent evolution in the DR locus. Infection, Genetics and Evolution, 12, 
1551-1557. 
 
RODRIGUES, L.C., MANGTANI, P. AND ABUBAKAR, I., 2011. How does the level of BCG 
vaccine protection against tuberculosis fall over time?. BMJ (Clinical research ed), 343, 
p.d5974. 
  
ROETZER, A., DIEL, R., KOHL, T. A., RÜCKERT, C., NÜBEL, U., BLOM, J., WIRTH, T., JAENICKE, 
S., SCHUBACK, S. & RÜSCH-GERDES, S. 2013. Whole genome sequencing versus traditional 
genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal 
molecular epidemiological study. PLoS Med, 10, e1001387. 
  
ROHDE, H., QIN, J., CUI, Y., LI, D., LOMAN, N. J., HENTSCHKE, M., CHEN, W., PU, F., PENG, Y. 
& LI, J. 2011. Open-source genomic analysis of Shiga-toxin–producing E. coli O104: H4. New 
England Journal of Medicine, 365, 718-724. 
  
RUDDY, M. C., DAVIES, A. P., YATES, M. D., YATES, S., BALASEGARAM, S., DRABU, Y., PATEL, 
B., LOZEWICZ, S., SEN, S., BAHL, M., JAMES, E., LIPMAN, M., DUCKWORTH, G., WATSON, J. 
M., PIPER, M., DROBNIEWSKI, F. A. & MAGUIRE, H. 2004. Outbreak of isoniazid resistant 
tuberculosis in north London. Thorax, 59, 279-285. 
  
RYAN, K. J. & RAY, C. G. 2004. Mycobacteria. Sherris Medical Microbiology: An Introduction 
to Infectious Diseases. 4th Edition, McGraw-Hill, New York, 439. 
 
SAMBROOK, J. AND RUSSELL, D.W., 2006. Purification of nucleic acids by extraction with 
phenol: chloroform. Cold Spring Harbor Protocols, 2006(1), pp.pdb-prot4455. 
  
  
 
 
228 
SARKAR, R., LENDERS, L., WILKINSON, K. A., WILKINSON, R. J. & NICOL, M. P. 2012. Modern 
lineages of Mycobacterium tuberculosis exhibit lineage-specific patterns of growth and 
cytokine induction in human monocyte-derived macrophages. PloS One, 7, e43170. 
  
SASSETTI, C. M., BOYD, D. H. & RUBIN, E. J. 2003. Genes required for mycobacterial growth 
defined by high density mutagenesis. Molecular Microbiology, 48, 77-84. 
  
SCHUITEMAKER, A. G. 1968. bacteriphages lysing mycobacteria. 
 
SCHUBERT, M., JÓNSSON, H., CHANG, D., DER SARKISSIAN, C., ERMINI, L., GINOLHAC, A., 
ALBRECHTSEN, A., DUPANLOUP, I., FOUCAL, A., PETERSEN, B. AND FUMAGALLI, M., 2014. 
Prehistoric genomes reveal the genetic foundation and cost of horse domestication. 
Proceedings of the National Academy of Sciences, 111(52), pp.E5661-E5669. 
  
SCHÜRCH, A. C. & VAN SOOLINGEN, D. 2012. DNA fingerprinting of Mycobacterium 
tuberculosis: From phage typing to whole-genome sequencing. Infection, Genetics and 
Evolution, 12, 602-609. 
 
SHABBEER, A., COWAN, L.S., OZCAGLAR, C., RASTOGI, N., VANDENBERG, S.L., YENER, B. AND 
BENNETT, K.P., 2012. TB-Lineage: an online tool for classification and analysis of strains of 
Mycobacterium tuberculosis complex. Infection, Genetics and Evolution, 12(4), pp.789-797. 
SHARMA, A., BLOSS, E., HEILIG, C. M. & CLICK, E. S. 2016. Tuberculosis Caused by 
Mycobacterium africanum, United States, 2004–2013. Emerging Infectious Diseases, 22, 
396-403. 
  
SHEPPARD, S. K., JOLLEY, K. A. & MAIDEN, M. C. 2012. A gene-by-gene approach to bacterial 
population genomics: whole genome MLST of Campylobacter. Genes, 3, 261-277. 
 
SEGEN, J.C., 1992. The dictionary of modern medicine. CRC Press. 
  
SINGH, B. 1964. The guinea pig virulence of Indian tubercle bacilli. American Review of 
Respiratory Disease, 89, 1-11. 
 
SMALL, P. M., MCCLENNY, N., SINGH, S., SCHOOLNIK, G., TOMPKINS, L. & MICKELSEN, P. 
1993. Molecular strain typing of Mycobacterium tuberculosis to confirm cross-
contamination in the mycobacteriology laboratory and modification of procedures to 
minimize occurrence of false-positive cultures. Journal of Clinical Microbiology, 31, 1677-
1682. 
  
SOINI, H., PAN, X., AMIN, A., GRAVISS, E. A., SIDDIQUI, A. & MUSSER, J. M. 2000. 
Characterization of Mycobacterium tuberculosis Isolates from Patients in Houston, Texas, by 
Spoligotyping. Journal of Clinical Microbiology, 38, 669-676. 
  
SPAHR, U. & SCHAFROTH, K. 2001. Fate of Mycobacterium avium subsp. paratuberculosis in 
Swiss hard and semihard cheese manufactured from raw milk. Applied and Environmental 
Microbiology, 67, 4199-4205. 
  
SREEVATSAN, S., PAN, X., STOCKBAUER, K., CONNELL, N., KREISWIRTH, B., WHITTAM, T. & 
MUSSER, J. 1997a. Restricted structural gene polymorphism in the Mycobacterium 
 
 
229 
tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci 
U S A, 94, 9869 - 9874. 
 
Statistics bulletin, 2013: Migration Statistics Wales 2011. Statistics for Wale.: 
https://gov.wales/statistics-and-research/migration-statistics/?lang=en.  
 
STEIN, R. A. 2011. Super-spreaders in infectious diseases. International Journal of Infectious 
Diseases, 15, e510-e513. 
 
STONEKING, M., 1995. Ancient DNA: how do you know when you have it and what can you 
do with it? American Journal of Human Genetics, 57(6), p.1259. 
  
STORY, A., ALDRIDGE, R., ABUBAKAR, I., STAGG, H., LIPMAN, M., WATSON, J. & HAYWARD, 
A. 2012. Active case finding for pulmonary tuberculosis using mobile digital chest 
radiography: an observational study. The International Journal of Tuberculosis and Lung 
Disease, 16, 1461-1467. 
  
STUCKI, D. & GAGNEUX, S. 2013. Single nucleotide polymorphisms in Mycobacterium 
tuberculosis and the need for a curated database. Tuberculosis, 93, 30-39. 
  
STUCKI, D., BRITES, D., JELJELI, L., COSCOLLA, M., LIU, Q., TRAUNER, A., FENNER, L., 
RUTAIHWA, L., BORRELL, S. & LUO, T. 2016. Mycobacterium tuberculosis lineage 4 
comprises globally distributed and geographically restricted sublineages. Nature Genetics. 
  
SUPPLY, P., ALLIX, C., LESJEAN, S., CARDOSO-OELEMANN, M., RÜSCH-GERDES, S., WILLERY, 
E., SAVINE, E., DE HAAS, P., VAN DEUTEKOM, H., RORING, S., BIFANI, P., KUREPINA, N., 
KREISWIRTH, B., SOLA, C., RASTOGI, N., VATIN, V., GUTIERREZ, M. C., FAUVILLE, M., 
NIEMANN, S., SKUCE, R., KREMER, K., LOCHT, C. & VAN SOOLINGEN, D. 2006. Proposal for 
Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number 
Tandem Repeat Typing of Mycobacterium tuberculosis. Journal of Clinical Microbiology, 44, 
4498-4510. 
  
SUPPLY, P., MAGDALENA, J., HIMPENS, S. & LOCHT, C. 1997. Identification of novel 
intergenic repetitive units in a mycobacterial two‐component system operon. Molecular 
Microbiology, 26, 991-1003. 
  
SUPPLY, P., WARREN, R. M., BAÑULS, A. L., LESJEAN, S., VAN DER SPUY, G. D., LEWIS, L. A., 
TIBAYRENC, M., VAN HELDEN, P. D. & LOCHT, C. 2003. Linkage disequilibrium between 
minisatellite loci supports clonal evolution of Mycobacterium tuberculosis in a high 
tuberculosis incidence area. Molecular Microbiology, 47, 529-538. 
 
TAKIFF, H. E. & FEO, O. 2015. Clinical value of whole-genome sequencing of Mycobacterium 
tuberculosis. The Lancet Infectious Diseases, 15, 1077-1090. 
 
TB FREE ENGLAND: http://www.tbfreeengland.co.uk/faqs/how-much-does-btb-cost/  
TESSEMA, B., BEER, J., MERKER, M., EMMRICH, F., SACK, U., RODLOFF, A. C. & NIEMANN, S. 
2013. Molecular epidemiology and transmission dynamics of Mycobacterium tuberculosis in 
Northwest Ethiopia: new phylogenetic lineages found in Northwest Ethiopia. BMC Infectious 
Diseases, 13, 1. 
 
 
 
230 
THIERRY, D., BRISSON-NOËL, A., VINCENT-LEVY-FREBAULT, V., NGUYEN, S., GUESDON, J.L. 
AND GICQUEL, B., 1990. Characterization of a Mycobacterium tuberculosis insertion 
sequence, IS6110, and its application in diagnosis. Journal of clinical microbiology, 28(12), 
pp.2668-2673. 
 
THOMAS E HERCHLINE, M. J. K. A. C. E. M. S. B., MD 2017. Tuberculosis (TB) Treatment & 
Management. Medscape. 
  
THOMAS, P. D., CAMPBELL, M. J., KEJARIWAL, A., MI, H., KARLAK, B., DAVERMAN, R., 
DIEMER, K., MURUGANUJAN, A. & NARECHANIA, A. 2003. PANTHER: a library of protein 
families and subfamilies indexed by function. Genome Research, 13, 2129-2141. 
  
THOMPSON, J. D., GIBSON, T. & HIGGINS, D. G. 2002. Multiple sequence alignment using 
ClustalW and ClustalX. Current Protocols in Bioinformatics, 2.3. 1-2.3. 22. 
 
THWAITES, G., CAWS, M., CHAU, T. T. H., D'SA, A., LAN, N. T. N., HUYEN, M. N. T., GAGNEUX, 
S., ANH, P. T. H., THO, D. Q. & TOROK, E. 2008. Relationship between Mycobacterium 
tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. 
Journal of Clinical Microbiology, 46, 1363-1368. 
 
TRAUNER, A., BORRELL, S., REITHER, K. AND GAGNEUX, S., 2014. Evolution of drug resistance 
in tuberculosis: recent progress and implications for diagnosis and therapy. Drugs, 74(10), 
pp.1063-1072. 
  
TUBERCULIST 2017. Mycobacterium tuberculosis H37Rv: TubercuList. 
  
TYLER, A. D., CHRISTIANSON, S., KNOX, N. C., MABON, P., WOLFE, J., VAN DOMSELAAR, G., 
GRAHAM, M. R. & SHARMA, M. K. 2016. Comparison of sample preparation methods used 
for the next-generation sequencing of Mycobacterium tuberculosis. PloS One, 11, e0148676. 
  
USLAN, D. Z., KOWALSKI, T. J., WENGENACK, N. L., VIRK, A. & WILSON, J. W. 2006. Skin and 
soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, 
treatment, and susceptibility. Archives of Dermatology, 142, 1287-1292. 
  
VAN EMBDEN, J., CAVE, M., CRAWFORD, J., DALE, J., EISENACH, K., GICQUEL, B., HERMANS, 
P., MARTIN, C., MCADAM, R., SHINNICK, T. & SMALL, P. 1993. Strain identification of 
Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized 
methodology. J Clin Microbiol, 31, 406 - 409.  
 
VAN EMBDEN, J., VAN GORKOM, T., KREMER, K., JANSEN, R., VAN DER ZEIJST, B. & SCHOULS, 
L. 2000. Genetic variation and evolutionary origin of the direct repeat locus of 
Mycobacterium tuberculosis complex bacteria. Journal of Bacteriology, 182, 2393-2401. 
  
VAN INGEN, J., RAHIM, Z., MULDER, A., BOEREE, M. J., SIMEONE, R., BROSCH, R. & VAN 
SOOLINGEN, D. 2012. Characterization of Mycobacterium orygis as M. tuberculosis complex 
subspecies. Emerging Infectious Diseases, 18, 653. 
  
VAN SOOLINGEN, D. 2001. Molecular epidemiology of tuberculosis and other mycobacterial 
infections: main methodologies and achievements. Journal of Internal Medicine, 249, 1-26. 
  
 
 
231 
VAN SOOLINGEN, D., HOOGENBOEZEM, T., DE HAAS, P. E., HERMANS, P. W., KOEDAM, M. 
A., TEPPEMA, K. S., BRENNAN, P. J., BESRA, G. S., PORTAELS, F. & TOP, J. 1997. A novel 
pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of 
an exceptional isolate from Africa. International Journal of Systematic and Evolutionary 
Microbiology, 47, 1236-1245. 
  
VOTINTSEVA, A.A., BRADLEY, P., PANKHURST, L., DEL OJO ELIAS, C., LOOSE, M., 
NILGIRIWALA, K., CHATTERJEE, A., SMITH, E.G., SANDERSON, N., WALKER, T.M. AND 
MORGAN, M.R., 2017. Same-day diagnostic and surveillance data for tuberculosis via whole-
genome sequencing of direct respiratory samples. Journal of Clinical Microbiology, 55(5), 
pp.1285-1298. 
  
WALES, N., ALLABY, R., WILLERSLEV, E. AND GILBERT, M.T.P., 2013. PALEOBOTANY| Ancient 
Plant DNA. 
 
WALKER, T. M., IP, C. L. C., HARRELL, R. H., EVANS, J. T., KAPATAI, G., DEDICOAT, M. J., EYRE, 
D. W., WILSON, D. J., HAWKEY, P. M., CROOK, D. W., PARKHILL, J., HARRIS, D., WALKER, A. S., 
BOWDEN, R., MONK, P., SMITH, E. G. & PETO, T. E. A. 2013. Whole-genome sequencing to 
delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. The 
Lancet Infectious Diseases, 13, 137-146. 
  
WALKER, T. M., KOHL, T. A., OMAR, S. V., HEDGE, J., ELIAS, C. D. O., BRADLEY, P., IQBAL, Z., 
FEUERRIEGEL, S., NIEHAUS, K. E. & WILSON, D. J. 2015. Whole-genome sequencing for 
prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective 
cohort study. The Lancet Infectious Diseases, 15, 1193-1202. 
  
WALKER, T., MONK, P., GRACE SMITH, E. & PETO, T. 2013a. Contact investigations for 
outbreaks of Mycobacterium tuberculosis: advances through whole genome sequencing. 
Clin Microbiol Infect. 
  
WARREN, R., STREICHER, E., SAMPSON, S., VAN DER SPUY, G., RICHARDSON, M., NGUYEN, 
D., BEHR, M., VICTOR, T. & VAN HELDEN, P. 2002. Microevolution of the direct repeat region 
of Mycobacterium tuberculosis: implications for interpretation of spoligotyping data. Journal 
of Clinical Microbiology, 40, 4457-4465. 
  
WATSON, J., ABUBAKAR, I., STORY, A., WELFARE, R., WHITE, P., GARNETT, G., MUGFORD, M., 
GARRETT, J. & S HAYWARD, A. 2007. Mobile targeted digital chest radiography in the control 
of tuberculosis among hard to reach groups.URL: http://discovery.ucl.ac.uk/56609/. UCL 
Discovery.  
 
WENIGER, T., KRAWCZYK, J., SUPPLY, P., NIEMANN, S. & HARMSEN, D. 2010. MIRU-
VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex 
bacteria. Nucleic Acids Res, 38, W326-31. 
  
WHITTLES, L. K. & DIDELOT, X. Epidemiological analysis of the Eyam plague outbreak of 
1665–1666.  Proc. R. Soc. B, 2016. The Royal Society, 20160618. 
  
WHO 2015. World Health Organization Global tuberculosis report 2015. In: ORGANISATION, 
W. H. (ed.). 
  
 
 
232 
WHO 2016. World Health Organization Global Tuberculosis report 2016:Executive summary. 
In: PREVENTION, T. S. (ed.). 
  
WHO 2017. World Health Organization Global Tuberculosis Report 2017: Executive 
summary. In: PREVENTION. 
  
WHO, G. 2010. Guidelines for treatment of tuberculosis. WHO Press Geneva, Switzerland.  
 
WILLIAMS, A., JAMES, B. W., BACON, J., HATCH, K. A., HATCH, G. J., HALL, G. A. & MARSH, P. 
D. 2005. An assay to compare the infectivity of Mycobacterium tuberculosis isolates based 
on aerosol infection of guinea pigs and assessment of bacteriology. Tuberculosis, 85, 177-
184. 
 
WILSON, G.S., 1943. The pasteurization of milk. British Medical Journal, 1(4286), p.261.  
WIRTH, T., HILDEBRAND, F., ALLIX-BÉGUEC, C., WÖLBELING, F., KUBICA, T., KREMER, K., VAN 
SOOLINGEN, D., RÜSCH-GERDES, S., LOCHT, C. & BRISSE, S. 2008a. Origin, spread and 
demography of the Mycobacterium tuberculosis complex. PLoS Pathog, 4, e1000160. 
 
WITNEY, A. A., COSGROVE, C. A., ARNOLD, A., HINDS, J., STOKER, N. G. & BUTCHER, P. D. 
2016. Clinical use of whole genome sequencing for Mycobacterium tuberculosis. BMC 
Medicine, 14, 1. 
  
WOHL, S., SCHAFFNER, S. F. & SABETI, P. C. 2016. Genomic Analysis of Viral Outbreaks. 
Annual Review of Virology, 3, 173-195. 
  
WONG, K.-C. & ZHANG, Z. 2014. SNPdryad: predicting deleterious non-synonymous human 
SNPs using only orthologous protein sequences. Bioinformatics, 30, 1112-1119. 
 
WORLD HEALTH ORGANISATION: JIM YONG KIM, A. S., ARACHU CASTRO, CHRIS VANDE, 
PAUL FARMER. 2017. Tuberculosis control [Online]. Available: 
http://www.who.int/trade/distance_learning/gpgh/gpgh3/en/index7.html. 
  
WORLD ORGANISATION OF ANIMAL HEALTH, F. A. A. O. O. T. U. N., International Union 
Against Tuberculosis and Lung Disease 2016. zoonotic tb. In: world health organisation, w. o. 
o. a. h., food and agriculture organisation of the united nations, international union against 
tuberculosis and lung disease (ed.).  
  
XIA, E., TEO, Y.-Y. & ONG, R. T.-H. 2016. SpoTyping: fast and accurate in silico 
Mycobacterium spoligotyping from sequence reads. Genome Medicine, 8, 19. 
 
YEBOAH-MANU, D., ASARE, P., ASANTE-POKU, A., OTCHERE, I.D., OSEI-WUSU, S., DANSO, E., 
FORSON, A., KORAM, K.A. AND GAGNEUX, S., 2016. Spatio-temporal distribution of 
Mycobacterium tuberculosis complex strains in Ghana. PloS one, 11(8), p.e0161892. 
YEBOAH-MANU, D., ASANTE-POKU, A., BODMER, T., STUCKI, D., KORAM, K., BONSU, F., 
PLUSCHKE, G. AND GAGNEUX, S., 2011. Genotypic diversity and drug susceptibility patterns 
among M. tuberculosis complex isolates from South-Western Ghana. PloS one, 6(7), 
p.e21906. 
 
 
233 
YIMER, S. A., NORHEIM, G., NAMOUCHI, A., ZEGEYE, E. D., KINANDER, W., TØNJUM, T., 
BEKELE, S., MANNSÅKER, T., BJUNE, G. & ASEFFA, A. 2015. Mycobacterium tuberculosis 
lineage 7 strains are associated with prolonged patient delay in seeking treatment for 
pulmonary tuberculosis in amhara region, Ethiopia. Journal of Clinical Microbiology, 53, 
1301-1309. 
  
YOUNG, R. A., MEHRA, V. & SWEETSER, D. 1985. Leprosy parasite Mycobacterium leprae. 
Nature, 316, 65K. 
 
ZACHARIAH, R., SPIELMANN, M.P., HARRIES, A.D., GOMANI, P., GRAHAM, S.M., BAKALI, E. 
AND HUMBLET, P., 2003. Passive versus active tuberculosis case finding and isoniazid 
preventive therapy among household contacts in a rural district of Malawi. The international 
journal of tuberculosis and lung disease, 7(11), pp.1033-1039. 
 
 
 
 
234 
Appendix 
Figure PH1: The figure below shows an un-rooted phylogeny of all isolates originally included in the cgMLST analysis and is the origin of the subset 
phylogeny presented in figure 3.6, chapter 3. Clades are colour coordinated to the lineages present within them with Welsh isolates individually 
coloured in red.  
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Table PH1: Below is a conclusion table showing the phylogenetic classification`s across all methods described in chapter 3 for each isolate. Classical 
grouping refers to both the Principal Genetic Group and SNP cluster group assignments. The further most right column shows whether the isolate has 
outbreak or background status. The bottom section highlights those isolates whereby phylogenetic classification for certain methods could not be 
completed due to lack of sequence data, “X” = no phylogenetic assignment possible. 
Isolate Classical grouping cgMLST association  SNP barcode Clinical Status 
BK22 1 SCG 1 Indo-oceanic(Baku et al.) Indo-oceanic(Baku et al.) Indo-oceanic(EAI3;EAI5) Background 
LL9 1 SCG 2 Beijing(2) Beijing(2) Beijing Background 
BK25 1 SCG 2 Beijing(2) Beijing(2) Beijing Background 
BK21 1 SCG 2/3a Beijing(2)* Beijing(2) Beijing Background 
LL5 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Outbreak isolate 
LL8 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Outbreak isolate 
BK23 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Background 
BK10 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Background 
BK11 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Background 
TH1 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Outbreak isolate 
TH2 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Outbreak isolate 
GO1 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Outbreak isolate 
GO2 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Outbreak isolate 
GO3 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Outbreak isolate 
GO4 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Outbreak isolate 
GO5 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Outbreak isolate 
GO6 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Outbreak isolate 
GO7 2 SCG 3b Euro-american(4) Euro-american(4) Haarlem(T1;H1) Outbreak isolate 
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GO8 2 SCG 3c Euro-american(4) Euro-american(4) X family(X2) Outbreak isolate 
LL11 2 SCG 3c Euro-american(4) Euro-american(4) X family(Baku et al.) Outbreak isolate 
BK14 2 SCG 3c Euro-american(4) Euro-american(4) X family (Baku et al.) Background 
BK15 2 SCG 3c Euro-american(4) Euro-american(4) X family(Baku et al.) Background 
BK12 2 SCG 3c Euro-american(4) Euro-american(4) X family(X2) Background 
BK13 2 SCG 3c Euro-american(4) Euro-american(4) X family(X2) Background 
NPTB6 2 SCG 4 Euro-american(4) Euro-american(4) X family(X1;X3) Outbreak isolate 
LL1 2 SCG 4 Euro-american(4) Euro-american(4) X family(X1;X3) Outbreak isolate 
LL3 2 SCG 4 Euro-american(4) Euro-american(4) X family(X1;X3) Outbreak isolate 
LL4 2 SCG 4 Euro-american(4) Euro-american(4) X family(X1;X3) Outbreak isolate 
BK18 2 SCG 4 Euro-american(4) Euro-american(4) X family(X1;X3) Background 
BK16 2 SCG 4 Euro-american(4) Euro-american(4) X family(X1;X3) Background 
BK17 2 SCG 4 Euro-american(4) Euro-american(4) X family(X1;X3) Background 
BK8 2 SCG 5 Euro-american(4) Euro-american(4) Latin American Mediterranean Background 
BK20 2 SCG 5 Euro-american(4) Euro-american(4) Latin American Mediterranean Background 
BK9 2 SCG 5 Euro-american(4) Euro-american(4) Latin American Mediterranean Background 
LL10 2 SCG 6 Euro-american(4)* Euro-american(4) X family(X1;X3) Outbreak isolate 
BK19 3 SCG 6 Euro-american(4)* Euro-american(4) T family Background 
NPTB5 3 SCG 6a Euro-american(4) Euro-american(4) T family Outbreak isolate 
NPTA8 3 SCG 6a Euro-american(4) Euro-american(4) T family Outbreak isolate 
NPTA6 3 SCG 6a Euro-american(4)* Euro-american(4) T family Outbreak isolate 
NPTA7 3 SCG 6a Euro-american(4) Euro-american(4) T family Outbreak isolate 
NPTA4 3 SCG 6a Euro-american(4) Euro-american(4) T family Outbreak isolate 
NPTA5 3 SCG 6a Euro-american(4) Euro-american(4) T family Outbreak isolate 
NPTB4 3 SCG 6a Euro-american(4) Euro-american(4) T family Outbreak isolate 
 
 
237 
NPTB1 3 SCG 6a Euro-american(4) Euro-american(4) T family Outbreak isolate 
NPTA2 3 SCG 6a Euro-american(4) Euro-american(4) T family Outbreak isolate 
NPTA3 3 SCG 6a Euro-american(4) Euro-american(4) T family Outbreak isolate 
NPTA1 3 SCG 6a Euro-american(4) Euro-american(4) T family Outbreak isolate 
BK1 3 SCG 6a Euro-american(4) Euro-american(4) T family Background 
BK2 3 SCG 6a Euro-american(4) Euro-american(4) T family Background 
BK3 3 SCG 6a Euro-american(4) Euro-american(4) T family Background 
NPTB3 3 SCG 6a Euro-american(4) Euro-american(4) T family Outbreak isolate 
NPTB2 3 SCG 6a Euro-american(4) Euro-american(4) T family Outbreak isolate 
BK4 3 SCG 6b Euro-american(4) Euro-american(4) H37Rv-like Background 
BK5 3 SCG 6b Euro-american(4) Euro-american(4) H37Rv-like Background 
BK6 3 SCG 6b Euro-american(4)* Euro-american(4) H37Rv-like Background 
BK7 3 SCG 6b Euro-american(4) Euro-american(4) H37Rv-like Background 
H37Rv 3 SCG 6b Euro-american(4) Euro-american(4) H37Rv Reference 
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With missing data 
Isola
te 
PG
G SCG Lineage Lineage  
Sublineag
e 
Outbreak/Backgr
ound 
BK24 X SCG 3b 
Euro-
american(4) 
Euro-
american(4) T family Background 
BK26 X 
SCG 
3b/c X X X Background 
GO9 X SCG 3c 
Euro-
american(4)* 
Euro-
american(4) X family(X2) Outbreak isolate 
BK27 X SCG 3c X X X Background 
LL2 X SCG 4 
Euro-
american(4) 
Euro-
american(4) 
X 
family(X1;X
3) Outbreak isolate 
LL7 X SCG 4 X X X Outbreak isolate 
NPTB
7 X SCG 6 X X X Outbreak isolate 
BK28 X SCG 6 X X X Background 
BK29 X SCG 6 X X X Background 
*represents isolates that could not be confidently assigned to a lineage by cgMLST 
association. 
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Table PH2a and PH2b (below): Tables showing the full SNP pattern of 48 loci identified in the Mestre et al (2011) study and used to construct figure 3.7. 
For both tables PH2a and PH2b, the first line indicates the gene and the second line indicates the position on that gene where polymorphisms were 
identified in relation to M. tuberculosis H37Rv strain for Beijing genotype classification. Due to the large amount of data, two separate tables are 
presented with table PH2a providing the pattern across first 23 positions and PH2b providing the pattern across the remaining 25 positions. 
Polymorphisms that characterize and allow the discrimination of the 26 sequence types defined previously, those with the prefix “Bmyc”, are highlighted 
in red. Also included in the table are the Welsh Beijing isolates (in red) LL9, BK21, BK25 and the control isolates (in blue):  H (Haarlem strain), BK4 (non-
Beijing welsh strain) and the reference strain H37Rv. 
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 PH2a ligD radA recF recX dnaQ recR recG uvrC 
Isolate 485 1030 1038 1738 456 557 827 734 807 23 175 458 227 263 483 631 130 267 853 496 865 1164 1301 
LL9 A C C C A T T C G C C G A T C T T C C C A G c 
BK21 A C C C A T T C G C G G A T C T T C C C A G c 
BK25 A C C C A T T C G C C G A T C T T C C C A G c 
H A C C C A T T C G C G G G T C T G C C C G G T 
BK4 A T C C G T T T G C G G G T C G G C C C G G T 
H37Rv A T C C G T T T G C G G G T C G G C C C G G T 
BmyC1 A C C C A T T C G C G G A T C T G C C C A G C 
BmyC2 A C C T A T T C G C G G A T C T G C C C A G C 
BmyC3 C C C T A T T C G C G G A T C T G C C C A G C 
BmyC4 A C C C A T T C G C G G A T C T T C C C A G C 
BmyC5 A C T C A T T C G C G G A T C T T C C C A C C 
BmyC6 A C C C A T T C G C G G A T C T T C C C A G C 
BmyC7 A C C C A T T C G C G G A T C T T C C A A G C 
BmyC8 A C C C A T T C G T G G A T C T T C C C A G C 
BmyC9 A C C C A T T C G C C G A T C T T C T C A G C 
BmyC10 A C C C A T T C G C C G A T C T T C C C A G C 
BmyC11 A C C C A T T C G C C G A T C T T T C C A G C 
BmyC12 A C C C A T T C T C C G A T C T T C C C A G C 
BmyC13 A C C C A T T C G C C G A T C T T C C C A G C 
BmyC14 A C C C A T T C G C C G A T T T T C C C A G C 
BmyC15 A C C C A T T C G C C G A T C T T C C C A G C 
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BmyC16 A C C C A T T C G C C G A T C T T C C C A G C 
BmyC17 A C C C A T T C G C C G A T C T T C C C A G C 
BmyC18 A C C C A T T C G C C G A T C T T C C C A G C 
BmyC19 A C C C A T T C G C C G A T C T T C C C A G C 
BmyC20 A C C C A T C C G C C A A T C T T C C C A G C 
BmyC21 A C C C A T C C G C C A A T C T T C C C A G C 
BmyC22 A C C C A T T C G C C G A T C T T C C C A G C 
BmyC23 A C C C A C T C G C C G A T C T T C C C A G C 
BmyC2C A C C C A T T C G C C G A T C T T C C C A G C 
BmyC25 A C C C A T T C G C G G A T C T T C C C A G C 
BmyC26 A C C C A T T C G C C G A T C T T C C C A G C 
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 PH2b 
ruv
B 
ligB recD tagA 
uvrD
1 
dnaZX 
ne
i 
nth alkA ligC 
mutT
2 
ogt mutT4 
rv297
9 
Isolate 843 
23
0 
27
1 
36
0 
41
6 
83
1 
53
7 
38
5 
1384 
27
4 
29
1 
22
9 
5 
10
1 
36
5 
3
1 
3
4 
63
0 
93
8 
172 
3
6 
11
0 
14
2 
29
7 
41 
LL9 G T T C T G C G G C T A G A T G G C A C A G G G G 
BK21 G T T C T G C G G C T A G A T G G C A G G T G G G 
BK25 G T T C T G C G G C T A G A T G G C A C A G G G G 
H G T T A T G C G G C C A C A T G A G A G G G C G C 
BK4 G T C A T G C G G C C A C A T G A G G G G G C G C 
H37Rv A T C A G G C G G C C A C A T G A G G G G G C G C 
BmyC1 G T T C G G C G G C T C G A T G G C A G G G C G G 
BmyC2 G T T C G G C G G C T C G A T G G C A G G G C G G 
BmyC3 G T T C G G C G G C T C G A T G G C A G G G C G G 
BmyC4 G T T C G G C G G C T C G A T G G C A G G G C G G 
BmyC5 G T T C G G C G G C T C G A T G G C A G G G C G G 
BmyC6 G T T C G G C G G C T C G A T G G C A G G G G G G 
BmyC7 G T T C G G C G G C T C G A T G G C A G G T G G G 
BmyC8 G T T C G G C G G C T C G A T G G C A G G G G G G 
BmyC9 G T T C G G C G G C T C G A T G G C A G G G G G G 
BmyC10 G T T C G G C G G C T C G A T G G C A C A G G G G 
BmyC11 G T T C G G C G G C T C G A T G G C A C A G G G G 
BmyC12 G T T C G G C G G C T C G A T G G C A C A G G G G 
BmyC13 G T T C G G C G A C T C G A T G G C A C A G G G G 
BmyC14 G C T C G G C G A C T C G A T G G C A C A G G G G 
BmyC15 G T T C G G C G G C T C G A G G G C A C A G G G G 
BmyC16 G T T C G G C G G T T C G A T G G C A C A G G G G 
BmyC17 G T T C G G C G G C T C G C T G G C A C A G G G G 
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BmyC18 G T T C G G C G G C T C G A T A G C A C A G G G G 
BmyC19 G T T C G G C A G C T C G A T G G C A C A G G A G 
BmyC20 G T T C G G C G G C T C G A T G G C A C A G G G G 
BmyC21 G T T C T G C G G C T C G A T G G C A C A G G G G 
BmyC22 G T T C G A C G G C T C G A T G G C A C A G G G G 
BmyC23 G T T C G G C G G C T C G A T G G C A C A G G G G 
BmyC2
C 
G T T C G G T G G C T C G A T G G C A C A G G G G 
BmyC25 G T T C G G C G G C T C G A T G G C A G G T G G G 
BmyC26 G T T C G G C G G C T C G A T G G C A G G G G G G 
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Table PH3a: A distance matrix based on the number of polymorphisms across the 48 defined in the Mestre et al (2011) study. The more red the cell, the higher the 
number of polymorphisms there are between any two given isolates. The bluer the cell the closer the lesser number of polymorphisms between any two given isolates.  
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BK25 0 4  13 19 21 7 8 9 6 8 5 7 6 5 2 3 3 3 5 3 3 3 3 4 4 3 3 3 3 6 4 
H 13 11 13  6 8 10 11 12 11 13 12 14 13 14 15 16 16 16 18 16 16 16 16 17 17 16 16 16 16 13 13 
BK4 19 17 19 6  2 16 17 18 17 19 18 20 19 20 21 22 22 22 24 22 22 22 22 23 23 22 22 22 22 19 19 
H37Rv 21 19 21 8 2  16 17 18 17 19 18 20 19 20 21 22 22 22 24 22 22 22 22 23 23 24 22 22 22 19 19 
BmyC1 7 5 7 10 16 16  1 2 1 3 2 4 3 4 5 6 6 6 8 6 6 6 6 7 7 8 6 6 6 3 3 
BmyC2 8 6 8 11 17 17 1  1 2 4 3 5 4 5 6 7 7 7 9 7 7 7 7 8 8 9 7 7 7 4 4 
BmyC3 9 7 9 12 18 18 2 1  3 5 4 6 5 6 7 8 8 8 10 8 8 8 8 9 9 10 8 8 8 5 5 
BmyC4 6 4 6 11 17 17 1 2 3  2 1 3 2 3 4 5 5 5 7 5 5 5 5 6 6 7 5 5 5 2 2 
BmyC5 8 6 8 13 19 19 3 4 5 2  3 5 4 5 6 7 7 7 9 7 7 7 7 8 8 9 7 7 7 4 4 
BmyC6 5 3 5 12 18 18 2 3 4 1 3  2 1 2 3 4 4 4 6 4 4 4 4 5 5 6 4 4 4 1 1 
BmyC7 7 3 7 14 20 20 4 5 6 3 5 2  3 4 5 6 6 6 8 6 6 6 6 7 7 8 6 6 6 1 3 
BmyC8 6 4 6 13 19 19 3 4 5 2 4 1 3  3 4 5 5 5 7 5 5 5 5 6 6 7 5 5 5 2 2 
BmyC9 5 5 5 14 20 20 4 5 6 3 5 2 4 3  3 4 4 4 6 4 4 4 4 5 5 6 4 4 4 3 1 
BmyC10 2 6 2 15 21 21 5 6 7 4 6 3 5 4 3  1 1 1 3 1 1 1 1 2 2 3 1 1 1 4 2 
BmyC11 3 7 3 16 22 22 6 7 8 5 7 4 6 5 4 1  2 2 4 2 2 2 2 3 3 4 2 2 2 5 3 
BmyC12 3 7 3 16 22 22 6 7 8 5 7 4 6 5 4 1 2  2 4 2 2 2 2 3 3 4 2 2 2 5 3 
BmyC13 3 7 3 16 22 22 6 7 8 5 7 4 6 5 4 1 2 2  2 2 2 2 2 3 3 4 2 2 2 5 3 
BmyC14 5 9 5 18 24 24 8 9 10 7 9 6 8 7 6 3 4 4 2  4 4 4 4 5 5 6 4 4 4 7 5 
BmyC15 3 7 3 16 22 22 6 7 8 5 7 4 6 5 4 1 2 2 2 4  2 2 2 3 3 4 2 2 2 5 3 
BmyC16 3 7 3 16 22 22 6 7 8 5 7 4 6 5 4 1 2 2 2 4 2  2 2 3 3 4 2 2 2 5 3 
BmyC17 3 7 3 16 22 22 6 7 8 5 7 4 6 5 4 1 2 2 2 4 2 2  2 3 3 4 2 2 2 5 3 
BmyC18 3 7 3 16 22 22 6 7 8 5 7 4 6 5 4 1 2 2 2 4 2 2 2  3 3 4 2 2 2 5 3 
BmyC19 4 8 4 17 23 23 7 8 9 6 8 5 7 6 5 2 3 3 3 5 3 3 3 3  4 5 3 3 3 6 4 
BmyC20 4 8 4 17 23 23 7 8 9 6 8 5 7 6 5 2 3 3 3 5 3 3 3 3 4  1 3 3 3 6 4 
BmyC21 3 7 3 16 22 24 8 9 10 7 9 6 8 7 6 3 4 4 4 6 4 4 4 4 5 1  4 4 4 7 5 
BmyC22 3 7 3 16 22 22 6 7 8 5 7 4 6 5 4 1 2 2 2 4 2 2 2 2 3 3 4  2 2 5 3 
BmyC23 3 7 3 16 22 22 6 7 8 5 7 4 6 5 4 1 2 2 2 4 2 2 2 2 3 3 4 2  2 5 3 
BmyC24 3 7 3 16 22 22 6 7 8 5 7 4 6 5 4 1 2 2 2 4 2 2 2 2 3 3 4 2 2  5 3 
BmyC25 6 2 6 13 19 19 3 4 5 2 4 1 1 2 3 4 5 5 5 7 5 5 5 5 6 6 7 5 5 5  2 
BmyC26 4 4 4 13 19 19 3 4 5 2 4 1 3 2 1 2 3 3 3 5 3 3 3 3 4 4 5 3 3 3 2  
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Table PH3b: A subset of the distance matrix seen above, highlighting the number of SNP`s, across the 48 
previously defined loci, between only those isolates most closely related to the Welsh isolates LL9, BK21 
and BK25. 
Table PH3b 
Isolates LL9 BK21 BK25 
Closest relative BmyC10 BmyC25 BmyC10 
Number of SNP`s 2 2 2 
 
The figure below highlights the genomic relationship between LL10 and the outbreak 
associated isolates defined in the original cgMLST analysis within chapter 4, figure 4.3. The 
minimum spanning tree was constructed on only the 1446 core genes that could be 
successfully aligned between LL10 and the cgMLST scheme defined in method section 2.3.1.  
The figure below shows that LL10 shares 3 allelic differences with both LL1 and LL4, equal to 
the divergence seen with LL3, more than the divergence seen with LL2 and less than the 
divergence seen between NPTB6 and isolates LL1 and LL4. Although not analysed using the full 
compliment, the analysis here across 1466 core genes shows LL10 to have less than the 12 
allelic differences with its closet relative and thus supports original epidemiological data which 
postulated that LL10 may be part of the Llwynhendy outbreak. This result suggests that further 
analysis of LL10 should be carried out to ascertain whether the close genomic relationship is 
replicated when the full complement of the cgMLST scheme is analysed.  
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Figure LL1: A minimum spanning tree based on 1466 core genes successfully aligned to the cgMLST scheme. Those isolates defined as outbreak related 
in the original cgMLST analysis in section 4, figure 4.3, are coloured green with LL10 coloured pink. 
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Table LL1: Distance matrix showing the number of allelic differences between all isolates defined in Figure 4.3. The distance matrix below correlates to 
figure and includes isolates that exceeded the 12 allelic dif ferences threshold and thus were not outbreak associated. The greater the red intensity the 
more different the isolates are from each other. The greater the intensity of blue in the cells the more closely related the isolates are. 
Isolates GO8 NPTB6 LL1 LL2 LL3 LL4 LL5 LL8 LL9 LL11 
GO8 0 246 245 238 243 248 275 307 573 266 
NPTB6 246 0 7 13 10 12 294 328 570 268 
LL1 245 7 0 8 2 4 296 327 585 266 
LL2 238 13 8 0 11 13 285 311 554 253 
LL3 243 10 2 11 0 6 296 325 579 267 
LL4 248 12 4 13 6 0 296 330 581 267 
LL5 275 294 296 285 296 296 0 201 529 297 
LL8 307 328 327 311 325 330 201 0 564 329 
LL9 573 570 585 554 579 581 529 564 0 561 
LL11 266 268 266 253 267 267 297 329 561 0 
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Table PH4: A table showing the % probability that 
each isolate is associated with a given lineage. 
Isolate 
Lineage 
4 
Lineage 
3 
Lineage 
2  
Lineage 
1 
NPTB5 100% 0% 0% 0% 
NPTA8 100% 0% 0% 0% 
NPTA6 9% 2% 0% 89% 
NPTA7 100% 0% 0% 0% 
NPTA4 100% 0% 0% 0% 
NPTA5 100% 0% 0% 0% 
GO8 100% 0% 0% 0% 
GO9 1% 3% 0% 96% 
NPTB4 100% 0% 0% 0% 
NPTB1 100% 0% 0% 0% 
NPTA2 100% 0% 0% 0% 
NPTA3 100% 0% 0% 0% 
NPTA1 100% 0% 0% 0% 
NPTB6 100% 0% 0% 0% 
LL1 100% 0% 0% 0% 
LL2 100% 0% 0% 0% 
LL3 100% 0% 0% 0% 
LL4 100% 0% 0% 0% 
LL5 100% 0% 0% 0% 
LL8 100% 0% 0% 0% 
LL9 0% 0% 100% 0% 
LL10 0% 23% 0% 77% 
LL11 100% 0% 0% 0% 
BK4 100% 0% 0% 0% 
BK8 100% 0% 0% 0% 
BK14 100% 0% 0% 0% 
BK5 100% 0% 0% 0% 
BK20 100% 0% 0% 0% 
BK18 100% 0% 0% 0% 
BK10 100% 0% 0% 0% 
BK6 0% 10% 0% 90% 
BK15 100% 0% 0% 0% 
BK9 100% 0% 0% 0% 
BK19 0% 3% 0% 97% 
BK1 100% 0% 0% 0% 
BK12 100% 0% 0% 0% 
BK21 75% 2% 16% 7% 
BK7 100% 0% 0% 0% 
BK13 100% 0% 0% 0% 
BK16 100% 0% 0% 0% 
BK2 100% 0% 0% 0% 
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BK11 100% 0% 0% 0% 
BK22 0% 0% 0% 100% 
BK3 100% 0% 0% 0% 
BK25 9% 24% 5% 63% 
BK17 100% 0% 0% 0% 
TH1 100% 0% 0% 0% 
GO6 100% 0% 0% 0% 
GO7 100% 0% 0% 0% 
NPTB3 100% 0% 0% 0% 
NPTB2 100% 0% 0% 0% 
TH2 100% 0% 0% 0% 
GO1 100% 0% 0% 0% 
GO2 100% 0% 0% 0% 
GO3 100% 0% 0% 0% 
GO4 100% 0% 0% 0% 
GO5 100% 0% 0% 0% 
 
